びまん性肺疾患の臨床　第4版

出版社： 金芳堂
著者：
発行日： 2012-07-25
分野： 臨床医学：内科  >  呼吸器一般
ISBN： 9784765315326
電子書籍版： 2012-07-25 （第4版第2刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

16,500 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

16,500 円(税込)

購入する

商品紹介

今回の改訂においても、第3版を踏襲し、「総論」「各論」「症例編」に分け、それぞれ詳しく記載した。総論においても、診断面ではCT所見と病理組織所見の対比の結果、画像所見だけで臨床診断を行うことがより容易になったこと、また新しい免疫学的抑制薬、生物学的製剤についても記されている。各論では膠原病の肺病変について詳細な研究成果を、 症例編では、37例をあげ、以前では鑑別診断の対象疾患にもなかったような疾患も記載されている。

目次

  • びまん性肺疾患の臨床　第4版

    ―目次―

    総論
    　総論1　びまん性肺疾患 ―概念，研究の歴史，今後の課題―
    　総論2　びまん性肺疾患の診断
    　総論3　びまん性肺疾患の診断：画像検査
    　総論4　肺機能検査
    　総論5　臨床検査・血液検査
    　総論6　気管支鏡検査
    　総論7　病理組織学的検査
    　総論8　びまん性肺疾患の管理と治療

    各論
    　各論1　特発性間質性肺炎
    　各論2　特発性間質性肺炎（IIPs）の各論
    　各論3　稀なIIPs/組織パターン，未分類IIPs
    　各論4　膠原病
    　各論5　膠原病に伴う肺病変
    　各論6　サルコイドーシス
    　各論7　過敏性肺炎・慢性過敏性肺炎
    　各論8　職業性肺疾患
    　各論9　薬剤性肺炎
    　各論10　好酸球性肺炎
    　各論11　肺血管炎
    　各論12　びまん性肺胞出血
    　各論13　肺塞栓・梗塞
    　各論14　ARDS
    　各論15　悪性腫瘍とリンパ球細胞増殖性疾患の臨床的側面
    　各論16　肺胞蛋白症
    　各論17　ランゲルハンス細胞組織球症
    　各論18　リンパ脈管筋腫症
    　各論19　気管・気管支・肺アミロイドーシス
    　各論20　肺胞微石症
    　各論21　誤嚥性肺炎・びまん性誤嚥性細気管支炎
    　各論22　肺感染症
    　各論23　慢性細気管支炎，閉塞性細気管支炎，
    　　　　　　びまん性気管支拡張症
    　各論24　肺気腫と気腔開大性肺疾患
    　各論25　肺高血圧症

    症例
    　症例1　亜急性に進行し，器質化肺炎の目立つびまん性肺疾患を
    　　　　　呈したperipheral T cell lymphoma，unspecifiedの一例
    　症例2　関節リウマチに合併した慢性細気管支炎に加わった
    　　　　　マイコプラズマ細気管支炎
    　症例3　多中心性キャッスルマン病(multicentric Castleman’s
    　　　　　disease)に合併した肺硝子様化肉芽腫
    　　　　　(pulmonary hyalinizing granuloma)
    　症例4　肺門リンパ節腫大により中枢部の肺動脈狭窄を起こし，
    　　　　　肺動脈圧上昇をきたしたサルコイドーシスの一例
    　症例5　縦隔の肉芽腫性炎症・線維化により，中枢部の肺動脈
    　　　　　狭窄と肺動脈圧上昇をおこしたサルコイドーシスの一例
    　ほか

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

総論

P.8 掲載の参考文献
1) 泉孝英 : びまん性肺疾患とは, 総合臨牀 37 : 2549-2552, 1988.
 
2) DeRemee RA : Clinical Profiles of Diffuse Infiltrative Diseases. Futura Publishing Co. Inc, Mount Kisco, 1990. (長井苑子訳, 泉孝英監訳 : びまん性肺疾患のマネージメント. 金芳堂, 1991.)
 
3) Flint A, Colby TV : Surgical Pathology of Diffuse Infiltrative Diseases. Grune & Stration, Orlando, 1987. (泉孝英, 北市正則監訳 : びまん性肺疾患の生検診断. 金芳堂, 1989.)
 
4) Katzenstein A-L A : Katzenstein and As kin's Surgical Pathology of Non-neoplastic Lung Diseases 3rd ed. WB Saunders, Philadelphia, 1997.
 
5) Comroe JH Jr, Forster RE II, Dubois AB, Briscoe WA, Carlsen F 著, 村尾誠訳 : 肺臨床生理学と肺機能検査法. 医歯薬出版, 1956.
 
6) Comroe JH編 本間日臣, 原沢道美, 吉田清一共訳 : 肺機能検査法. 医歯薬出版, 1957.
 
7) Costabel U : Atlas der Bronchoalveolren Lavage. Georg thieme Verlag, Stuttgart, 1994. (長井苑子, 泉孝英監訳 : 気管支肺胞洗浄〔BAL〕アトラス. 金芳堂, 1995.)
 
8) ATS/ERS/WASOG statement on sarcoidosis. Am J Respir Crit Care Med 160 : 736-755, Eur Resir J ; 14 : 735-737, Sarcoidosis Vasc Diffuse Lung Dis 16 : 149-173, 1999. (邦訳 : 長井苑子, 泉孝英監訳 : ATS 間質性肺疾患ガイドライン. サルコイドーシス, 特発性間質性肺炎, 特発性肺線維症. 医学書院, 2003.)
 
9) ATS/ERS : Idiopathic pulmonary fibrosis : diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 161 : 646-664, 2000. (邦訳 : 長井苑子, 泉孝英監訳 : ATS 間質性肺疾患ガイドライン. サルコイドーシス, 特発性間質性肺炎, 特発性肺線維症. 医学書院, 2003.)
 
10) ATS/ERS International multidisciplinary consensus classification of idiopathic interstitial pneumonia. Am J Respir Crit Care Med : 277-304, 2002. (邦訳 : 長井苑子, 泉孝英監訳 : ATS 間質性肺疾患ガイドライン. サルコイドーシス, 特発性間質性肺炎, 特発性肺線維症. 医学書院, 2003.)
 
11) Raghu G, Collard HR, Egan JJ, et al : ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement : idiopathic pulmonary fibrosis : evidencebased guidelines for diagnosis and management. Am J Respir Crit Care Med 15 : 183 : 788-824, 2011.
 
12) Morimoto T, Azuma A, Abe S, et. al : Epidemiology of sarcoidosis in Japan. Eur Respir J 31 : 372-379, 2008.
 
13) Baughman RP, Teirstein AS, Judson MA, et al : Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164 (10 Pt 1) : 1885-1889, 2001.
 
14) Baughman RP, Nagai S, Balter M, et al : Defining the clinical outcome status (COS) in sarcoidosis : results of WASOG Task Force. Sarcoidosis Vasc Diffuse Lung Dis 28 : 56-64, 2011.
 
15) Nagai S, Handa T, Ito Y, et al. Outcome of sarcoidosis. Clin Chest Med 29 : 565-574, 2008 ;
PubMed
16) 泉孝英 : 特発性肺線維症の臨床. 日内会誌 84 : 1396-1406, 1995.
 
17) Crystal RG, Fulmer GD, Roberts RC, et al : Idiopathic pulmonary fibrosis : Clinical, histlogic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med 85 : 769-788, 1976.
 
18) Harasawa M, Fukuchi Y, Morinari H ed : Interstitial Pneumonia of Unknown Etiology. University of Tokyo Press, Tokyo, 1989.
 
19) 安藤正幸, 近藤有好, 佐藤篤彦, 他編 : 間質性肺炎の病態と治療-厚生省特定疾患調査研究班の成果と最近の動向. 診療新社.
 
20) 泉孝英 : IIPとIPFの鑑別診断. 呼吸 ; 18 : 201-207, 334-341, 1999.
 
21) 泉孝英 : 繊維化性間質性肺炎-特発性間質性肺炎・肺線維症を中心に-. 日胸疾会誌 27 : 1268-1273, 1989.
 
22) 日本呼吸器学会びまん性肺疾患診断・治療ガイドライン作成委員会編集 特発性間質性肺炎診断と治療の手引き 改定第2版. 南江堂, 2011.
 
23) King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011 Jun 28.
 
24) Marmai C, Sutherland RE, Kim KK, et al : Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 301 : L71-78, 2011.
PubMed
25) Nagai S, Kitaichi M, Itoh H, et al : Idiopathic nonspecific interstitial pneumonia/fibrosis. comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 12 : 1010-1019, 1998.
PubMed
26) Bjoraker JA, Ryu JH,Edwin MK, et al : Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 157 : 199-203, 1998.
PubMed
27) Nagai S, Handa T, Tabuena R, et al : Nonspecific interstitial pneumonia : a real clinical entity? Clin Chest Med 25 : 705-715, 2004.
PubMed
28) Kim DS, Nagai S. Idiopathic nonspecific interstitial pneumonia : an unrecognized autoimmune disease? Am J Respir Crit Care Med 176 : 632-633, 2007.
PubMed
29) Travis WD, Hunninghake G, King TE Jr, ; American Thoracic Society : Idiopathic nonspecific interstitial pneumonia : report of an American Thoracic Society project. Am J Respir Crit Care Med 15 : 177 : 1338-1347, 2008.
 
30) Kinder BW, Collard HR, Koth L, et al : Idiopathic nonspecific interstitial pneumonia : lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med. 2007 Oct 1 ; 176 : 691-697 ; Epub 2007 Jun 7.
 
31) Hamada K, Nagai S, Tanaka S,et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest. 131 : 650-656, 2007.
PubMed
32) King TE Jr, Tooze JA, Schwarz MI, et al. Predicting survival in idiopathic pulmonary fibrosis : scoring system and survival model. Am J Respir Crit Care Med 164 : 1171, 2001.
PubMed
33) Spain DM : Patterns of pulmonary fibrosis as related to pulmonary function. Ann Intern Med 33 : 1150-1163, 1950.
PubMed
34) Nagai S, Nagao T, Hoshino Y : Heterogeneity of pulmonary fibrosis : interstitial pneumonia and sarcoidosis. Curr Opin in Pul Med 7 : 262-271, 2001.
 
P.14 掲載の参考文献
1) びまん性肺疾患研究会編 : びまん性肺疾患研究会119回の開催記録, びまん性肺疾患研究会事務局, 2008.
 
2) 長井苑子 : 初診外来でのスクリーニング, 長井苑子著, 間質性肺疾患の外来診療, 医学書院 : 5-23, 2007.
 
3) Wells AU, Nicholson AG, Hansell DM : Challenges in pulmonary fibrosis ・ 4 : Smoking-induced diffuse interstitial lung diseases. Thorax 62 : 904-910, 2007.
 
4) Cohen R, Velho V : Update on respiratory disease from coal mine and silica dust. Clin Chest Med 23 : 811-826, 2002.
PubMed
5) 長坂行雄 : 石綿 (アスベスト) 肺, 治療学 40 : 1207-1211, 2006.
Medical*Online
6) Mapel D, Coultas D : Disorders due to minerals other than silica, coal, and asbestos, and to metals. In Occupational disorders of the lung. Hendrick DJ, Sherwood Burge P, Beckett WS, Churg A. Ed. W. B. Saunders, London : 163-190, 2002.
 
7) Spurzem JR, Romberger DJ, Von Essen SG : Agricultural lung disease. Clin Chest Med 23 : 795-810, 2002.
PubMed
8) Nakashima K, Takeshita T, Morimoto K : Diagnosis and prevention of diseases induced by isocyanate. Environ Health Prev Med 7 : 40-46, 2002.
PubMed
9) 稲瀬直彦, 菅守隆, 田口善夫, 千田金吾 : 過敏性肺炎の診断と治療update (座談会) 呼吸 30 : 593-602, 2011.
 
10) Raghu G, Collard HR, Egan JJ, et al : An Official ATS/ERS/JRS/ALAT statement : idiopathic pulmonary fibrosis : evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183 : 788-824, 2011.
PubMed
11) Olson AL, Brown KK : Connective tissue disease-associated lung disorders. Eur Respir Mon, 46 : 225-250, 2009.
 
12) Flieder DB, Travis WD : Pathologic characteristics of drug-induced lung disease. Clin Chest Med 25 : 37-45, 2004.
PubMed
13) Steele MP, Speer MC, Loyd JE, et al : Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 172 : 1146-1152, 2005.
PubMed
14) 岡田文人, 安藤ゆみ子, 森宣 : 肺のリンパ腫, リンパ腫様肉芽腫症, 血管内リンパ腫, HTLV-1 関連肺病変のCT所見, 日本胸部臨床 70 : 552-559, 2011.
Medical*Online
15) Vasu TS, Cavallazzi R, Hirani A, et al : Clinical and radiologic distinctions between secondary bronchiolitis obliterans organaizing pneumonia and cryptogenic organizing pneumonia. Respir Care 54 : 1028-1032, 2009.
PubMed
16) 長坂行雄 : びまん性汎細気管支炎, 瀬良好澄監修, 三上理一郎, 北谷文彦, 泉孝英編, びまん性肺疾患の臨床, 金芳堂, 107-113, 1987.
 
17) Akira M, Kozuka T, Yamamoto S, et al : Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 178 : 372-378, 2008.
PubMed
18) Konishi K, Gibson KF, Lindell KO, et al : Gene expression profiles of acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 180 : 167-175, 2009.
PubMed
19) Nishiyama O, Taniguchi H, Kondoh Y, et al : A simple assessment of dyspnea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur Respir J 36 : 1067-1072, 2010.
PubMed
20) 保田昇平, 家田泰浩, 野村佳代, 他 : IPF (典型的間質性肺炎) のファインクラックは必ずしも吸気の終末ではない. 薬理と臨床 20 : 293-297, 2010.
 
21) 長澄人, 熊本牧子, 田村猛夏, 他 : 石綿肺と肺音-クラックルの有無と胸部X線所見の進展との関連性-. 薬理と臨床 21 : 189-191, 2011.
Medical*Online
22) St. John AC, Dorinsky PM : Cryptogenic bronchiolitis. Clin Chest Med 14 : 667-675, 1993.
 
23) Kanematsu T, Kitaichi M, Nishimura K, et al : Clubbing of the fingers and smooth-muscle proliferation in fibrotic changes in patients with idiopathic pulmonary fibrosis. Chest 105 : 339-342, 1994.
PubMed
P.22 掲載の参考文献
1) 日本呼吸器学会びまん性肺疾患-診断・治療ガイドライン作成委員会. 特発性間質性肺炎. 診断と治療の手引き. 南江堂, 東京 : 4-9, 2004.
 
2) 高橋雅士, 新田哲久, 高桜竜太郎, 他 : 末梢肺野解剖とHRCT. 臨床放射線 53 : 1-13, 2008.
 
3) Murata K, Takahashi M, Mori M, et al : Peribronchovascular interstitium of the pulmonary hilum : Normal and abnormal findings on thin-section electron-beam CT. Am J Roentgenol 166 : 309-312, 1996.
 
4) Murata K, Itoh H, Todo G, et al : Centrilobular lesions of the lung : demonstration by highresolution CT and pathological correlation. Radiology 161 : 641-645, 1986.
PubMed
5) Webb WR, Muller NL and Naidich eds : High-resolution CT of the lung, 4th ed. Lippincott and Williams & Wilkins, Philadelphia : 65-167, 2009.
 
6) Murata K, Khan A, Herman PG : Pulmonary parenchymal disease : Evaluation with high resolution CT. Radiology 170 : 629-635, 1989.
PubMed
7) 村田喜代史, 上甲剛, 村山貞之編 : 胸部のCT (第3版), メディカル・サイエンス・インターナショナル社, 東京 : 405-410, 2011.
 
8) Muller NL and Silva CIS : Imaging of the chest. Saunders, Philadelphia : 97-212, 2008.
 
P.28 掲載の参考文献
1) 日本呼吸器学会肺生理専門委員会 (編) : 呼吸機能検査ガイドライン-スパイロメトリー, フローボリューム曲線, 肺拡散能力-, 日本呼吸器学会. 2004.
 
2) 長坂行雄 : 外来でできるスパイロメトリー-使い方と結果の見方, 日医雑誌 138 : 2486-2490, 2010.
 
3) Nathan SD, Shlobin OA, Weir N, et al : Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest 140 : 221-229, 2011.
PubMed
4) Raghu G, Collard HR, Egan JJ, et al : An Official ATS/ERS/JRS/ALAT statement : idiopathic pulmonary fibrosis : evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183 : 788-824, 2011.
PubMed
5) Ley B, Collard HR, King TE Jr. : Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183 : 431-440, 2011.
PubMed
6) Nicholson AG, Fulford LG, Colby TV, et al : The Relationship between Individual Histologic Features and Disease Progression in Idiopathic Pulmonary Fibrosis. Am. J. Respir. Crit. Care Med 166 : 173-177, 2002.
PubMed
7) Devouassoux G, Cottin V, Liote H, et al : Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis. Eur Respir J 33 : 1053-1061, 2009.
PubMed
8) Cohen MM, Polloxk-BarZiv S, Johnson SR : Emerging clinical picture of lymphangio leiomyomatosis. Thorax 60 : 875-879, 2005.
 
9) Paciocco G, Uslenghi E, Bianchi A, et al : Diffuse cystic lung diseases : correlation between radiologic and functional status. Chest 125 : 135-142, 2004.
PubMed
10) Egan JJ, Martinez FJ, Wells AU, http://www.ncbi.nlm.nih.gov/pubmed?term=%22Williams%20T%22%5BAuthor%5D et al : Lung function estimates in idiopathic pulmonary fibrosis : the potential for a simple classification. Thorax 60 : 270-273, 2005.
 
11) Han MK, Martinez FJ : Exercise testing in interstitial lung disease-diagnosis and management. Eur Respir Mon 46 : 7-23, 2009.
 
P.33 掲載の参考文献
1) 日本呼吸器学会びまん性肺疾患診断・治療ガイドライン作成委員会編 : 特発性間質性肺炎診断と治療の手引き : 改訂第2版. 13, 2011.
 
2) Kohno N, Kyoizumi S, Awaya Y, et al : New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 96 : 68-73, 1989.
PubMed
3) Kobayashi J, Kitamura S : Kl-6 : A serum marker for interstitial pneumonia. Chest 108 : 311-315, 1995.
PubMed
4) Ohnishi H, Yokoyama A, kondo K, et al : Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med 165 : 378-381, 2002.
PubMed
5) Yokoyama A, Kohno K, Hamada H, et al : Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 158 : 1680-1684, 1998.
 
6) 高橋弘毅, 白鳥正典, 千葉弘文 : IPFのバイオマーカー2) SP-D, SP-A. 呼吸器内科 19 : 597-604, 2011.
 
7) Takahashi H, Fujishima T, Koba H, et al : Serum surfactant protein A and D as prognostic factor in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 162 : 1109-1114, 2000.
 
8) Kinder BW, Brown KK, McCormack FX, et al : Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest 135 : 1557-1563, 2009.
 
9) Ichiyasu H, Ichikado K, Yamashita A, et al : Pneumocyte biomerkers, KL-6 and surfactant protein D reflect the distinct findings of high-resolution computed tomography. Respiration 2011, in press.
 
10) 井上義一, 岸潤, 新井徹, 他 : 間質性肺病変とKL-6, SP-A, SP-D. 肺の画像からみて. 日胸 61 : 125-133, 2002.
 
11) 新井徹, 井上義一, 深水玲子, 他 : 特発性間質性肺炎における血清KL-6, SP-D濃度と画像所見 (HRCT) の検討. 第70回間質性肺疾患研究会討議記録 : 36-43, 2004.
 
12) Inoue Y, Trapnell BC, Tazawa R, et al : Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis. Am J Respir Crit Care Med 177 : 752-762, 2008.
PubMed
13) 平形道人 : 多発性筋炎・皮膚筋炎における自己抗体とその臨床免疫学的意義. Jpn J Clin Immunol 30 : 444-454, 2007.
 
14) Sato S, Hirakata M, Kuwana M, et al : Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dsermatomyositis. Arthritis Rheum 52 : 1571-1576, 2005.
PubMed
15) 千葉弘文, 大塚満雄, 工藤和実, 他 : 血清中にSP-Dに対する自己抗体を認めたDermatomyositisの一例. 分子呼吸器学 11 : 83, 2007.
 
16) 岳中耐夫 : サルコイドーシスの診断. 血液検査所見. サルコイドーシス, 新しい診断と治療のABC3. 泉孝英 (編集). 最新医学社 : 92-101, 2002.
 
17) 佐々木毅 : 血清インターロイキン2 受容体 (sIL-2R). 臨床検査ガイド 2011-2012. Medical Practice編集委員会 : 716-717, 2011.
 
18) 正木康史, 梅原久範 : IgG4関連疾患 (ミクリッツ病) とシェーグレン症候群-19世紀より続いた2つの病気をめぐる議論, そして今後. 医学のあゆみ 236 : 175-181, 2011.
Medical*Online
19) Young LR, VanDyke R, Gulleman PM, et al : serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest 138 : 674-681, 2010.
PubMed
20) Kitamura T, Tanaka N, Watanabe J, et al : Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colonystimulating factor. J Exp Med 190 : 875-880, 1999.
 
21) Nylund CM, D'Mello S, Kim MO, et al : Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease. J Pediatr Gastroenterol Nutr ; 52 : 542-548, 2011.
PubMed
22) 新井徹, 井上義一, 北市正則 : さまざまな過敏性肺炎 1) 夏型過敏性肺炎. 呼吸器科 13 : 404-411, 2008.
 
23) 管守隆 : 過敏性肺炎をめぐって. 夏型過敏性肺炎. 呼吸器科 4 : 294-303, 2003.
 
24) 大谷義夫, 宮崎泰成, 稲瀬直彦, 他 : さまざまな過敏性肺炎 2) 鳥関連過敏性肺炎 (鳥飼病). 呼吸器科 13 : 412-419, 2008.
 
25) 前田由起子, 檜澤伸之, 福居嘉信, 他 : 粘液塞栓を伴う気管支喘息における血清および気管支肺胞洗浄液中CEA濃度. 日呼吸会誌 42 : 988-993, 2004.
Medical*Online
26) 高山重光, 片岡直之, 臼井裕, 他 : 良性肺疾患における血清CA19-9の検討. 日胸疾会誌 28 : 1326-1331, 1990.
 
27) Nakayama M, Saroh H, Ichikawa H, et al : Cytokeratin 19 fragment in patients with nonmalignant respiratory diseases. Chest 12 : 2001-2006, 2003.
 
28) Arai T, Hamano E, Inoue Y, et al : Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GMCSF. Respir Med 98 : 1227-1330, 2004.
 
29) 社団法人日本呼吸器学会薬剤性肺障害ガイドライン作成委員会編 : 薬剤性肺障害の評価, 治療についてのガイドライン : 33-52, 2006.
 
30) Tasaka S, Hasegawa N, obayashi S, et al : Serum indicators for the diagnosis of Pneumocystis pneumonia. Chest 131 : 1173-1180, 2007.
 
31) 権藤久司, 坂巻壽, 武元良整, 他 : 日本造血細胞移植学会ガイドライン-サイトメガロウィルス感染症. 日本造血細胞移植学会ガイドライン委員会編 : 8, 1999.
 
32) 新井徹, 井上義一, 北市正則, 他 : 特発性間質性肺炎および膠原病肺の免疫抑制療法中に発生したサイトメガロウィルス抗原血症の検討. 厚生労働科学研究費補助金 難治性疾患克服研究事業「びまん性肺疾患に関する調査研究班」平成19年度研究報告書 : 108-112, 2008.
 
P.41 掲載の参考文献
1) Polychronopoulos VS, Prakash UB : Airway involvement in sarcoidosis. Chest 136 : 1371-1380, 2009.
PubMed
2) Ryu JH, Sekiguchi H, Yi ES : Pulmonary manifestations of IgG4-related sclerosing disease. Eur Respir J.
PubMed
3) Pickford HA, Swensen SJ, Utz JP : Thoracic cross-sectional imaging of amyloidosis. AJR Am J Roentgenol 168 : 351-355, 1997.
PubMed
4) Cordier JF, Valeyre D, Guillevin L, et al : Pulmonary Wegener's granulomatosis. A clinical and imaging study of 77 cases. Chest 97 : 906-912, 1990.
PubMed
5) Daum TE, Specks U, Colby TV, et al : Tracheobronchial involvement in Wegener's granulomatosis. Am J Respir Crit Care Med 151 : 522-526, 1995.
PubMed
6) Schnabel A, Holl-Ulrich K, DalhoffK, et al : Efficacy of transbronchial biopsy in pulmonary vaculitides. Eur Respir J 10 : 2738-2743, 1997.
PubMed
7) Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL cooperative group steering committee. Am Rev Respir Dis 141 : S169-202, 1990.
 
8) Haslam PL, Baughman RP : Report of ERS task force : Guidelines for measurement of acellular components and standardization of BAL. Eur Respir J 14 : 245-248, 1999.
PubMed
9) 厚生労働省難治性疾患克服研究事業びまん性肺疾患調査研究班 : 気管支肺胞洗浄 [BAL] 法の手引き. 克誠堂出版. 2008.
 
10) Meyer KC : Bronchoalveolar lavage as a diagnostic tool. Semin Respir Crit Care Med ; 28 : 546-560, 2007.
PubMed
11) Baumann HJ, Klose H, Simon M, et al : Fiber optic bronchoscopy in patients with acute hypoxemic respiratory failure requiring noninvasive ventilation - a feasibility study. Crit Care 15 : R179, 2011.
PubMed
12) Raghu G, Collard HR, Egan JJ, et al : An official ATS/ERS/JRS/ALAT statement : Idiopathic pulmonary fibrosis : Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183 : 788-824, 2011.
PubMed
13) Maldonado F, Parambil JG, Yi ES, et al : Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage. Eur Respir J 33 : 1361-1366, 2009.
PubMed
14) Ohshimo S, Bonella F, Cui A, et al : Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179 : 1043-1047, 2009.
PubMed
15) Costabel U, Bonella F, Ohshimo S, et al : Diagnostic modalities in sarcoidosis : BAL, EBUS, and PET. Semin Respir Crit Care Med 31 : 404-408, 2010.
PubMed
16) Kantrow SP, Meyer KC, Kidd P, et al : The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J 10 : 2716-2721, 1997.
PubMed
17) Murayama J, Yoshizawa Y, Ohtsuka M, et al : Lung fibrosis in hypersensitivity pneumonitis. Association with CD4+ but not CD8+ cell dominant alveolitis and insidious onset. Chest 104 : 38-43, 1993.
 
18) Ohtani Y, Saiki S, Sumi Y, et al : Clinical features of recurrent and insidious chronic bird fancier's lung. Ann Allergy Asthma Immunol 90 : 604-610, 2003.
PubMed
19) White B, Moore WC, Wigley FM, et al : Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med 132 : 947-954, 2000.
PubMed
20) Kinder BW, Brown KK, Schwarz MI, et al : Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. Chest ; 133 : 226-232, 2008.
PubMed
21) Wells AU: The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease. Eur Respir Rev 19 : 237-241, 2010.
 
22) Poletti V, Romagna M, Allen KA, et al : Bronchoalveolar lavage in the diagnosis of disseminated lung tumors. Acta Cytol 39 : 472-477, 1995.
PubMed
23) Zompi S, Couderc LJ, Cadranel J, et al : Clonality analysis of alveolar b lymphocytes contributes to the diagnostic strategy in clinical suspicion of pulmonary lymphoma. Blood 103 : 3208-3215, 2004.
 
24) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 : 388-416, 2005.
PubMed
25) Zedtwitz-Liebenstein K, Jaksch P, Bauer C, et al : Association of cytomegalovirus DNA concentration in epithelial lining fluid and symptomatic cytomegalovirus infection in lung transplant recipients. Transplantation 77 : 1897-1899, 2004.
PubMed
26) Chemaly RF, Yen-Lieberman B, Chapman J, et al : Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients. Am J Transplant 5 : 544-548, 2005.
PubMed
27) Sebastien P, Armstrong B, Monchaux G, et al: Asbestos bodies in bronchoalveolar lavage fluid and in lung parenchyma. Am Rev Respir Dis 137 : 75-78, 1988.
PubMed
28) Rossman MD, Kern JA, Elias JA, et al : Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease. Ann Intern Med 108 : 687-693, 1988.
PubMed
29) Tazi A : Adult pulmonary langerhans' cell histiocytosis. Eur Respir J 27 : 1272-1285, 2006.
PubMed
30) 日本呼吸器内視鏡学会 : 気管支鏡 臨床医のためのテクニックと画像診断 第2版. 医学書院. 2008.
 
31) British thoracic society guidelines on diagnostic flexible bronchoscopy. Thorax 56 Suppl 1 : i1-21, 2001.
 
32) Gerna G, Lilleri D, Rognoni V, et al : Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients. Am J Transplant 9 : 1142-1150. 2009.
PubMed
33) Yasufuku K, Nakajima T, Motoori K, et al : Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest 130 : 710-718, 2006.
PubMed
P.45 掲載の参考文献
1) 阪本考司, 横山俊樹, 麻生裕紀, 他 : びまん性肺疾患に対する外科的肺生検の検討-合併症, 診断効率と早期死亡について-. 日呼吸会誌 44 (10) : 675-680, 2006.
Medical*Online
2) 金沢実, 河端美則, 高柳昇, 他 : びまん性肺疾患の外科的肺生検アンケート. 日呼吸会誌 38 (10) : 770-777, 2000.
Medical*Online
3) 日本呼吸器学会 びまん性肺疾患診断・治療ガイドライン作成委員会 : 特発性間質性肺炎 診断と治療の手引き (改訂第2版), 南江堂, 2011.
 
4) Raghu G, Collard H, Egan J, et al : An Official ATS/ERS/JRS/ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management. Am J Respir Crit Care Med 183 : 788-824, 2011.
PubMed
5) 大野彰二, 中屋孝清, 坂東政司, 他 : 臨床調査個人票に基づく特発性間質性肺炎の全国疫学調査. 日呼吸会誌 45 (10) : 759-764, 2007.
Medical*Online
6) 榎本達治, 川本雅司, 功刀しのぶ, 他 : 胸腔鏡下肺生検後に急性増悪した特発性肺線維症症例の検討. 日呼吸会誌 40 (10) : 806-811, 2002.
Medical*Online
P.48 掲載の参考文献
1) 山中晃 : 病理からみた肺生検, 日本胸部臨床 39 : 259-267, 1980.
 
2) 北川正信 : 生検の進歩- 技術と解釈 (肺) -, 臨床検査 31 : 1176-1182, 1987.
 
3) Katzenstein : Handling and interpretation of lung biopsies. A-L.A. : Katzenstein and Askin's surgical pathology of non-neoplastic lung disease. 4th ed., Elsevier, Amsterdam : 1-15, 2006.
 
4) 岡輝明 : 肺の非腫瘍性疾患の病理診断を行うための検体の取り扱いと肺構造の要点, 病理と臨床 24 : 792-800, 2006.
Medical*Online
5) 山鳥一郎 : 12. 肺 (非腫瘍性疾患) 外科病理マニュアル, 病理と臨床 vol. 26 臨時増刊号 : 201-206, 2008.
 
P.52 掲載の参考文献
1) Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos O, Semenzato G, Sharma OP : ATS/ ERS/ WASOG statement on sarcoidosis. American Thoracic Society/ European Respiratory Society/ World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG/ World Association of Sarcoidosis and Other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16 : 149-173, 1999.
PubMed
2) American Thoracic Society, Europian respiratory Society, ATS/ ERS international multidisciplinary consensus classification of idiopathic interstitial pneumonia. Am J Respir Crit Care Med 165 : 277-304, 2002.
 
3) Dong Soon Kim, Harold R. Collard and Talmadge E. King, Jr. : Classification and Natural History of the Idiopathic Interstitial Pneumonias The Proceedings of the American Thoracic Society 3 : 285-292, 2006.
PubMed
4) 長井苑子 : 間質性肺疾患 : 外来診療の実際. 医学書院. 2007.
 
5) Richard J. Castriotta, Basil A. Eldadah, W. Michael Foster, Jeffrey B. Halter, William R. Hazzard, James P. Kiley, Talmadge E. King, Jr. : Frances McFarland Horne, Susan G. Nayfield, Herbert Y. Reynolds, Kenneth E. Schmader, Galen B. Toews, and Kevin P : High Workshop on Idiopathic Pulmonary Fibrosis in Older Adults Chest 138 : 3 693-703, 2010.
PubMed
6) King TE, Toooze JA, Schwarz MI, Brown KR, Cherniak RM : Predicting survival in idiopathic pulmonary fibrosis : scoring system and survival model. Am J Respir Crit Care Med 164 : 1171-1181, 2001.
 
7) Corte TJ, Copley SJ, Desai SR, Zappala CJ, Hansell DM, Nicholson AG, Colby TV, Renzoni E, Maher TM, Wells AU : Significance of Connective Tissue Disease features in Idiopathic Interstitial Pneumonia. Eur Respir J, 2011.
PubMed
8) Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, Jones KD, King TE Jr. Idiopathic nonspecific interstitial pneumonia : lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 176 : 691-697, 2007.
PubMed
9) Handa T, Nagai S, et al : Incidence of Pulmonary Hypertension and Its Clinical Relevance in Patients with Interstitial Pneumonias : Comparison Between Idiopathic and Collagen Vascular Disease Associated Interstitial Pneumonias. Int Med 46 : 831-837, 2007.
 
10) Nagai S, Handa T, Kim D. : Pharmacotherapy in patients with idiopathic pulmonaryfibrosis. Expert Opin Pharmacother 9 : 1909-1925, 2008.
 
11) Mathai SC, Hummers LK, Champion HC, Wigley FM, Zaiman A, Hassoun PM, Girgis RE : Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases : impact of interstitial lung disease. Arthritis Rheum. 60 : 569-577, 2009.
PubMed
12) Hamada, K, Nagai, S, Tanaka, S, Handa T, Shigematsu M, Nagao T, et al : Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 131 : 650-656, 2007.
PubMed
13) The registry of the international society for heart and lung transplantation : 27 annual report 2010. J Heart and Lung Transplantation 29 : 1083-1141, 2010.
 
P.55 掲載の参考文献
1) 福原俊一, 他 (編) : 臨床のためのQOL評価ハンドブック. 医学書院. 2001.
 
2) Martinez TY, et al : Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest 117 : 1627-1632, 2000.
PubMed
3) Clark M, et al : A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis. Thorax 56 : 482-486, 2001.
 
4) Martinez JAB, et al : Dyspnea scales as a measure of health-related quality of life in patients with idiopathic pulmonary fibrosis. Med Sci Monit 8 : CR405-410, 2002.
 
5) Ohno S, et al : Reassessment of the classification of the severity in idiopathic pulmonary fibrosis using SF-36 questionnaire. Intern Med 44 : 196-199, 2005.
PubMed
6) Tomioka H, et al : Health-related quality of life in patients with idiopathic pulmonary fibrosis-Cross-sectional and longitudinal study-. Intern Med 46 : 1533-1542, 2007.
PubMed
7) Krishnan V, et al : Sleep quality and health-related quality of life in idiopathic pulmonary fibrosis. Chest 134 : 693-698, 2008.
PubMed
8) Nishiyama O, et al : Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? Respir Med 99 : 408-414, 2005.
PubMed
9) Tzanakis N, et al : Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Eur J Intern Med 16 : 105-112, 2005.
PubMed
10) Peng S, et al : Cross-sectional and longitudinal construct validity of the Saint George's Respiratory Questionnaire in patients with IPF. Respirology 13 : 871-879, 2008.
 
11) Swigris JJ, et al : Development of the ATAQ-IPF : a tool to assess quality of life in IPF. Health Qual Life Outcomes 8 : 77, 2010.
PubMed
12) King TE Jr, et al : BUILD-1 : A randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 177 : 75-81, 2008.
PubMed
13) The Idiopathic Pulmonary Fibrosis Clinical Research Network. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med 363 : 620-628, 2010.
PubMed
14) Richeldi L, et al : Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 365 : 1079-1087, 2011.
PubMed
15) Nishiyama O, et al : Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 13 : 394-399, 2008.
PubMed
16) Lanken PN, et al : An official American Thoracic Society clinical policy statement : palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med 177 : 912-927, 2008.
PubMed
17) Raghu G, et al : An official ATS/ERS/JRS/ALAT statement : idiopathic pulmonary fibrosis : evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183 : 788-824, 2011.
PubMed
P.60 掲載の参考文献
1) Tanizawa K, Handa T, Nakashima R, et al : HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. Respir Med 105 : 1380-1387, 2011.
PubMed
2) 日本呼吸器学会 : びまん性肺疾患診断・治療ガイドライン作成委員会. 特発性間質性肺炎 診断と治療の手引き 改訂第2版. 南江堂. 2011.
 
3) Raghu G, Depaso WJ, Cain K, et al : Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis : a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis 144 : 291-296, 1991.
PubMed
4) ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis : An official ATS/ERS/JRS/ALAT statement : idiopathic pulmonary fibrosis : evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183 : 788-824, 2011.
PubMed
5) Demedts M, Behr J, Buhl R, et al : IFIGENIA Study Group. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 24 : 2229-2242, 2005.
 
6) Nagai S, Hamada K, Shigematsu M, et al : Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis. Intern Med 41 : 1118-1123, 2002.
PubMed
7) Raghu G, Johnson WC, Lockhart D, Mageto Y. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone : results of a prospective, open-label Phase II study. Am J Respir Crit Care Med 159 : 1061-1069, 1999.
PubMed
8) Azuma A, Nukiwa T, Tsuboi E, et al : Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 171 : 1040-1047, 2005.
PubMed
9) Taniguchi H, Ebina M, Kondoh Y, et al : Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 35 : 821-829, 2010.
PubMed
10) Idiopathic Pulmonary Fibrosis Clinical Research Network : A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med 363 : 620-628, 2010.
PubMed
11) ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension : the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J30 : 2493-2537, 2009.
 
12) King TE Jr, Behr J, Brown KK, et al : BUILD-1 : a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 177 : 75-81, 2008.
PubMed
13) King TE Jr, Brown KK, Raghu G, et al : BUILD-3 : a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 184 : 92-99, 2011.
PubMed
14) Olschewski H, Ghofrani HA, Walmrath D, et al : Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Am J Respir Crit Care Med 160 : 600-607, 1999.
PubMed
15) Richeldi L, Costabel U, Selman M, et al. Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis. N Engl J Med 365 : 1079-1087, 2011.
PubMed
P.64 掲載の参考文献
1) 日本呼吸器学会びまん性肺疾患診断・治療ガイドライン作成委員会編 : 特発性間質性肺炎診断と治療の手引き 改訂第2版, 37-49, 2011.
 
2) 井上義一 : 間質性肺炎の合併症とその管理の実際. Medical Practice 24 : 1071-1077, 2007.
Medical*Online
3) Brant A, Eaton T. : Serious complications with talc slurry pleurodesis. Respirology 6 : 181-185, 2001.
PubMed
4) Aihara K, handa T, nagai S, et al : Efficacy of blood-patch pleurodesis for secondaly spontaneous pneumothorax in interstitial lung disease. Intern Med 50 : 1157-1162, 2011.
PubMed
5) Kurihara M, Kataoka S, Ishikawa A, et al : Latest treatment for spontaneous pneumothorax. Gen Thorac Cardiovasc Surg 58 : 113-119, 2010.
 
6) 渡辺洋一, 松尾圭祐, 玉置明彦, 他 : 難治性気胸, 気管支瘻に対するEWS (endobronchial Watanabe Spigot) を用いた気管支充填術の有用性. 気管支学 23 : 510-515, 2001.
Medical*Online
7) Sasada S, Tamura K, Chang Y, et al : Clinical evaluation of endobronchial bronchial occlusion with silicone spigots for the management of persistent pulmonary air leaks. Intern Med 50 : 1169-1173, 2011.
PubMed
8) Lynch JP III, Belperio JA, Fishbein MC, et al : Pulmonary hypertension complicating interstitial lung disease. In Schwarz MI, King TE, Jr. eds. Interstitial lung disease. 5th ed. PMPH-USA 85-102, 2011.
 
9) Cottin V, Nunes H, Brillet P-Y, et al : Combined pulmonary fibrosis and emphysema : a distinct underrecognized entity. Eur Respir J 26 : 586-593, 2005.
 
10) 新井徹, 井上義一, 北市正則, 他 : 特発性間質性肺炎および膠原病肺の免疫抑制療法中に発生したサイトメガロウィルス抗原血症の検討. 厚生労働科学研究費補助金 難治性疾患克服研究事業「びまん性肺疾患に関する調査研究班」平成19年度研究報告書 : 108-112, 2008.
 
11) Takizawa Y, Inokuma S, Tanaka Y, et al : Clinical characteristics of cytomegalovirus infection in rheumatic diseases : multicentre survey in a large patient population. Rheumatology (Oxford) 47 : 1373-1378, 2008.
 
12) 花田豪郎, 宮本篤, 宇留賀公紀, 他 : 間質性肺炎を合併した肺アスペルギルス症の臨床的検討. 厚生労働科学研究費補助金 難治性疾患克服研究事業「びまん性肺疾患に関する調査研究班」平成22年度研究報告書 : 251-257, 2011.
 
13) 水谷英明, 弦間昭彦 : 特発性間質性肺炎に合併する肺癌の疫学と発生機序. 医学のあゆみ 8 : 579-583, 2009.
 
14) 小澤雄一, 乾直輝 : 間質性肺炎合併肺癌に対する化学療法. 医学のあゆみ 8 : 589-593, 2009.
Medical*Online
15) 田口善夫. 間質性肺炎に合併した肺癌に対する放射線療法. 医学のあゆみ 8 : 594-597, 2009.
Medical*Online
16) 松村晃秀, 井上義一 : 間質性肺炎に合併した肺癌手術～急性増悪とその予防策. 医学のあゆみ 8 : 598-602, 2009.
Medical*Online
17) Sawada Y, Inokuma S, Sato T, et al : Leflunomide-induced interstitial lung disease : prevalence and risk factors in Japanese patients with rheumatoid arthritis. Rheumatology 48 : 1069-1072, 2009.
 
18) Rhagu G, Freudenberger TD, Yang S, et al : High prevalence of abnormal acid gastrooesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 27 : 136-142, 2006.
 
19) 岩田猛邦, 郡 義明 : 細気管支炎および誤嚥性細気管支炎. 最新内科学体系60巻 ; 呼吸器疾患 I. 中山書店 145-153, 1994.
 
P.66 掲載の参考文献
1) 日本呼吸器学会 肺生理専門委員会, 日本呼吸管理学会 酸素療法ガイドライン作成委員会 : 酸素療法ガイドライン. 2006.
 
2) 日本呼吸器学会肺生理専門委員会在宅呼吸ケア白書ワーキンググループ : 在宅呼吸ケア白書 2010.
 
3) ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension : the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30 : 2493-2537, 2009.
 
4) Pouwels-Fry S, Pouwels S, Fournier C, et al : Effects of oxygen on exercise-induced increase of pulmonary arterial pressure in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 25 : 133-139, 2008.
PubMed
5) Harris-Eze AO, Sridhar G, Clemens RE, Gallagher CG, Marciniuk DD. Oxygen improves maximal exercise performance in interstitial lung disease. Am J Respir Crit Care Med 150 : 1616-1622, 1994.
PubMed
6) 長井苑子 : 間質性肺疾患の外来診療. 東京. 医学書院 : p25, 2010.
 
7) ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis : An official ATS/ERS/JRS/ALAT statement : idiopathic pulmonary fibrosis : evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183 : 788-824, 2011.
PubMed
P.68 掲載の参考文献
1) 日本呼吸管理学会呼吸リハビリテーションガイドライン作成委員会, 日本呼吸器学会ガイドライン施行管理委員会, 日本理学療法士協会呼吸リハビリテーションガイドライン作成委員会 : 呼吸リハビリテーションマニュアル-運動療法.
 
2) Nishiyama O, Kondoh Y, Kimura T, et al : Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 13 : 394-399, 2008.
PubMed
3) Salhi B, Troosters T, Behaegel M, Joos G, Derom E : Effects of pulmonary rehabilitation in patients with restrictive lung diseases. Chest. Chest 137 : 273-279, 2010.
PubMed
P.73 掲載の参考文献
1) Bernard GR, Artigas A, Brigham KL, et al : The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149 : 818-824, 1994.
PubMed
2) 日本呼吸器学会ARDSガイドライン作成委員会 : ALI/ARDS診療のためのガイドライン. 学研メディカル秀潤社, 2010.
 
3) Schwarz MI, Albert RK : "Imitators" of the ARDS Implications for Diagnosis and Treatment. Chest 125 : 1530-1535, 2004.
PubMed
4) Papazian L, Doddoli C, Chetaille B, et al : A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med 35 : 755-762, 2007.
PubMed
5) Arabi Y, Ahmed R, Ahmed Q, et al : Risks and benefits of open-lung biopsy in the mechanically ventilated critically ill population : a cohort study and literature review. Med Sci Monit 13 : CR365-371, 2007.
 
6) Lim SY, Suh GY, Choi JC, et al : Usefulness of open lung biopsy in mechanically ventilated patients with undiagnosed diffuse pulmonary infiltrates : influence of comorbidities and organ dysfunction. Crit Care 11 : R93, 2007.
PubMed
7) Flabouris A, Myburgh J : The utility of open lung biopsy in patients requiring mechanical ventilation. Chest 115 : 811-817, 1999.
PubMed
8) Dellinger RP, Levy MM, Carlet JM, et al : Surviving Sepsis Campaign : International guidelines for management of severe sepsis and septic shock : 2008. Intensive Care Med 34 : 17-60, 2008.
PubMed
9) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 342 : 1301-1308, 2000.
PubMed
10) Brower RG, Lanken PN, MacIntyre N, et al ; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network : Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351 : 327-336, 2004.
PubMed
11) Fan E, Wilcox ME, Brower RG, et al : Recruitment maneuvers for acute lung injury : a systematic review. Am J Respir Crit Care Med 178 : 1156-1163, 2008.
PubMed
12) Myers TR, MacIntyre NR : Respiratory controversies in the critical care setting. Does airway pressure release ventilation offer important new advantages in mechanical ventilator support? Respir Care 52 : 452-458, 2007.
PubMed
13) Fernandez-Perez ER, Yilmaz M, Jenad H, et al : Ventilator Settings and Outcome of Respiratory Failure in Chronic Interstitial Lung Disease. Chest 133 : 1113-1119, 2008.
PubMed
14) Mallick S : Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit. Respir Med 102 : 1355-1359, 2008.
PubMed
15) Blivet S, Philit F, Sab JM, et al : Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure. Chest 120 : 209-212, 2001.
 
16) Saydain G, Islam A, Afessa B, et al : Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. Am J Respir Crit Care Med 166 : 839-842, 2002.
 
17) Al-Hameed FM, Sharma S : Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis. Can Respir J 11 : 117-122, 2004.
 
18) Tomii K, Tachikawa R, Chin K, et al : Role of non-invasive ventilation in managing life-threatening acute exacerbation of interstitial pneumonia. Intern Med 49 : 1341-1347, 2010.
PubMed
19) Yokoyama T, Kondoh Y, Taniguchi H, et al : Noninvasive ventilation in acute exacerbation of idiopathic pulmonary fibrosis. Intern Med 49 : 1509-1514, 2010.
PubMed
20) Suh GY, Kang EH, Chung MP, et al : Early intervention can improve clinical outcome of acute interstitial pneumonia. Chest 129 : 753-761, 2006.
PubMed
21) Ichikado K, Suga M, Muller NL, et al : Acute interstitial pneumonia : comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am J Respir Crit Care Med 165 : 1551-1556, 2002.
PubMed
22) Miyazaki Y, Tateishi T, Akashi T, et al : Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest 134 : 1265-1270, 2008.
PubMed
23) Suda T, Kaida Y, Nakamura Y, et al : Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med 103 : 846-853, 2009.
PubMed
24) Inase N, Sawada M, Ohtani Y, et al : Cyclosporin A followed by the treatment of acute exacerbation of idiopathic pulmonary fibrosis with corticosteroid. Intern Med 42 : 565-570, 2003.
PubMed
25) Sakamoto S, Homma S, Miyamoto A, et al : Cyclosporin A in the treatment of acute exacerbation of idiopathic pulmonary fibrosis. Inter Med 49 : 109-115, 2010.
 
26) 岡本竜哉, 一安秀範, 一門和哉, 他 : 特発性肺線維症 (IPF) の臨床的検討-急性増悪例の解析-. 日呼吸会誌 44 : 359-367, 2006.
Medical*Online
27) 井上哲郎, 田中栄作, 加藤晃史, 他 : 間質性肺炎におけるシクロスポリン (ネオーラル) の血中濃度モニタリングに関する検討. 日呼吸会誌 42 : 153-157, 2004.
Medical*Online
28) 榎本紀之, 須田隆文, 橋本大, 他 : 間質性肺炎症例に対するシクロスポリン使用経験と血中濃度モニタリング. 日呼吸会誌 42 : 934-940, 2004.
Medical*Online
29) Ambrosini V, Cancellieri A, Chilosi M, et al : Acute exacerbation of idiopathic pulmonary fibrosis : report of a series. Eur Respir J 22 : 821-826, 2003.
PubMed
30) Churg A, Muller NL, Silva CI, et al : Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am J Surg Pathol 31 : 277-284, 2007.
PubMed
31) Horita N, Akahane M, Okada Y, et al : Tacrolimus and steroid treatment for acute exacerbation of idiopathic pulmonary fibrosis. Intern Med 50 : 189-195, 2011.
PubMed
32) Kubo H, Nakayama K, Yanai M, et al : Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 128 : 1475-1482, 2005.
PubMed
33) Tamakuma S, Ogawa M, Aikawa N, et al : Relationship between neutrophil elastase and acute lung injury in humans. Pulm Pharmacol Ther 17 : 271-279, 2004.
PubMed
34) Zeiher BG, Artigas A, Vincent JL, et al : Neutrophil elastase inhibition in acute lung injury : results of the STRIVE study. Crit Care Med 32 : 1695-1702, 2004.
PubMed
35) 中村万里, 小倉高志, 宮沢直幹, 他 : 高度呼吸不全を呈した特発性肺線維症急性増悪におけるシベレスタットナトリウム使用成績と予後因子の検討. 日呼吸会誌 45 : 455-459, 2007.
Medical*Online
36) Aoki H, Kodama M, Tani T, et al : Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 167 : 412-417, 1994.
PubMed
37) Cruz DN, Antonelli M, Fumagalli R, et al : Early use of polymyxin B hemoperfusion in abdominal septic shock : the EUPHAS randomized controlled trial. JAMA 301 : 2445-2452, 2009.
PubMed
38) Tsushima K, Kubo K, Koizumi T, et al : Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory distress syndrome. J Clin Apher 17 : 97-102, 2002.
PubMed
39) Kushi H, Miki T, Okamaoto K, et al : Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care 9 : R653-R661, 2005.
PubMed
40) Kawamata T, Imaizumi H, Yoshida M, et al : Polymyxin B-immobilized fiber improves hyperdynamic state in MRSA septic patients. Intensive Care Med 23 : 130-131, 1997.
 
41) Tani T, Hanasawa K, Kodama M, et al : Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg 25 : 660-668, 2001.
PubMed
42) Kushi H, Miki T, Okamaoto K, et al : Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care 9 : R653-R661, 2005.
PubMed
43) Kushi H, Nakahara J, Miki T, et al : Hemoperfusion with an immobilized polymyxin B fiber column inhibits activation of vascular endothelial cells. Ther Apher Dial 9 : 303-307, 2005.
PubMed
44) Cantaluppi V, Assenzio B, Pasero D, et al : Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med 34 : 1638-1645, 2008.
PubMed
45) Abe S, Seo Y, Hayashi H, et al : Neutrophil Adsorption by Polymyxin B-Immobilized Fiber Column for Acute Exacerbation in Patients with Interstitial Pneumonia : A Pilot Study. Blood Purif 29 : 321-326, 2010.
PubMed
46) Abe S, Hayashi H, Seo Y, et al : Reduction in Serum High Mobility Group Box-1 Level by Polymyxin B-Immobilized Fiber Column in Patients with Idiopathic Pulmonary Fibrosis with Acute Exacerbation. Blood Purif 32 : 310-316, 2011.
PubMed
47) Wang Y, Liu Y, Sarker KP, et al : Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett 470 : 151-155, 2000.
 
48) Seo Y, Abe S, Kurahara M, et al : Beneficial effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on acute exacerbation of idiopathic pulmonary fibrosis. Intern Med 45 : 1033-1038, 2006.
PubMed
49) Enomoto N, Suda T, Uto T, et al : Possible therapeutic effect of direct haemoperfusion with a polymyxin B immobilized fibre column (PMX-DHP) on pulmonary oxygenation in acute exacerbations of interstitial pneumonia. Respirology 13 : 452-460, 2008.
PubMed
50) 宮本京介, 田坂定智, 長谷川直樹, 他 : 間質性肺炎の急性増悪に対するPMX-DHPの効果と施行前後での各種臨床指標の推移. 日呼吸会誌 47 : 978-983, 2009.
Medical*Online
P.79 掲載の参考文献
1) Christie JD, Edwards LB, Kucheryavaya AY, et al : The registry of the International Society for Heart and Lung Transplantation. Twenty-eight official adult lung and heart-lung transplant report? 2011. J Heart Lung Transplant 30 : 1104-1122, 2011.
 
2) Shiraishi T, Okada Y, Sekine Y, et al : Registry of the Japanese Society of Lung and Heart-Lung Transplantation : the official Japanese lung transplantation report 2008. Gen Thorac Cardiovasc Surg 57 : 395-401, 2009.
PubMed
3) Starnes VA, Bowdish ME, Woo MS, et al : A decade of living lobar lung transplantation. Recipient outcomes. J Thorac Cardiovasc Surg 127 : 114-122, 2004.
 
4) Date H : Update on living-donor lobar lung transplantation. Curr Opin Organ Transplant 16 : 453-457, 2011.
PubMed

各論

P.88 掲載の参考文献
1) 日本呼吸器学会びまん性肺疾患診断・治療ガイドライン作製委員会. 特発性間質性肺炎診断と治療の手引き改訂2版. 南江堂, 2011.
 
2) American Thoracic Society/ European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002.
PubMed
3) Hamman L, Rich AR : Acute diffuse interstitial fibrosis of the lungs. Bull Johns Hopkins Hosp 74 : 177-212, 1944.
 
4) 本間日臣, 他 : 肺線維症. 最新医学 9 : 116-129, 1954.
 
5) 山中晃. 病理学的診断. 原因不明の肺線維症とその周辺. 厚生省特定疾患肺線維症調査研究班 11-12, 1980.
 
6) Crystal RG, et al : Idiopathic pulmonary fibrosis. Clinical histologic, radiologic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med 85 : 769-788, 1976.
 
7) 田村昌士 : 特発性間質性肺炎の診断基準 (改定案) について. 厚生省特定疾患間質性肺疾患調査研究班. 昭和55年度研究報告書 : 4-6, 1981.
 
8) King TE, Costabel U, Cordier JF, et al : Idiopathic pulmonary fibrosis : Diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 161 : 646-664, 2000.
 
9) Travis WD, Hunninghake G, King TEJ et al : Idiopathic Nonspecific Interstitial Pneumonia. Am J Respir Crit Care Med 177 : 1338-1347, 2008.
 
10) Raghu G, Collard HR, Egan JJ, et al : ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement : idiopathic pulmonary fibrosis : evidencebased guidelines for diagnosis and management. Am J Respir Crit Care Med 15 183 (6) : 788-824, 2011.
 
11) Travis WD, Costabel U, Hansell DM, et al : An official ATS/ERS statement : Update of the international multidiciplinary classification of the IZPs. Am J Respir Crit Care Med 2013 (in press).
 
P.97 掲載の参考文献
1) American Thoracic Society/European Resiratory Society International Multidiscipinary Consensus CClassification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002.
 
2) Muller NL, Miller RR, Webb WR, et al : Fibrosing alveolitis : CT-pathologic correlation. Radiology 160 : 585-588, 1986.
PubMed
3) Epler GR, McLoud TC, Gaensler EA, et al : Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 298 : 934-939, 1978.
PubMed
4) Idiopathic Pulmonary Fibrosis : Diagnosis and Treatment . International Consensus Statement. Am J Respir Crit Care Med. 2000 February 1, 161 (2) : 646-664, 2000.
 
5) Johkoh T, Muller NL, Cartier Y, Kavanagh PV, Hartman TE, Akira M, et al : Idiopathic interstitial pneumonias : diagnostic accuracy of thin-section CT in 129 patients. Radiology 211 (2) : 555-560, 1999.
PubMed
6) MacDonald SL, Rubens MB, Hansell DM, Copley SJ, Desai SR, du Bois RM, et al : Nonspecific interstitial pneumonia and usual interstitial pneumonia : comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 221 (3) : 600-605, 2001.
PubMed
7) Hunninghake GW, Lynch DA, Galvin JR, Gross BH, Muller N, Schwartz DA, et al : Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 124 (4) : 1215-1223, 2003.
PubMed
8) Elliot TL, Lynch DA, Newell JD, Jr., Cool C, Tuder R, Markopoulou K, et al : High-resolution computed tomography features of nonspecific interstitial pneumonia and usual interstitial pneumonia. J Comput Assist Tomogr 29 (3) : 339-345, 200.
 
9) Lynch DA, David Godwin J, Safrin S, Starko KM, Hormel P, Brown KK, et al : High-resolution computed tomography in idiopathic pulmonary fibrosis : diagnosis and prognosis. Am J Respir Crit Care Med 172 (4) : 488-493, 2005.
 
10) Lynch DA, Travis WD, Muller NL, Galvin JR, Hansell DM, Grenier PA, et al : Idiopathic interstitial pneumonias : CT features. Radiology 236 (1) : 10-21, 2005.
PubMed
11) Sumikawa H, Johkoh T, Ichikado K, Taniguchi H, Kondoh Y, Fujimoto K, et al : Usual interstitial pneumonia and chronic idiopathic interstitial pneumonia : analysis of CT appearance in 92 patients. Radiology 241 (1) : 258-266, 2006.
PubMed
12) Sumikawa H, Johkoh T, Colby TV, Ichikado K, Suga M, Taniguchi H, et al : Computed tomography findings in pathological usual interstitial pneumonia : relationship to survival. Am J Respir Crit Care Med 177 (4) : 433-439, 2008.
PubMed
13) Souza CA, Muller NL, Lee KS, Johkoh T, Mitsuhiro H, Chong S : Idiopathic Interstitial Pneumonias : Prevalence of Mediastinal Lymph Node Enlargement in 206 Patients. Am J Roentgenol 186 : 995-999, 2006.
 
14) Raghu G, Collard HR, Egan J, et. al : Idiopathic Pulmonary Fibrosis : Evidence Based Guidelines for Diagnosis and Management A Joint ATS/ERS/JRS/ALAT Statement. Am J Respir Crit Care Med 183 : 788-824, 2011.
 
15) Nishimura K, Kitaichi M, Izumi T, et al : Usual interstitial pneumonia : histologic correlation with high-resolution CT. Radiology 182 : 337-342, 1992.
PubMed
16) Churg A, Muller NL, Silva CI, Wright JL : Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am J Surg Pathol 31 : 277-284, 2007.
PubMed
17) Akira M, Hamada H, Sakatani M, et al : CT findings during accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgeno 168 : 79-83, 1997.
 
18) Akira M, Kozuka T, Yamamoto S, Sakatani M. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 15 ; 178 : 372-378, 2008.
 
19) Silva CI, Muller NL, Fujimoto K, Kato S, Ichikado K, Taniguchi H, et al : Acute exacerbation of chronic interstitial pneumonia : high-resolution computed tomography and pathologic findings. J Thorac Imaging 22 : 221-229, 2007.
PubMed
20) Fujimoto K, Taniguchi H, Johkoh T,et al : Acute exacerbation of idiopathic pulmonary fibrosis : high-resolution CT scores predict mortality. Eur Radiol 2011, in press
 
21) Cottin V, Donsbeck AV, Revel D, Loire R, Cordier JF : Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 158 : 1286-1293, 1998.
 
22) Park JS, Lee KS, Kim JS, Park CS, Suh YL, Choi DL, et al : Nonspecific interstitial pneumonia with fibrosis : radiographic and CT findings in seven patients. Radiology 195 : 645-648, 1995.
PubMed
23) Johkoh T, Muller NL, Colby TV, Ichikado K, Taniguchi H, Kondoh Y, et al : Nonspecific interstitial pneumonia : correlation between thin-section CT findings and pathologic subgroups in 55 patients. Radiology 225 : 199-204, 2002.
PubMed
24) Carrington CB, Gaensler EA, Coutu RE, et al : Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 298 : 801-809, 1978.
PubMed
25) Feigin DS, Friedman PJ : Chest radiography in desquamative interstitial pneumonitis : a review of 37 patients. AJR Am J Roentgenol 134 : 91-99, 1980.
PubMed
26) Gaensler EA, GoffAM, Prowse CM : Desquamative interstitial pneumonia. N Engl J Med 274 : 113-128, 1966.
PubMed
27) Hartman TE, Primack SL, Swensen SJ, et al : Desquamative interstitial pneumonia : thin-section CT findings in 22 patients. Radiology 187 : 787-790, 1993.
PubMed
28) Akira M, Yamamoto S, Hara H, et al : Serial computed tomographic evaluation in desquamative interstitial pneumonia. Thorax 52 : 333-337, 1997.
PubMed
29) Heyneman LE, Ward S, Lynch DA, et al : Respiratory bronchiolitis, respiratory bronchiolitisassociated interstitial lung disease, and desquamative interstitial pneumonia : different entities or part of the spectrum of the same disease process? AJR Am J Roentgenol 173 : 1617-1622, 1999
PubMed
30) Holt RM, Schmidt RA, Godwin D, et al : High resolution CT in respiratory bronchiolitis-associated interstitial lung disease. J Comput Assist Tomogr 17 : 46-50, 1993.
 
31) Park JS, Brown KK, Tuder RM, et al : Respiratory bronchiolitis-associated interstitial lung diseases : radiologic features with clinical and pathologic correlation. J Comput Assist Tomogr 26 : 13-20, 2002.
PubMed
32) Muller NL, Guerry-Force ML, Staples CA, et al : Differential diagnosis of bronchiolitis obliterans with organizing pneumonia and usual interstitial pneumonia : clinical, functional, and radiologic findings. Radiology 162 : 151-156, 1987.
PubMed
33) Yamamoto M, Ina Y, Kitaichi M, et al : Clinical features of BOOP in Japan. Chest 102 : 21S-25S, 1992.
PubMed
34) Lee KS, Kullnig P, Hartman TE, et al : Cryptogenic organizing pneumonia : CT findings in 43 patients. AJR Am J Roentgenol 162 : 543-546, 1994.
PubMed
35) Akira M, Yamamoto S. Sakatani M : Bronchiolitis obliterans organizing pneumonia manifesting as multiple large nodules or masses. AJR Am J Roentgenol 170 : 291-295, 1998.
PubMed
36) Ujita M, Renzoni EA, Veeraraghavan S, et al : Organizng pneumonia : perilobular pattern at thinsection CT. Radiology 232 : 757-761, 2004.
PubMed
37) Johkoh T, Muller NL, Ichikado K, et al : Perilobular pulmonary opacities : high-resolution CT findings and pathologic correlation. J Thorac Imaging 14 : 172-177, 1999.
PubMed
38) Kim SJ, Lee KS, Ryu YH, et al : Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia : diagnostic implications. AJR Am J Roentgenol 180 : 1251-1254, 2003.
PubMed
39) Primack SL, Hartman TE, Ikezoe J, et al : Acute interstitial pneumonia : radiographic and CT findings in nine patients. Radiology 188 : 817-820, 1993.
PubMed
40) Bouros D, et al : Acute interstitial pneumonia. Eur Respir J 15 : 412-418, 2000.
PubMed
41) Johkoh T, et al : Acute interstitial pneumonia : thin-section CT findings in 36 patients. Radiology 211 : 859-863, 1999.
PubMed
42) Ichikado K, et al : Acute interstitial pneumonia : high-resolution CT findings correlated with pathology. Am J Roentgenol 168 : 333-338, 1997.
 
43) Ichikado K, et al : Hyperoxia-induced diffuse alveolar damage in pigs : correlation between thinsection CT and histopathologic findings. Radiology 216 : 531-538, 2000.
PubMed
44) Ichikado K, et al : Acute interstitial pneumonia : comparison of high-resolution computed tomography findings between survivors and non-survivors. Am J Respir Crit Care Med 165 : 1551-1556, 2002.
 
45) Liebow AA, Carrington CB : Diffuse lymphoreticular infiltrations associated with fysproteinemia. Med Clin North Am 57 : 809-884, 1973.
PubMed
46) Johkoh T, Muller NL, Pickford HA, et. al : Lymphocytic Interstitial Pneumonia : thin-section CT findings in 22 patients. Radiology 212 : 567-572, 1999.
 
47) 上甲剛 ATS-ERS02診断基準によるリンパ球性間質性肺炎 (lymphocytic interstitial pneumonia (LIP)) のCT所見 平成20年度厚生労働科学研究費補助金 (特定疾患対策研究事業) 報告書 p147-149
 
P.111 掲載の参考文献
1) Kitaichi M : Pathologic features and the classification of interstitial pneumonia of unknown etiology. Bull Chest Dis Res Inst., Kyoto Univ 23 : 1-18, 1990.
PubMed
2) Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Shhroeder DR, Offord KP : Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157 : 199-203, 1998.
 
3) Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, Colby TV : Idiopathic nonspecific interstitial pneumonia/fibrosis : comparison with idiopathic pulmonary fibrosis and BOOP (corrigendum : Eur Resp J 1999 ; 13 : 171). Eur Respir J 12 : 1010-1019, 1998.
 
4) American Thoracic Society : European Respiratory Society. Idiopathic pulmonary fibrosis : diagnosis and treatment : international consensus statement. Am J Respir Crit Care Med 161 : 646-664, 2000.
PubMed
5) American Thoracic Society : European Respiratory Society. American Thoracic Society/European Respiratory Societt International Multidiscilinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002.
 
6) Raghu G, Collard HR, Egan JJ, Martinez FJ et al : Amerucan Thoracic Society Documents : An Official ATS/ERS/JRS/ALAT Statement : Idiopathic pulmonary fibrosis : Evidence-based guidelines for diagnosis and management. Am, J Respir Crit Care Med 183 : 788-824, 2011.
PubMed
7) Travis WD, Hunninghake G, King TE Jr, Lynch DA et al : Idiopathic nonspecific interstitial pneumonia. Report of an American Thoracic Society project. Am J Respir Crit Care Med 177 : 1338-1347, 2008.
PubMed
8) 北市正則, 盧美淑 : びまん性線維化肺疾患の新しい分類 : 特発性間質性肺炎の病理組織所見, ATS/ERS 国際分類 (2002) について. 綜合臨床 52 : 1830-1842, 2003.
 
9) Colby TV : Pathologic aspects of bronchiolitis oblierans organizingpneumonia. Edited by Izumi T. Chest 102 : 38S-43S, 1992.
 
10) Kitaichi M : Broonchiolitis obliterans organizing pneumonia (BOOP). In : Basic and Clinical Aspects of Pulmonary Fibrosis, Ed by Taksihima T, CRC Press, Boca Raton : 463-483, 1994.
 
11) Katzenstsin ALA Myers JL, Mazur MT : Acute interstitial pneumonia. A clinicopathologic, ultrastructural and cell kinetic study. Am J Surg Pathol 10 : 256-267, 1986.
 
12) Collard HR, Moore BB, Flaherty KR et al : Acute exacerbation of idiopathic pulmonary fiobrosis. Am J Respir Crit Care Med 176 : 636-643, 2007.
PubMed
13) Portnoy J, Veraldi KL, Schwarz MI, Cool CD, Curran-Everett D, Cherniack R, King TEJr, Brown KK : Respiraory bronchiolitis-interstitial lung disease. Long-term outcome. Chest 131 : 664-671, 2007.
 
14) Liebow AA, Steer A, Billingsley JG : Desquamative interstitial pneumonia. Am J Med 39 : 369-404, 1965.
PubMed
15) Carrington CB, Gaensler EA, Coutu RE FitzGerald MX, Gupta RG : Natural history and treated course of usual and desquamative interstitial pneumonia. New Engl J Med 298 : 801-809, 1978.
PubMed
16) 網谷良一, 新実彰男, 久世文幸 : 特発性上葉限局型肺線維症. 呼吸 11 : 693-699, 1992.
Medical*Online
17) Frankel SK, Cool CD, Lynch DA, Brown KK : Idiopathic pleuroparenchymal fibroelastosis. Chest126 : 2007-2013, 2004.
PubMed
18) 北市正則, 玉舎学, 杉本親寿, 大塚淳司, 新井徹, 井上義一, 林清二 : 特発性肺線維症. 病理-特発性肺線維症 (IPF) の臨床経過, 画像所見と整合性のある病理診断は可能かをめぐって. 泉孝英編集, 最新医学別冊 55 : 25-32, 2008.
 
P.120 掲載の参考文献
1) American Thoracic Society, Europian respiratory Society,ATS/ERS international multidisciplinary consensus classification of idiopathic interstitial pneumonia. Am J Respir Crit Care Med 165 : 277-304, 2002.
 
2) Liebow AA : New concepts and entities in pulmonary diseases. In : Liebow AA, Smith DE, eds. Pp 322-365, The Lung. Williams Wilkins, Baltimore, 1967.
 
3) Carrington CB, Gaensler EA, Cutou RE, et al : Natural history and treated course of usual and desquamative interstitial pneumonia. N Eng J Med 298 : 801-809, 1978.
 
4) Katzenstein ALA, Fiorelli RF : Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol. 18 : 36-147, 1994.
 
5) Bjoraker JA, Ryu JH, Edwin MK, et al : Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157 : 199-203, 1998.
PubMed
6) Nagai s, Kitaichi M, Itoh H, et al : Idiopathic nonspecific interstitial pneumonia/fibrosis : comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J. 12 : 1010-1019, 1998.
PubMed
7) Selman M, King TE, Pardo A, et al : Idiopathic pulmonary fibrosis : prevailing and evolving hypothesis about its pathogenesis and implication for therapy. Ann Intern Med 134 : 136, 2001.
PubMed
8) Willis BC, Liebler JM, Luby-Phelps K, et. al : Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1 : potential role in idiopathic pulmonary fibrosis. Am J Pathol. 166 (5) : 1321-1332, 2005.
 
9) Flaherty, KR, Travis, WD, Colby, TV, et al : Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 164 : 1722-1727, 2001.
PubMed
10) Strieter RM. Pathogenesis and natural history of usual interstitial pneumonia. The whole story or the last chapter of a long novel. Chest 128 : 526s-532s, 2005.
PubMed
11) Castriotta RJ, Eldadah BA, Foster WM, Halter JB, Hazzard WR, Kiley JP, King TE Jr, Horne FM, Nayfield SG, Reynolds HY, Schmader KE, Toews GB, High KP : Workshop on idiopathic pulmonary fibrosis in older adults. Chest 138 : 693-703, 2010 Sep.
PubMed
12) Fernandez Perez ER, Daniels CE, Schroeder DR, et al : Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis : a population-based study. Chest. Jan 137 : 129-137. 2010
PubMed
13) Cottin V, Nunes H, Brillet PY, et al : Combined pulmonary fibrosis and emphysema : a distinct underrecognised entity. Eur Respir J 26 : 586-593, 2005.
PubMed
14) Flaherty KR, Andrei AC, Murray S, et al : Idiopathic pulmonary fibrosis : prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med. Oct 1 174 : 803-809, 2006.
PubMed
15) Swigris JJ, Swick J, Wamboldt FS, et al : Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis. Chest. Sep 136 : 841-848, 2009.
PubMed
16) Patel NM, Lederer DJ, Borczuk AC, Kawut SM : Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 132 : 998-1006, 2007.
PubMed
17) Handa T, Nagai S, Miki S, Ueda S, Yukawa N, Fushimi Y, Ito Y, Ohta K, Mimori T, Mishima M, Izumi T : Incidence of pulmonary hypertension and its clinical relevance in patients with interstitial pneumonias : comparison between idiopathic and collagen vascular disease associated interstitial pneumonias.Intern Med 46 : 831-837, 2007.
PubMed
18) Tabuena RP, Nagai S, Tsutsumi T, Handa T, Minoru T, Mikuniya T, Shigematsu M, Hamada K, Izumi T, Mishima M : Cell profiles of bronchoalveolar lavage fluid as prognosticators of idiopathic pulmonary fibrosis/usual interstitial pneumonia among Japanese Patients. Respiration. t ; 72 : 490-498, 2005.
 
19) Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK : An Official ATS/ERS/JRS/ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management. Am J Respir Crit Care Med. Mar 15 ; 183 : 788-824, 2011.
 
20) Nagao T, Nagai S, Kitaichi M, Hayashi M, Shigematsu M, Mishima M : Serial evaluation of HRCT findings in patients with IPF/UIP. Respiration 69 : 413-419, 2002.
 
21) Sverzellati N, Wells AU, Tomassetti S, et al : Biopsy-proved Idiopathic pulmonary fibrosis : spectrum of nondiagnostic thin-section CT diagnosis. Radiology 254 : 957-964, 2010.
PubMed
22) 日本呼吸器学会 : 特発性間質性肺炎 診断と治療の手引き 2007 南江堂
 
23) Flaherty KR, Colby TV, Travis WD, Toews GB, Mumford J, Murray S, Thannickal VJ, Kazerooni EA, Gross BH, Lynch JP 3rd, Martinez F Fibroblastic foci in usual interstitial pneumonia : idiopathic versus collagen vascular disease. JAm J Respir Crit Care Med 167 (10) : 1410-1415, 2003.
 
24) Kim DS, Collard HR, King TE Jr : Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc. Jun3 : 285-292, 2006.
 
25) Ley B, Collard HR, King TE Jr : Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. Feb 15 ; 183 : 431-440, 2011.
 
26) Collard HR, Bethany BM, Flaherty KR, et al : Pulmonary perspective Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176 : 636-643, 2007.
 
27) Song JW, Hong SB, Lim CM, Koh Y, Kim D : Acute exacerbation of idiopathic pulmonary fibrosis : incidence, risk factors and outcome. Eur Respir J. 37 : 356-363, 2011.
PubMed
28) Ganesh Raghu, Harold R. Collard, Jim J. Egan, Fernando J. Martinez, Juergen Behr, Kevin K. Brown, Thomas V. Colby, Jean-Francois Cordier, Kevin R. Flaherty, Joseph A. Lasky, David A. Lynch, Jay H. Ryu, Jeffrey J. Swigris, Athol U. Wells, Julio Ancochea, Demosthenes Bouros, Carlos Carvalho, Ulrich Costabel, Masahito Ebina, David M. Hansell, Takeshi Johkoh, Dong Soon Kim, Talmadge E. King, Jr., Yasuhiro Kondoh, Jeffrey Myers, Nestor L. Muller, Andrew G. Nicholson, Luca Richeldi, Moises Selman, Rosalind F. Dudden, Barbara S. Griss, Shandra L. Protzko, and Holger J. Schunemann on behalf of the ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management Am. J. Respir. Crit. Care Med., Mar 183 : 788-824, 2011.
 
29) King TE Jr, Albera C, Bradford WZ, et al : Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE) : a multicentre, randomised, placebo-controlled trial. Lancet 374 : 222-228, 2009.
PubMed
30) Demedts M, Behr J, Buhl R, et al : High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. Nov 24 ; 353 : 2229-2242, 2005.
PubMed
31) Nagai S, Hamada K, Shigematsu M, Taniyama M, Yamauchi S, Izumi T : Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis. Intern Med 41 : 1118-1123, 2002 Dec.
PubMed
32) Azuma A, Nukiwa T, Tsuboi E, et al : Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. May 1 ; 171 : 1040-1047, 2005.
PubMed
33) Taniguchi H, Ebina M, Kondoh Y, et al : Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J. Apr 35 (4) : 821-829, 2010.
PubMed
34) Noble PW, Albera C, Bradford WZ, et al : Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY) : two randomised trials. Lancet. May 21 ; 377 : 1760-1769, 2011.
PubMed
35) Raghu G, Brown KK, Costabel U, et al : Treatment of idiopathic pulmonary fibrosis with etanercept : an exploratory, placebo-controlled trial. Am J Respir Crit Care Med 178 : 948-955, 2008.
PubMed
36) King TE Jr, Behr J, Brown KK, et al : BUILD-1 : a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. Jan 1 ; 177 : 75-81, 2008.
PubMed
37) Zisman DA, Schwarz M, Anstrom KJ, Collard HR, Flaherty KR : A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med. Aug 12 ; 363 : 620-628, 2010.
PubMed
38) The Idiopathic Pulmonary Fibrosis Clinical Research Network, Zisman DA, Schwarz M, Anstrom KJ, Collard HR, Flaherty KR : A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med 363 : 620-628, 2010.
PubMed
39) Daniels CE, Lasky JA, Limper AH, Mieras K, Gabor E, Schroeder DR : Imatinib treatment for idiopathic pulmonary fibrosis : Randomized placebo-controlled trial results. Am J Respir Crit Care Med. Mar 15 ; 181 : 604-610, 2010.
 
40) Richeldi L, Costabel U, Selman M, et al : Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 365 : 1079-1087, 2011.
PubMed
P.130 掲載の参考文献
1) Kitaichi M : Pathologic features and the classification of interstitial pneumonia of unknown etiology. Bull Chest Dis Res Inst Kyoto Univ 23 : 1-18, 1990.
PubMed
2) Katzenstein AL, Fiorelli RF : Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 18 : 136-147, 1994.
PubMed
3) Cottin V, Donsbeck AV, Revel D, Loire R, Cordier JF : Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12patients. Am J Respir Crit Care Med 158 : 1286-1293, 1998.
 
4) Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, Offord KP : Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157 : 199-203, 1998.
PubMed
5) Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, Colby TV : Idiopathic nonspecific interstitial pneumonia/fibrosis : comparison with idiopathic pulmonary fibrosis and BOOP (corrigendum : Eur Respir J 1999 ; 13 : 171). Eur Respir J 12 : 1010-1019, 1998.
 
6) Travis WD, Matsui K, Moss JE, Ferrans VJ : Idiopathic nonspecific interstitial pneumonia : prognostic significance of cellular and fibrosing patterns. Survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 24 : 19-33, 2000.
 
7) Muller NL, Colby TV : Idiopathic interstitial pneumonias : high-resolution CT and histologic findings. Radiographics 17 : 1016-1022, 1997.
 
8) Daniil ZD, Gilchrist FC, Nicholson AG, Hansell DM, Harris J, Colby TV, du Bois RM : A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 160 : 899-905, 1999.
PubMed
9) American Thoracic Society/European Respiratory Society : American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002.
PubMed
10) 日本呼吸器学会びまん性肺疾患診断・治療ガイドライン作製委員会. 非特異性間質性肺炎 (NSIP). 特発性間質性肺炎診断と治療の手引き改訂2版. 南江堂. p74-82, 2011.
 
11) Travis WD, Hunninghake G, King TE Jr, et al : Idiopathic Nonspecific Interstitial Pneumonia. Report of an American Thoracic Society Project. Am J Respir Crit Care Med. 177 : 1338-1347, 2008.
PubMed
12) Kinder GW, Collard HR, Koth L, et al : Idiopathic Nonspecific Interstitial Pneumonia. Lung Manifestation of Undifferentiated Connective Tissue Disease? Am J Respir Crit Care Med. 176 : 691-697, 2007.
 
13) Fischer A, West SG, Swigris JJ, et al : Connective Tissue Disease-Associated Interstitial Lung Disease : A Call for Clarification. Chest 138 : 251-256, 2010.
 
14) Vij R, Noth I, Strek ME : Autoimmune-Featured Interstitial Lung Disease : A Distinct Entity Chest 140 : 1292-1299, 2011.
PubMed
15) Akira M, Inoue Y, Arai T, et al : Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia. Thorax 66 : 61-65, 2011.
PubMed
16) Sumikawa H, Johkoh T, Yamamoto S, et al : Volume Histogram Analysis for Lung Thin-Section Computed Tomography : Differentiation Between Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia. J Comput Assist Tomogr 31 : 936-942, 2007.
PubMed
17) Akira M, Inoue Y, Kitaichi M, et al : Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia with and without Concurrent Emphysema : Thin-Section CT Findings. Radiology. 251 : 271-279, 2009.
PubMed
18) Park JS, Lee KS, Kim JS, Park CS, Suh YL, Choi DL, Kim KJ : Nonspecific interstitial pneumonia with fibrosis : radiographic and CT findings in seven patients. Radiology 195 : 645-648, 1995.
PubMed
19) Kim TS, Lee KS, Chung MP, Han J, Park JS, Hwang JH, Kwon OJ, Rhee CH : Nonspecific interstitial pneumonia with fibrosis : high-resolution CT and pathologic findings. Am J Roentgenol 171 : 1645-1650, 1998.
 
20) Kim EY, Lee KS, Chung MP, Kwon OJ, Kim TS, Hwang JH : Nonspecific interstitial pneumonia with fibrosis : serial high-resolution CT findings with functional correlation. Am J Roentgenol 173 : 949-953, 1999.
 
21) Flaherty KR, Travis WD, Colby TV, et al : Histopathologic Variability in Usual and Nonspecific Interstitial Pneumonias. Am J Respir Crit Care Med 164 : 1722-1727, 2001.
PubMed
22) Kondoh Y, Taniguchi H, Yokoi T, et al : Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Eur Respir J 25 : 528-533, 2005.
PubMed
23) Watanabe K, Higuchi K, Ninomiya K, et al : Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia. Eur Respir J 20 : 1213-1219, 2002.
PubMed
24) Park IN, Jegal Y, Kim DS, et al : Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J 33 : 68-76, 2009.
PubMed
25) Akira M, Inoue Y, Yamamoto Y, et al : Non-specific interstitial pneumonia : findings on sequential CT svcans of nine patients. Thorax 55 : 854-859, 2000.
 
26) Hartman TE, Swensen SJ, Hansell DM, et al : Nonspecific interstitial pneumonia : variable appearance at high-resolution chest CT. Radiology 217 : 701-705, 2000.
PubMed
P.136 掲載の参考文献
1) Colby TV : Bronchiolitis : pathologic considerations. Am J Clin Pathol 109 : 101-109, 1998.
PubMed
2) Niewoehner DE, Kleinerman J,Rice DB : Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 291 : 755-758, 1974.
PubMed
3) Cosio MG, Hale KA, Niewoehner DE : Morphologic and morphometric effect of prolonged cigarette smoking on the small airways. Am Rev Respir Dis 122 : 265-271, 1980.
PubMed
4) Wright JL, Lawson LM, Pare PD, et al : Morphology of peripheral airways in current smokers and ex-smokers. Am Rev Respir Dis 127 : 474-477, 1983.
PubMed
5) Myers JL, Veal CF, Shin MS, et al : Respiratory bronchiolitis causing interstitial lung disease ; a clinicopathological study of six cases. Am Rev Respir Dis 135 : 880-884, 1987.
PubMed
6) Yousem SA, Colby TV, Gaensler EA : Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 64 : 1373-1380, 1989.
PubMed
7) Sadikot RT, Johnson J, Loyd JE, et al : Respiratory bronchiolitis associated with severe dyspnea, exertional hypoxemia, and clubbing. Chest 117 : 282-285, 2000.
PubMed
8) Moon J, du Bois RM, Colby TV, et al : Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 54 : 1009-1014, 1999.
PubMed
9) Katzenstein AA, Myers JL : Idiopathic pnlmonary fibrosis ; clinical of pathologic classification. Am J Respir Crit Care Med 157 : 1301-1315, 1998.
 
10) Heyneman LE, Ward S, Lynch DA, et al : Respiratory bronchiolitis, respiratory bronchiolitisassociated interstitial lung disease, and desquamative interstitial pneumonia : different entities or part of the spectrum of the same disease process? AJR 173 : 1617-1622, 1999.
PubMed
11) Ryu JH, Colby TV, Hartman TE, et al : Smoking-related interstitial lung diseases ; a concise review. Eur Respir J 17 : 122-132, 2001.
PubMed
12) Caminati A, Harari S : Smoking-related interstitial pneumonias and pulmonary Langerhans Cell Histiocytosis. Proc Am Thorac Soc 3 : 299-306, 2006.
PubMed
13) Patel RR, Ryu JH,Vassallo R : Cigarette smoking and diffuse lung disease. Drugs 68 : 1511-1527, 2008.
PubMed
14) Attili AK, Kazerooni EA, Gross BH, et al : Smoking-related interstitial lung disease : Radiologicclinical-pathologic correlation.RadioGraphics 28 : 1383-1398, 2008.
 
15) 野間恵之, 小橋陽一郎 : Respiratory bronchiolitis associated interstitial lung disease (RB-ILD). 臨床画像 15 : 1340-1346, 1999.
 
16) King TE : Respiratory bronchiolitis associated interstitial lung disease. Clinics in Chest Medicine 14 : 693-698, 1993.
PubMed
17) Portnoy J, Veraldi KL, Schwarz MI,et al : Respiratory bronchiolitis-interstitial lung disease : Longterm outcome. Chest 131 : 664-671, 2007.
PubMed
18) Gruden JF, Webb WR : CT finding in a proved case of respiratory bronchiolitis. AJR 161 : 44-46, 1993.
 
19) Holt RM, Schmidt RA, Godwin JD, et al : High resolution CT in respiratory bronchiolitisassociated interstitial lung disease. JCAT 17 : 46-50, 1993.
 
20) Churg A, Muller NL, Wright JL : Respiratory bronchiolitis/interstitial lung disease fibrosis, pulmonary function, and evolving concepts. Arch Pathol Lab Med 134 : 27-32, 2010
PubMed
P.142 掲載の参考文献
1) Liebow AA, Steer A, Billingsley JG, et al : Desquamative interstitial pneumonia. Am J Med 39 : 369-404, 1965.
PubMed
2) Brewer DB, Heath D, Asquith P : Electron microscopy of desquamative interstitial pneumonia. J Pathol 97 : 317-323, 1969.
PubMed
3) Tubbs RR, Benjamin SP, Reich NE, et al : Desquamative interstitial pneumonia. Cellular phase of fibrosing alveolitis. Chet 72 : 159-165, 1977.
 
4) King TE Jr : Idiopathic pulmonary fibrosis. In : Schwarz MI, King TE Jr, Eds. Interstitial lung disease, 2nd ed. St. Louis : Mosby Year Book 367-403, 1993.
 
5) Carrington CB, Gaensler EA, Coutu RE, et al : Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 298 : 801-809, 1978.
PubMed
6) Travis WD, Colby TV, Koss MN : Non-neoplastic Disorders of the Lower Respiratory Tract. American Registry of Pathology, Washington : 109-115, 2002.
 
7) 日本呼吸器学会編. 特発性間質性肺炎診断と治療の手引き, 改訂第2版. 南江堂 : 93-96, 2011.
 
8) American Thoracic Society : Idiopathic pulmonary fibrosis : diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and European Respiratory Society (ERS). Am J Respir Crit Care Med 161 : 646-664, 2000.
PubMed
9) Myers JL, Veal CF Jr, Shin MS, et al : Respiratory bronchiolitis causing interstitial lung disease : a clinicopathologic study of six cases. Am Rev Respir Dis 135 : 880-884, 1987.
PubMed
10) Katzenstein A : Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease. 4th edition. Saunders : 61-66, 2006.
 
11) Gaensler EA, Gogg AM, Prowse CM : Desquamative interstitial pneumonia. New Engl J Med 274 : 113-128, 1966.
 
12) American Thoracic Sosiety/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002.
PubMed
13) Feigin DS, Friedman PJ : Chest radiography in desquamative interstitial pneumonitis : a review of 37 patients. AJR 134 : 91-99, 1980.
PubMed
14) Heyneman LE, Ward S, Lynch DA, et al : Respiratory bronchiolitis, respiratory bronchiolitisassociated interstitial lung disease, and desquamative interstitial pneumonia : different entities or part of the spectrum of the same disease process? AJR 173 : 1617-1622, 1999.
PubMed
15) 石井寛, 迎寛, 松永優子, 他 : 剥離性間質性肺炎の一例～本邦報告例の臨床的検討～. 日呼吸会誌 40 : 160-165, 2002.
 
16) Kawabata Y, Takemura T, Hebisawa A, et al : Eosinophilia in bronchoalveolar lavage fluid and architectural destruction are features of desquamative interstitial pneumonia. Histopathology 52 : 194-202, 2008.
PubMed
17) Nicholson AG, Colby TV, Dubois RM, et al : The prognostic significance of the histologic pattern interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 162 : 2213-2217, 2000.
 
18) 余語由里香, 小山田吉孝, 石井誠, 他 : 胸腔鏡下肺生検後に急性増悪した剥離性間質性肺炎の1例. 日呼吸会誌 41 : 386-391, 2003.
Medical*Online
19) Arai T, Inoue Y, Hayashi S, et al : Intractable desqumative interstitial pneumonia in a tattooed man. Intern Med 45 : 1055-1058, 2006.
 
20) Flusser G, Gurman G, Zirkin H, et al : Desquamative interstitial pneumonitis causing acute respiratory failure, responsive only to immunosuppressants. Respiration 58 : 324-326, 1991.
PubMed
21) Gould TH, Buist MD, Meredith D, et al : Fluminant desquamative interstitial pneumonitis. Anesthe Intensive Care 26 : 677-679, 1998.
 
P.148 掲載の参考文献
1) Davison AG, Heard BE, et al : Cryptogenic organizing pneumonia. Q J Med 52 : 382-394, 1983.
PubMed
2) Epler GR, Colby TV, et al : Bronchiolitis obliterans organizing pneumonia. N Engl J Med 312 : 152-158, 1985.
PubMed
3) ATS/ERS International Multidisciplinary Consensus Classification of Idiopathic Interstitial Pneumonias : General Principles and Guidelines. American Thoracic Society, Toronto, May 2000.
 
4) Epler GR : Bronchiolitis oblterans organizing pneumonia. Arch Intern Med 161 : 158-164, 2001.
 
5) Katzenstein ALA : Acute lung injury patterns : Diffuse alveolar damage andbronchiolitis obliterans-organaizing pneumonia. In Surgical pathology of non-neoplastic lung disease. 4th ed. Saunders : 34-49, 2006.
 
6) Muller NL, Staples CA, et al : Bronchiolitis obliterans organizing pneumonia : CT features in 14 patients. AJR 154 : 983-987, 1990.
PubMed
7) Lee KS, Kullnig, et al : Cryptogenic organizing pneumonia : CT findings in 43 patients. AJR 162 : 543-546, 1994.
PubMed
8) Akira M, Yamamoto S, et al : Bronchiolitis obliterans organizing pneumonia manifesting as multiple large nodules or masses. AJR 170 : 291-295, 1998.
PubMed
9) Kim SJ, Lee KS, et al : Reversed halo sigh on high-resolution CT of cryptogenic organizing pneumonia : Diagnostic implications. AJR 180 : 1251-1254, 2003.
 
10) Ujita M, Renzoni EA, at al : Organizing pnumonia : Perilobular pattern at thin-section CT. Radilogy 232 : 757-761, 2004.
 
11) 泉考英, 長井苑子, 他 : BOOP症例におけるBALF 細胞所見-特にUIP症例との比較-日胸疾会誌 27 : 474-480, 1989.
 
12) Poletti V, Cazzato S, et al : The diagnostic value of bronchoalveolar lavage and transbronchial lung biopsy in cryptogenic organizing pneumonia. Eur Respir J 9 : 2513-2516, 1996.
PubMed
13) Jara-Palomares, Gomez-Izquierdo L, et al : Utility of high-resolution computed tomography and BAL in cryptogenic organizing pneumonia. Resp Med 104 : 1706-1711, 2010.
 
14) Drakopanagiotakis F, Paschlaki K, et al : Cryptogenic and secondary organizing pneumonia. Clinical presentation, ragiographic findings, treatment response, and prognosis. Chest 139 : 893-900, 2011.
 
P.154 掲載の参考文献
1) American Thoracic Society/European Respiratory Society. Acute interstitial pneumonia. In American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 15 ; 165 (2) : 292-294, 2002.
 
2) Katzenstein A-L A : Acute interstitial pneumonia (Hamman-Rich disease). In Surgical pathology of non-neoplastic lung disease. 4th ed. Saunders : 66-69, 2006.
 
3) Ichikado K, Suga M, Muller NL, et al : Acute interstitial pneumonia : comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am J Respir Crit Care Med 1 ; 165 (11) : 1551-1556, 2002.
PubMed
4) Kondoh Y, Taniguchi H, Kawabata Y, et al : Acute exacerbations in idiopathic pulmonary fibrosis ; analysis of clinical and pathologic findings in three cases. Chest 103 : 1808-1912, 1993.
PubMed
5) Collard HR, Moore BB, Flaherty KR, et al : Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176 : 636-643, 2007.
PubMed
6) 日本呼吸器学会びまん性肺疾患診断・治療ガイドライン作成委員会. 特発性肺線維症 (IPF) の急性増悪. 特発性間質性肺炎診断と治療の手引き 改訂第2版 南江堂 : 67-73, 2011.
 
7) Raghu G, Collard HR, Egan JJ, et al : An official ATS/ERS/JRS/ALAT statement : idiopathic pulmonary fibrosis : evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 15 ; 183 (6) : 788-824, 2011.
 
8) Song JW, Hong SB, Lim CM, et al : Acute exacerbation of idiopathic pulmonary fibrosis : incidence, risk factors and outcome. Eur Respir J 37 (2) : 356-363, 2011.
PubMed
9) Kondoh Y, Taniguchi H, Katsuta, et al : Risk factors of acute exacerbation of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 27 (2) : 103-110, 2010.
PubMed
10) Taniguchi H, Ebina M, Kondoh Y, et al : Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 35 (4) : 821-829, 2010.
PubMed
11) Wootton SC, Kim DS, Kondoh Y, et al : Viral Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Am. J. Respir. Crit. Care Med 183 : 1698-1702, 2011.
PubMed
12) Park IN, Kim DS, Shim TS, Lim CM, Lee SD, et al : Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 132 : 214-220, 2007.
PubMed
13) Suda T, Kaida Y, Nakamura Y, Enomoto N, Fujisawa T, et al : Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med 103 : 846-853, 2009.
PubMed
14) Tachikawa R, Tomii K, Ueda H, et al : Clinical features and outcome of acute exacerbation of interstitial pneumonia : collagen vascular disease-related versus idiopathic. Respiration 83 : 20-27, 2012.
PubMed
15) Olson AL, Huie TJ, Groshong SD, Cosgrove GP, Jansen WJ, et al : Acute exacerbations of fibrotic hypersensitivity pneumonitis Chest 134 : 844-850, 2008.
 
16) Akira M, Kozuka T, Yamamoto S, et al : Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med 178 : 372-378, 2008.
PubMed
17) Fujimoto K, Taniguchi H, Jokoh T et al : Acute exacerbation of idiopathic pulmonary fibrosis : high-resolution CT scores predict mortality. Eur Radiol 22 : 83-92, 2012.
 
18) Kubo H, Nakayama K, Yanai M, et al : Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 128 (3) : 1475-1482, 2005.
PubMed
19) Seo Y, Abe S, Kurahara M, et al : Beneficial effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on acute exacerbation of idiopathic pulmonary fibrosis. Intern Med 45 (18) : 1033-1038, 2006.
PubMed
20) Enomoto N, Suda T, Uto T, et al : Possible therapeutic effect of direct haemoperfusion with a polymyxin B immobilized fibre column (PMX-DHP) on pulmonary oxygenation in acute exacerbations of interstitial pneumonia. Respirology 13 (3) : 452-460, 2008.
PubMed
21) Tomii K, Tachikawa R, Chin K, et al : Role of non-invasive ventilation in managing life-threatening acute exacerbation of interstitial pneumonia. Intern Med 49 (14) : 1341-1347, 2010.
PubMed
22) Yokoyama T, Kondoh Y, Taniguchi H, et al : Noninvasive ventilation in acute exacerbation of idiopathic pulmonary fibrosis. Intern Med 49 (15) : 1509-1514, 2010.
PubMed
P.161 掲載の参考文献
1) Liebow AA, Carrington CB : The interstitial pneumonias. In : Simon M, PotchenEJ, LeMay M, eds. Frontiers of pulmonary radiology 1. New York : Grune and Stratton, 102-141, 1969.
 
2) Liebow AA, Carrington CB : Diffuse lymphoreticular infiltration associated with dysproteinemia. Med Clin North Am 57 : 809-843, 1973.
PubMed
3) Colby TV, Carrington CB : Lymphoreticular tumors and infiltrates of the lung. Pathol Annu 18 Pt 1 : 27-70, 1983.
 
4) Koss MN, Hochholtzer L, Langloss JM, et al : Lymphoid interstitial pneumonitis : clinicopathologic findings in 18 patients. Pathology 19 : 178-185, 1987.
 
5) Travis WD, Galvin JR : Non-neoplastic pulmonary lymphoid lesions. Thorax 56 : 964-971, 2001.
PubMed
6) American Thoracic Society/ European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002.
PubMed
7) Travis WD, Hunninghake G, King TE Jr., et al : Idiopathic nonspecific interstitial pneumonia : report of an American Thoracic Society project. Am J Respir Crit Care Med 177 : 1338-1347, 2008.
PubMed
8) Cha SI, Fessler MB, Cool CD, Schwarz MI, Brown KK : Lymphoid interstitial pneumonia : clinical features, associations and prognosis. Eur Respir J 28 : 364-369, 2006.
PubMed
9) 日本呼吸器学会びまん性肺疾患診断・治療ガイドライン作製委員会 : リンパ急性間質性肺炎 (LIP). 特発性間質性肺炎診断と治療の手引き改訂2版. 南江堂. 100-102, 2011.
 
10) Strimlan CV, Rosenow EC, Weiland LH, et al : Lymphocytic interstitial pneumonitis. Review of 13 cases. Ann Intern Med 88 : 616-621, 1978.
PubMed
11) Julsrud PR, Brown LR, Li CY, et al : Pulmonary processes of mature-appearing lymphocytes : Pseudolymphoma, well-differentiated lymphocytic lymphoma, and lymphocytic interstitial pneumonia. Radiology 127 : 289-296, 1978.
PubMed
12) McGuinness G, Scholes JV, Jagirdar JS, et al : Unusual lymphoproliferative disorders in nine adults with HIV or AIDS : CT and pathologic findings. Radiology 197 : 59-65, 1995.
PubMed
13) Amorosa JK, Miller RW, Laraya-Cuasay L, et al : Bronchiectasis in children with lymphocytic interstitial pneumonia and acquired immune deficiency syndrome. Plain film and CT observations. Pediatr Radiol 22 : 603-606, 1992.
PubMed
14) Johkoh T, Muller NL, Pichford HA, et al : Lymphocytic interstitial pneumonia : thin-section CT findings in 22 patients. Radiology 212 : 567-572, 1999.
 
15) Honda O, Johkoh T, Ichikawa K, et al : Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high resolution CT. Am J Roentgenol 173 : 71-74, 1999.
 
16) Fishback N, Koss M : Update of lymphoid interstitial pneumonitis. Curr Opin Pulm Med 2 : 429-433, 1996.
PubMed
17) Koss MN, Hochholzer L, Langloss JM, et al : Lymphoid interstitial pneumonia : Clinicopathological and immunopathological findings in 18 cases. Pathology 19 : 178-185, 1987.
 
18) DcCoteau WE, Tourville D, Ambrus JL, et al : Lymphoid interstitial pneumonia and autoerythrocyte sensitization syndrome. A case with deposition of immunoglobulins on the alveolar basement membrane. Arch Intern Med 134 : 519-522, 1974.
PubMed
19) Nicholson AG, Wotherspoon AC, Diss TC, et al : Reactive pulmonary lymphoid disorders. Histopathology 26 : 178-185, 1995.
 
20) Betsuyaku T, Munakata M, Yamaguchi E, et al : Establishing diagnosis of pulmonary malignant lymphoma by gene rearrangement analysis of lymphocytes in bronchoalveolar lavage fluid. Am J Respir Crit Care Mrd 149 : 526-529, 1994.
 
21) Kradin RL, Young RH, Kradin LA, et al : Immunoblastic lymphoma arising in chronic lymphoid hyperplasia of the pulmonary interstitium. Cancer 50 : 1339-1343, 1982.
PubMed
22) Teruya-Feldstein J, Temeck BK, Sloas MM, et al : Pulmonary malignant lymphoma of mucosaassociated lymphoid tissue (MALT) arising in a pediatric HIV-positive patient. Am J Surg Pathol 19 : 357-363, 1995.
 
23) Murphy PM, Fox C, Travis MD, et al : Acquired immunodeficiency syndrome may present as severe restrictive lung disease. Am J Med 86 : 237-240, 1989.
 
24) Travis WD, Matsui K, Moss JE, et al : Idiopathic nonspecific interstitial pneumonia : prognostic significance of cellular and fibrosing patterns. Survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 24 : 19-33, 2000.
 
25) Schwarz M : Lymphoplasmacytic infiltrations of the lung. In : Schwarz M, ed. Interstitial Lung Disease. 4th ed. BC Decker, Hamilton, 2003.
 
P.165 掲載の参考文献
1) Sontheimer RD : Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J. Am. Acad. Dermatol 46 : 626-636, 2002.
PubMed
2) Aletaha D, Neogi T, Silman AJ, et al : 2010 Rheumatoid arthritis classification criteria : an American College of Rheumatology/European League Against Rheumatism collabolative initiative. Ann Rheum. Dis 69 : 1580-1588, 2010.
PubMed
3) Fischer A, West SG, Suigiris JJ, et al : Connective tissue disease-associated with interstitial lung disease a call for classification. Chest 138 : 251-256, 2010.
 
4) Kinder BW, Collard HR, Koth L, et al : Idiopathic nonspecific interstitial pneumonia : Lung manifestation of undefferenciated connective tissue disease? Am. J. Respir. Crit. Care Med 176 : 691-697, 2007.
PubMed
5) Wolfe F, Caplan L, Micaud K : Treated for rheumatoid arthritis and the risk of hospitalization for pneumonia associated with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis Rheum 54 : 628-634, 2006.
 
P.170 掲載の参考文献
1) American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002.
PubMed
2) Ikezoe J, et al : High-resolution CT findings of lung disease in patients with poly myositis and dermatomyositis. J Thorac Imag 11 : 250-259, 1996.
 
3) Douglas WW, et al : Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 164 : 1182-1185, 2001.
PubMed
4) Arroliga AC, et al : Pulmonary manifestation of scleroderma. J Thorac Imag 7 : 30-45, 1992.
 
5) Chan TYK, et al : Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis : morphological differences on computed tomographic scan. Thorax 52 : 265-270, 1997.
 
6) Bankier AA, et al : Discrete lung involvement in systemic lupus erythematosus : CT assessment. Radiology 196 : 835-840, 1995.
PubMed
7) Deheinzelin D, et al : Interstitial lung disease in primary sjogren's syndrome. Am J Respir Crit Care Med 154 : 794-799, 1996.
PubMed
8) 野間恵之ほか : 皮膚筋炎・多発筋炎に伴う間質性肺炎とUIPの比較 HRCT像を中心に. 臨放 42 : 105-110, 1997.
 
9) Fischer A, et al : Connective tissue disease associated interstitial lung disease : a call for clarification. Chest 138 : 251-256, 2010.
 
10) Fujita J, et al : Idiopathic non-specific interstitial pneumonia : as an "autoimmune interstitial pneumonia". Respiratory Med 99 : 234-240, 2005.
 
P.177 掲載の参考文献
1) Lie JT : Pulmonary involvement in collagen-vascular disorders. In : Saldana MJ ed. Pathology of Pulmonary Disease. J.B. Lippincott, Philadelphia, 781-790, 1994.
 
2) Arnett FC, Edworthy SM, Bloch DA et al : The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 : 315-324, 1988.
PubMed
3) Vitali C, Bombardieri S, Moutsopulus HM et al : The European Study Group on Diagnostic Criteria for Sjoegren's syndrome. Assessment for the European classification criteria for Sjoegren's syndrome in a series of clinically defined cases : results of a prospective multicenter study. Ann Rheum Dis 55 : 116-121, 1996.
 
4) Tan EM, Cohen AS, Fries JF et al : The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 : 1271-1277, 1982.
PubMed
5) Subcommittee for the scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheuma 23 : 581-590, 1980.
 
6) Bohan A, Peter JB : Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292 : 344-347, 1975.
PubMed
7) Smolen JS, Steiner G : Mixed connective tissue disease : to be or not to be. Arthritis Rheuma 41 : 768-777, 1998.
 
8) McGuigan LE, Gecy AF, Edmonds JP : The immunopathology of anlylosing spondylitis. - a review. Semin Arthritis Rheum 15 : 81, 1985.
 
9) 北市正則 : 膠原病の肺病理. 呼吸 17 (11) : 1236-1241, 1998.
Medical*Online
10) 北市正則 : 膠原病の病理診断マニュアル. II. 各論-臓器病変と鑑別診断-. 8. 肺・上気道. 病理と臨床 23 臨時増刊 : 139-146, 2005.
 
11) Kitaichi M, Nagai S, Ito I, Yanagai S : Pulmonary pathology in association with connective tissue disorders. Curr Diag Pathol 10 : 291-303, 2004.
 
12) 北市正則 : 膠原病の気道病変-病理所見 : 特に細胞性細気管支炎 (cellular bronchiolitis) について-. Therapeutic Research 28 (8) : 1639-1645, 2007.
Medical*Online
13) 末松栄一 : RA肺障害の見方. 2009年第10回博多リウマチセミナー. 1-7, 2009.
 
14) Yousem SA, Colby TV, Carrington CB : Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 13 : 770-777, 1985.
 
15) Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, Kim DS, Handa T, Izumi T, Mishima M : Pulmonary manifestations of primary Sjoegren's syndrome. A clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171 : 632-638, 2005.
PubMed
16) Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM : Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 165 : 1581-1586, 2002.
PubMed
17) Kim DS,Yoo B, Koh Y, KimEK, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Colby TV, Kitaichi M : The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 19 : 121-127, 2002.
 
18) Tazelaar HD, Viggiano RW, Rickersgill J, Colby TV : Interstitial lung disease in polymyositis and dermatomyositis : Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 141 : 727-733, 1990.
 
19) Douglas WW, Tazelaar HD, Hartmann TE, Hartman RP, Decker PA, Schroeder DR, Ryu JH : Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 164 : 1182-1185, 2001.
 
20) Kinder BW, Collard HR, KothL, Daikh DI, Wolters PJ, Elicker B, Jones KD, King TEJr : Idiopathic nonspecific interstitial pneumonia. Lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 176 : 691-697, 2007.
PubMed
21) Fischer A, West SG, Swigris JJ, Brown KK, duBois RM : Connective tissue disease-associated interstitial lung disease : a call for clarification. Chest 138 : 251-256, 2010.
 
22) Vij R, Noth I, Strek ME : Autoimmune-featured interstitial lung disease : a distinct entity. Chest 140 : 1292-1299, 2011.
PubMed
P.181 掲載の参考文献
1) 中島洋 : 治療, 臨床経過をめぐる包括的討論 関節リウマチの胸部病変 固有病変から薬剤性肺炎まで 日本呼吸器学会雑誌 44 増 : 57, 2006.
 
2) Kim DS : Interstitial lung disease in rheumatoid arthritis : recent advances. Curr. Opin. Pulm. Med 12 : 346-353, 2006.
PubMed
3) American Thoracic Society : American Thoracic Society/European Respiraory Society. International Multidisciplinary Concensus Classification of the Idiopathic interstitial pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiraory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 Am. J. Respir. Crit. Care Med 165 : 277-304, 2002.
 
4) Nicholson AG, Colby TV, Wells AU : Histopathological approach to patterns of Interstitial pneumonia in patients with connective tissue disorders. Sarcoidosis Vasc. Diffuse Lung Dis 19 : 10-17, 2002.
 
5) Park JH, Kim DS, Park IN, et al : Prognosis of fibrotic interstitial pneumonia : idiopathic versus collagen vascular disease-related. Am. J. Respir. Crit. Care Med 175 : 705-711, 2007.
PubMed
6) 荒武弘一朗, 江口勝美, 右田清志他 : 間質性肺炎の急性増悪を認めた慢性関節リウマチの1剖検例 日本臨床免疫学会会誌 21 : 129-136, 1998.
 
7) 日本呼吸器学会 : 薬剤性肺障害の評価, 治療についてのガイドライン (社団法人日本呼吸器学会薬剤性肺障害ガイドライン作成委員会), 東京, 社団法人日本呼吸器学会 : 9-32, 2006.
 
8) 酒井文和, 長谷川瑞江, 木村文子 : 薬剤性肺障害 : 抗リウマチ薬 画像診断, 24 : 224-232, 2008.
 
9) Yamazaki H, Isogai S, Sakurai T, et al : A case of adalimumab-associated interstitial pneumonia with rheumatoid arthritis. Mod. Rheumatol 20 : 518-521, 2010.
PubMed
10) Miwa Y, Isozaki T, Wakabayashi K, et al : Tacrolimus-induced lung injury in a rheumatoid arthritis patient with interstitial pneumonia. Mod. Rheumatol 18 : 208-211, 2008.
 
P.185 掲載の参考文献
1) Sontheimer RD : Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J. Am. Acad. Dermatol. 46 : 626-636, 2002.
PubMed
2) Goff BL, Cherin P, Cantagrel A et al : Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis. Arthritis Rheum 61 : 108-111, 2009.
 
3) Yoshida K, Kurosawa D, Kingetsu I, et al : Pneumomediastinum in dermatomyositis itself is not a poor prognostic factor : report of a case and review of the. Rheumatol. Int 28 : 913-917, 2011.
 
4) American Thoracic Society : American Thoracic Society/European Respiraory Society. International Multidisciplinary Concensus Classification of the Idiopathic interstitial pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiraory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 Am. J. Respir. Crit. Care Med 165 : 277-304, 2002.
 
5) Nicholson AG, Colby TV, Wells AU : Histopathological approach to patterns of Interstitial pneumonia in patients with connective tissue disorders. Sarcoidosis Vasc. Diffuse Lung Dis.
PubMed
6) Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M, et al : Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur. Respir J 22 : 245-250, 2003.
PubMed
7) Fujisawa T, Suda T, Nakamura Y, et al : Differences in clinical features and prognosis of Interstitial lung disease between polymyositis and dermatomyositis. J. Rheumatol 32 : 58-64, 2005.
PubMed
8) Sakamoto N, Mukae H, Fujii T, et al : Nonspecific interstitial pneumonia with poor prognosis associated with amyopathic dermatomyositis. Intern. Med 43 : 838-842, 2004.
PubMed
9) Ye S, Chen XX, Lu XY, et al : Adult clinically amyopathic dermatomyositis associated withrapid progressive Interstitial lung disease : a retrospecive cohort study. Clin. Rheumatol 26 : 1647-1654, 2007.
 
10) Huh JW, Kim DS, Lee CK, et al : Interstitial lung disease associated with polymyositisdermatomyositis. Respir. Med 101 : 1761-1769, 2007.
 
11) Suda T Fujisawa T, Enomoto N, et al : Two distinct types of interstitial lung disease associated with amyopathic dermatomyositis. Eur. Respir J 28 : 1005-1012, 2006.
 
12) Koreeda Y, Higashimoto I, Yamamoto M, et al : Clinical and rathological findings of interstitial lung disease with anti-aminoacyl-tRNAsynthetase autoantibodies. Intern Med 49 : 361-369, 2010.
 
13) Fathi M, Lundberg IE : Interstitial lung disease in polymyositis and dermatomyositis. Curr. Opin. Rheumatol 17 : 701-706, 2005.
PubMed
14) Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M, et al : Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur. Respir. J 22 : 245-250, 2003.
PubMed
15) Kotani T, Makino S, Takeuchi T, et al : Early intervention with cortocosteroids and cyclosporinA and 2-hour postdose blood concentration monitering improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis. J. Rheumatol 35 : 254-259, 2008.
 
16) Yamasaki Y, Yamada H, Yamasaki M, et al : Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis. Rheumatology 46 : 124-130, 2007.
PubMed
17) Takada K, Kishi J, Miyasaka N : Step-up versus primary intensive approach to he treatment of interstitial pneumonia associated with dermatomyositis/polymyositis : a retrospective study. Mod. Rheumatol 17 : 123-130, 2007.
 
18) Nagai K, Takeuchi T, Kotani T, et al : Therapeutic drug monitoring of cyclosporine microemulsion in interstitial pneumonia with dermatomyositis. Mod. Rheumatol 21 : 32-36, 2011.
PubMed
19) Ando M, Miyazaki E, Yamasue M, et al : Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine. Clin. Rheumatol 29 : 443-445, 2010.
PubMed
20) kameda H, Hasegawa H, Ogawa H, et al : Combination therapy with corticosteroid, cyclosporine A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J. Rheumatol 32 : 1719-1726, 2005.
 
P.189 掲載の参考文献
1) Fisher MR, Mathai SC, Champion HC, et al : Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 54 : 3043-3050, 2006.
PubMed
2) American Thoracic Society : American Thoracic Society/European Respiraory Society. International Multidisciplinary Concensus Classification of the Idiopathic interstitial pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiraory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 Am J Respir Crit Care Med 165 : 277-304, 2002.
 
3) Nicholson AG, Colby TV, Wells AU : Histopathological approach to patterns of Interstitial pneumonia in patients with connective tissue disorders. Sarcoidosis Vasc. Diffuse Lung Dis 19 : 10-17, 2002.
 
4) Lasti PI, Wells AU : Evaluation and management of alveolitis and interstitial lung disease in scleroderma. Curr. Opin. Rhumatol 15 : 748-755, 2003.
 
5) Bouros D, Wells AU, Nicholson AG, et al : Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 165 : 1581-1586, 2002.
PubMed
6) 小谷卓矢, 武内徹, 槇野茂樹 : 全身性強皮症に伴う間質性肺炎の臨床・画像・治療 日本胸部臨床 69 : 199-209, 2010.
Medical*Online
7) Hamaguchi Y, hasegawa M, Fujimoto M, et al : The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br J Dermatol 158 : 487-495, 2008.
PubMed
8) Kim DS, Yoo B, Lee JS, et al : The major histopathologic patterns of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc. Diffuse Lung Dis 19 : 121-127, 2002.
 
9) Tashkin DP, Elashoff R, Clements PJ, et al : Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354 : 2655-2666, 2006.
PubMed
10) Tashkin DP, Elashoff R, Clements PJ, et al : Effect of 1-fear treatement with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med 176 : 1026-1034, 2007.
 
11) Dheda K, Lalloo UG, Cassim B, et al : Experience with azathioprine in systemic sclerosis associated with interstitial lung disease. Clin Rheumatol 23 : 306-309, 2004.
PubMed
12) Gerbino AJ, Goss CH, Molitor JA : Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease. Chest 133 : 455-460, 2008.
PubMed
P.196 掲載の参考文献
1) Hatron PY, Tillie-Leblond I, Launay D, Hachulla E, Fauchais AL, Wallaert B : Pulmonary manifestations of Sjogren's syndrome. Presse Med. Jan ; 40 (1 Pt 2) : e49-64, 2011.
 
2) Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al : Classification criteria for Sjogren's syndrome : a revised version of the European criteria proposed by the American-European Consensus Group Ann Rheum Dis 61 : 554-558, 2002.
 
3) Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, Kim DS, Handa T, Izumi T, Mishima M : Pulmonary manifestations of primary Sjogren's syndrome : a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171 : 632-638, 2005.
PubMed
4) Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH : Interstitial lung disease in primary Sjogren syndrome Chest 130 : 1489-1495, 2006.
PubMed
5) Shi JH, Liu HR, Xu WB, Feng RE, Zhang ZH, Tian XL, Zhu YJ : Pulmonary Manifestations of Sjogren's Syndrome.Respiration 78 : 377-386, 2009.
PubMed
6) American Thoracic Society ; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002.
PubMed
7) Deheinzelin D, Capelozzi VL, Kairalla RA, Barbas Filho JV, Saldiva PH, de Carvalho CR : Interstitial lung disease in primary Sjogren's syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 154 : 794-799, 1996.
PubMed
8) Sarkar PK, Patel N, Furie RA, Talwar A : Pulmonary manifestations of primary Sjogren's syndrome.Indian J Chest Dis Allied Sci 51 : 93-101, 2009.
PubMed
9) Rajagopala S, Singh N, Gupta K, Gupta D : Pulmonary amyloidosis in Sjogren's syndrome : a case report and systematic review of the literature. Respirology 15 : 860-866, 2010.
PubMed
P.200 掲載の参考文献
1) Douglas WW, Tazelaar HD, Hartman TE, et al : Polymyositis-dermatomyositis associated interstitial lung disease.Am J Respir Crit Care Med 164 : 1182, 2001.
PubMed
2) Yoshinouchi T, Ohtsuki Y, Fujita J, et al : Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis.Rheumatol Int 26 : 121, 2005.
PubMed
3) Ito I, Nagai S, Kitaichi M, et al : Pulmonary Manifestations of Primary Sjogren's Syndrome : a clinical, radiologic, and pathologic study. Am J RespirCrit Care Med 171 : 632-638, 2005.
 
4) Kim DS, Yoo B, Lee JS, et al : The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. SarcoidosisVasc Diffuse Lung Dis 19 : 121, 2002.
 
5) Fischer A, Meehan RT, Feghali-Bostwick CA, et al : Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease.Chest 130 : 976, 2006.
PubMed
6) Eschun GM, Mink SN, Sharma S : Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis.Chest 123 : 297, 2003.
PubMed
7) Katzenstein AL, Fiorelli RF : Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 18 : 136-147, 1994.
PubMed
8) American Thoracic Society, European Respiratory Society : American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002.
PubMed
9) Travis WD, Hunninghake G, King TE Jr, et al : Idiopathicnonspecific interstitial pneumonia : report of an AmericanThoracic Society project. Am J RespirCrit Care Med 177 : 1338-1347, 2008.
 
10) Sato T, Fujita J, Yamadori I,et al : Non-specific interstitial pneumonia ; as the first clinical presentation of various collagen vascular disorders. Rheumatol Int 26 : 551-555, 2006.
PubMed
11) Park IN, Jegal Y, Kim DS,et al : Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. EurRespir J 33 : 68-76, 2009.
PubMed
12) Romagnoli M, Nannini C, Piciucchi S, et al : Idiopathic nonspecific interstitial pneumonia : an interstitial lung disease associated with autoimmune disorders? EurRespir J 38 : 384-391, 2011.
PubMed
13) Fujita J, Ohtsuki Y, Yoshinouchi T, et al : Idiopathic non specific interstitial pneumonia : as an "autoimmune interstitial pneumonia". Respir Med 99 : 234-240, 2005.
PubMed
14) Homma Y, Ohtsuka Y, Tanimura K, et al : Can interstitial pneumonia as the sole presentation of collagen vascular diseases be differentiated from idiopathic interstitial pneumonia. Respiration 62 : 248-251, 1995.
PubMed
15) Song JW, Do KH, Kim MY,et al : Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest 136 : 23-30, 2009.
PubMed
16) LeRoy EC, Maricq HR, Kahaleh MB : Undifferentiated connective tissue syndromes. Arthritis Rheum 23 : 341-343, 1980.
PubMed
17) Kinder BW, Collard HR, Koth L, et al : Idiopathic nonspecific interstitial pneumonia : lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 176 : 691-697, 2007.
PubMed
18) Kinder BW, Shariat C, Collard HR,et al : Undifferentiated connective tissue disease-associated interstitial lung disease : changes in lung function. Lung 188 : 143-149, 2010.
PubMed
19) Bodolay E, Csiki Z, Szekanecz Z,et al : Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 21 : 313-320, 2003.
PubMed
20) Mosca M, Neri R, Bombardieri S. Undifferentiated connective tissue (UCTD) : a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 17 : 615-620, 1999.
 
21) Mosca M, Tani C, Talarico R, Undifferentiated connective tissue disease (UCTD) : Simplified systemic autoimmune disease. Autoimmun Rev 10 : 256-258, 2011.
PubMed
22) Fischer A, West SG, Swigris JJ, et al : Connective tissue disease-associated interstitial lung disease : a call for clarification. Chest 138 : 251-256, 2010.
 
23) Vij R, Noth I, Strek ME, et al : Autoimmune-featured interstitial lung disease : a distinct entity. Chest 140 : 1292-1299, 2011.
PubMed
24) Ito M, Yasuo M, Yamamoto H, et al : Central airway stenosis in a patient with autoimmune pancreatitis. Eur Respir J 33 : 680-683, 2009.
 
P.207 掲載の参考文献
1) Hunninghake GW, Costabel U, Ando M, et al : ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16 (2) : 149-173, 1999.
PubMed
2) Rossman MD, Thompson B, Frederick M, et al : ACCESS Group HLA and environmental interactions in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 25 (2) : 125-132, 2008.
PubMed
3) CJ, Rabin DL, Rybicki BA, Cherniack R : ACCESS Research Group : A case control etiologic study of sarcoidosis : environmental and occupational risk factors. Am J Respir Crit Care Med 170 (12) : 1324-1330, 2004.
 
4) Ishige I, Eishi Y, Takemura T, et al : Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22 (1) : 33-42, 2005.
PubMed
5) Nagai S, Handa T, Ito Y, Ohta K, et al : Outcome of sarcoidosis. Clin Chest Med 29 (3) : 565-574, 2008.
PubMed
6) Morimoto T, Azuma A, Abe S, et al : Epidemiology of sarcoidosis in Japan. Eur Respir J 31 (2) : 372-379, 2008.
PubMed
7) サルコイドーシスの診断基準と診断の手引き- 2006 (編集日本サルコイドーシス/肉芽腫性疾患学会, 日本呼吸器学会, 日本心臓病学会, 日本眼科学会, 厚生労働省科学研究-特定疾患対策事業-びまん性肺疾患研究班)
 
8) 長井苑子 : 間質性肺疾患 : 外来診療の実際 医学書院, 2007.
 
9) Hamada K, Nagai S, Tsutsumi T, Izumi T : Ionized calcium and 1,25-dihydroxyvitamin D concentration in serum of patients with sarcoidosis. Eur Respir J 11 : 1015-1020, 1998.
PubMed
10) Tsutumi T, Nagai S, Imai K, et al : Soluble interleukin-2 receptors in blood from patients with sarcoidois and idiopathic pulmonary fibrosis. Sarcoidosis 11 : 102-109, 1994.
 
11) Lynch JP 3rd, Kazerooni EA, Gay SE : Pulmonary sarcoidosis. Clin Chest Med 18 (4) : 755-785, 1997.
PubMed
12) Akira M, Kozuka T, Inoue Y, et al : Long-term follow-up CT scan evaluation in patients with pulmonary sarcoidosis. Chest 127 (1) : 185-191, 2005.
PubMed
13) Handa T, Nagai S, Niimi A, Fushimi Y, Ohta K, Mishima M, Izumi T. Clinical and radiographic indices associated with airflow limitation in patients with sarcoidosis. Chest 130 (6) : 1851-1856, 2006.
PubMed
14) サルコイドーシス治療に関する見解- 2003 (編集日本サルコイドーシス/肉芽腫性疾患学会, 日本呼吸器学会, 日本心臓病学会, 日本眼科学会, 厚生労働省科学研究-特定疾患対策事業-びまん性肺疾患研究班)
 
15) Gottlieb JE, Israel HL, Steiner RM, et al : Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest 111 (3) : 623-631, 1997.
PubMed
16) Baughman RP,Costabel U, duBois RM : Treatment of sarcoidosis Clinic in Chest Med 29 (3) : 533-548, 2008.
 
17) Schutt AC, Bullington WM, Judson MA : Pharmacotherapy for pulmonary sarcoidosis : a Delphi consensus study. Resp Med 104 (5) : 717-723, 2010.
 
18) Handa T, Nagai S, Miki S, et al : Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 129 (5) : 1246-1252, 2006.
PubMed
19) AF Shorr, DL Helman, DB Davies and SD Nathan : Pulmonary hypertension in advanced sarcoidosis : epidemiology and clinical characteristics Eur Respir J 25 : 783-788, 2005.
 
20) Nunes H, Humbert M, Capron F, et al : Pulmonary hypertension associated with sarcoidosis : mechanisms, haemodynamics and prognosis. Thorax. 61 (1) : 68-74, 2006.
PubMed
21) Robert P. Baughman, Marjolein Drent, et al : Barnathan and on behalf of the Sarcoidosis Investigators Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement Am J Respir Crit care Med 174 : 795-802, 2006.
 
22) Baughman RP, Nagai S, Balter M, et al : Defining the clinical outcome status (COS) in sarcoidosis : results of WASOG Task Force. Sarcoidosis Vasc Diffuse Lung Dis 28 (1) : 56-64, 2011.
 
23) Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, et al : Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 15 ; 164 (10 Pt 1) : 1885-1889, 2001.
 
24) The registry of the international society for heart and lung transplantation : 27 annual report 2010.
 
P.214 掲載の参考文献
1) Pepys J, et al : Farmer's lung. Thermophilic Actinomycetes as a source of "farmer's lung hay" antigen. Lancet 7308 : 607-611, 1963.
PubMed
2) Shimazu K, et al : Hypersensitivity pneumonitis induced by Trichosporon cutaneum. Am Rev Respir Dis 130 : 407-411, 1984.
PubMed
3) Ando M, et al : Difference in the phenotypes of bronchoalveolar lavage lymphocytes in patients with summer-type hypersensitivity pneumonitis, farmer's lung, ventilation pneumonitis, and bird fancier's lung : report of a nationwide epidemiologic study in Japan. J Allergy Clin Immunol 87 : 1002-1009, 1991.
PubMed
4) Yoshizawa Y, et al : Chronic hypersensitivity pneumonitis in Japan : a nationwide epidemiologic survey. J Allergy Clin Immunol 103 : 315-320, 1999.
PubMed
5) Ohtani Y, et al : Clinical features of recurrent and insidious chronic bird fancier's lung. Ann Allergy Asthma Immunol 90 : 604-610, 2003.
 
6) Ohtani Y, et al : Chronic bird fancier's lung : histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 60 : 665-671, 2005.
PubMed
7) 武村民子 : 通常型間質性肺炎とは何か 病理診断上の問題点 3. 慢性過敏性肺炎, 最新医学 66 (6) : 45-49, 2011.
 
8) 稲瀬直彦, 他 : 過敏性肺炎の診断と治療update 呼吸 30 (7) : 593-602, 2011.
Medical*Online
9) Khoor A, et al : Diffuse pulmonary disease caused by nontuberculous mycobacteria in immunocompetent people (hot tub lung). Am J Clin Pathol. 115 : 755-762, 2001.
PubMed
10) 釼持広知, 他 : 24時間循環風呂に関連したMACに対するhypersensitivity pneumonitisの1例 日呼吸会誌 43 (11) : 689-692, 2005.
Medical*Online
P.220 掲載の参考文献
1) 産業保健ハンドブック IV じん肺 臨床・予防管理・補償のすべて 産業医学振興財団編 東京 2007.
 
2) ILO List of Occupational Diseases (revised 2010) (http://www.ilo.org/safework/info/publications/WCMS_125137/lang--en/index.htm)
 
3) Kogevinas M, et al : Lancet. 28 ; 370 (9584) : 336-341, 2007.
PubMed
P.225 掲載の参考文献
1) Akira M : High-resolution CT in the evaluation of occupational and environmental disease. Radiol Clin North Am 40 : 43-59, 2002.
PubMed
2) Marchiori E, Souza CA, Escuissato DL, et al : Silicoproteinosis : high-resolution CT findings in 13 patients. AJR 189 : 1402-1406, 2007.
PubMed
3) 篠崎健史 : じん肺の画像診断と病理組織像. 画像診断 19 : 1325-1334, 1999.
 
4) Akira M, Yamamoto S, Inoue Y, et al : High-resolution CT of asbestosis and idiopathic pulmonary fibrosis. AJR Am J Roentgenol 181 : 163-169, 2003.
PubMed
5) Gevenois PA, Maertelaer V, Madani A, et al : Asbestosis, pleural plaques and diffuse pleural thickening : Three distinct benign responses to asbestos exposure. Eur Respir J 11 : 1021-1027, 1998.
PubMed
6) Akira M : Imaging of occupational and environmental lung diseases. Clin Chest Med 29 : 117-131, 2008.
PubMed
7) Vahlensieck M, Overlack A, Muller K-L : Computed tomographic high-attenuation mediastinal lymph nodes after aluminum exposition. Eur Radiol 10 : 1945-1946, 2000.
 
8) Kraus T, Schaller KH, Angerer J, et al : Aluminosis-detection of an almost forgotten disease with HRCT. J Occup Med Toxicol 1 : 4-12, 2006.
PubMed
9) Mendelson DS, Gendal ES, Janus CL, et al : Computed tomography of the thorax in workers exposed to hard metals. Br J Ind Med 48 : 208-210, 1991.
PubMed
10) Gotway MB, Golden JA, Warnock M, et al : Hard metal interstitial lung disease : high-resolution computed tomography appearance. J Thorac Imag 17 : 314-318, 2002.
 
11) Choi JW, Lee KS, Chung MP, et al : Giant cell interstitial pneumonia : high-resolution CT and pathologic findings in four adult patients. AJR 184 : 268-272, 2005.
PubMed
12) Okuno K, Kobayashi K, Kotani Y, et al : A case of hard metal lung disease resembling a hypersensitivity pneumonia in radiological images. Inter Med 49 : 1185-1189, 2010.
 
13) Kaneko Y, Kikuchi N, Ishii Y, et al : Upper lobe-dominant pulmonary showing deposits of hard metal component in the fibrotic lesions. Inter Med 49 : 2143-2145, 2010.
 
14) Kim KI, Kim CW, Lee MK, et al : Imaging of occupational lung disease. Radiographics 21 : 1371-1391, 2001.
PubMed
P.232 掲載の参考文献
1) Gibbs AR, Attanoos RL : Environmental- and toxin-induced lung diseases. In : Zander DS and Farver CF (eds). Pulmonary Pathology, Churchill Livingstone Elsevier, Philadelphia : 374-396, 2008.
 
2) Naye RL, Godleski JJ, Roggli VL : The pneumoconiosis : Coal worker's pneumoconiosis, Silicosis and silicatosis, Asbestosis, Rare pneumoconiosis : Metalloconioses. In : Saldana MJ (ed) : Pathology of Pulmonary Disease. J.B. Lippincott Co, Philadelphia : 369-422 (369-385, 387-393, 395-410, 411-422), 1994.
 
3) Sporn TA, Roggli VL : Pneumoconiosies mineral and vegetable. In : Thomashefski JF Jr et al (eds). Dail and Hammar's Pulmonary Patholology, Vol 1, Non-neoplastic lung disease, Springer, New York : 911-949, 2008.
 
4) Zenker FA : Ueber Staubinhalationskrankhelten der lungen, Leipzig, 1866.
 
5) Butnor KJ, Roggli VL : Pneumoconioses. In : Lesie KO and Wick MR (eds), Practical Pulmonary Pathology. Elsevier and Sunders, Philadelphi, 2nd Ed : 311-337, 2011.
 
6) Gharaee-Kermani M, Gyetko MR, Hu B, Phan SH : Expert Review : New insights into the pathogenesis of idiopathic pulmonary fibrosis : A potential role for stem cells in the lung parenchyma and implications for therapy. Pharamaceutical Research 24 : 819-841, 2007.
 
7) Raghu G, Collard HR, Egan JJ, Martinez FJ, et al : American Thoracic Society Documents : An Official ATS/ERS/JRS/ALAT Statement : Idiopathic pulmonary fibrosis : Evidence-based guidelines for diagnosis and management. Am, J Respir Crit Care Med 183 : 788-824, 2011.
PubMed
8) 荒川浩明 : 職業性肺疾患, 珪肺. 村田喜代史他編集 : 胸部のCT, 第3版. メデイカル・サイエンス・インターナショナル, 東京 : 534-537, 2011.
 
9) Roggli VL : The pneumoconioses : Asbestosis. In : Saldana MJ (ed) : Pathology of Pulmonary Disease. J.B. Lippincott Co, Philadelphia : 395-410, 1994.
 
10) Roggli VL, Pratt PC. In : Roggli VL, Greenberg SD, Pratt PC (eds) : Pathology of asbestosassociated disease. Little, Brown & Co., Boston : 77, 1992.
 
11) Hammar SP, Dodson RF. Asbestos. In : Tomashefski JFJr, et al (eds) : Dail and Hammar's Pulmonary Pathology, Vol. 1, Nonneoplastuic lung disease, Springer, New York : 950-1031, 2008.
 
12) Craighead JE, Abraham JL, Pratt PC, Churg A, Seemayer TA,et al : Asbestos-associated diseases. Arch Patjhol Lab Med 106 : 543-597, 1982.
 
13) 森永謙二, 井内康輝 : 第1章, 石綿の基礎 (知識). 第2章, 石綿関連疾患-疫学, 臨床, 画像および病理-. 産業保健ハンドブック. 石綿関連疾患- 予防, 診断, 労災補償. 第三版, 財団法人産業医学振興財団発行, 東京 : 11-38, 39-51, 2005.
 
14) Morgan RH (chairman) : Asbestos related diseases. Clinical, epidemiologic, pathologic, and radiologic characteristics and manifestation. American College of Radiology. Chicago : 1-107, 1982.
 
15) 北市正則, 北川善行 : 超硬合金肺. 別冊 日本臨床, 領域別症候群シリーズNo.3 呼吸器症候群, 上巻 : 566-568, 1994.
 
16) 北市正則 : サルコイードーシス, 慢性過敏性肺臓炎, 慢性ベリリウム肺の肺病変の病理組織学的比較検討. 日胸疾会誌 22 : 769-782, 1984.
 
17) Kitaichi M : Pathology of pulmonary sarcoidosis. Clin Dermatol 4 : 108-115, 1986.
PubMed
18) 北市正則, 長井苑子, 泉孝英 : ベリリウム肺. 日本サルコイードーシス学会編集, 最近のサルコイードーシス, 現代医療社, 東京 : 234-236, 1993.
 
19) Handa T, Nagai S, Kitaichi M, Chin K, Ito Y, Oga T, Takahashi K, Watanabe K, Mishima M, Izumi T : Long-term complications and prognosis of chronic beryllium disease. Sarcoidosis Vasculitis and Diffuse Lung Diseases 26 : 24-31, 2009. (Nov 2009)
 
P.236 掲載の参考文献
1) 森永謙二, 篠原也寸志 : アスベスト (石綿) とは. (独) 労働者健康福祉機構編アスベスト関連疾患日常診療ガイド, 労働調査会東京 : 12-23, 2006.
 
2) 岸本卓巳 : 石綿ばく露作業と石綿肺. 和田, 攻編 産業保健ハンドブック IV じん肺, Edition東京 : (財) 産業医学振興財団 ; 155-158, 2007.
 
3) 山下龍一 : 日常生活でさらされ石綿肺, 初の救済認定 環境機構 (2011年3月2日). 朝日新聞電子版, 東京, 2011.
 
4) 城戸優光 : 粉じんとじん肺. 和田, 攻編産業保健ハンドブック IV じん肺, (財) 産業医学振興財団東京 : 14-20, 2007.
 
5) Kline JN, Schwartz DA, Monick MM, Floerchinger CS, Hunninghake GW : Relative release of interleukin-1 beta and interleukin-1 receptor antagonist by alveolar macrophages. A study in asbestos-induced lung disease, sarcoidosis, and idiopathic pulmonary fibrosis. Chest 104 : 47-53, 1993.
PubMed
6) Perkins RC, Scheule RK, Hamilton R, Gomes G, Freidman G, Holian A : Human alveolar macrophage cytokine release in response to in vitro and in vivo asbestos exposure. Exp Lung Res 19 : 55-65, 1993.
 
7) Zhang Y, Lee TC, Guillemin B, Yu, M.-C, Rom, W N : Enhanced IL-1 β and tumor necrosis factor-α release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immnnol 150 : 4188-4196, 1993.
 
8) 厚生労働省 : 人口動態調査統計 年代別石綿肺死亡数の推移
 
9) Akira M, Yamamoto S, Inoue Y, Sakatani M : High-resolution CT of asbestosis and idiopathic pulmonary fibrosis. AJR Am J Roentgenol 181 : 163-169, 2003.
PubMed
10) Bergin CJ, Castellino RA, Blank N, Moses L : Specificity of high-resolution CT findings in pulmonary asbestosis : do patients scanned for other indications have similar findings? AJR Am J Roentgenol 163 : 551-555, 1994.
PubMed
11) 岸本卓巳 : アスベスト肺 (石綿肺) とはどんな病気か. (独) 労働者健康福祉機構編 アスベスト関連疾患日常診療ガイド, 労働調査会東京 : 56-59, 2006.
 
12) 岸本卓巳 : アスベストばく露によっておこる医学的所見 (独) 労働者健康福祉機構編 アスベスト関連疾患日常診療ガイド, 労働調査会 東京 : 27-33, 2006.
 
P.241 掲載の参考文献
1) 田村猛夏 : 職業性肺癌, 日本胸部臨床 68 : S145, 2009.
Medical*Online
2) Vanhee D. Gosset P. Boitelle A. et al : Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis. Eur Respir J 8 : 834, 1995.
PubMed
3) Haux F : New developments in the understanding of immunology in silicosis. Curr Opin Allergy Clin Immunol 7 : 168, 2007.
 
4) 海老原勇 : 離職後のじん肺の進行と免疫指標-経時的検討. 労働科学 66 : 249, 1990
 
P.245 掲載の参考文献
1) Handa T, Nagai S, Kitaichi M, et al : Long-term complications and prognosis of chronic beryllium disease. Sarcoidosis Vasc Diffuse Lung Dis 26 : 24-31, 2009.
PubMed
2) Izumi T, Kobara Y, Inui S, et al : The first seven cases of chronic beryllium disease in ceramic factory workers in Japan. Ann N Y Acad Sci 278 : 636-653, 1976.
PubMed
3) Hardy HL, Tabershaw IR : Delayed chemical pneumonitis occurring in workers exposed to beryllium compounds. J Ind Hyg Toxicol 28 : 197-211, 1946.
PubMed
4) 濱田薫, 木村弘 : II. びまん性肺疾患 D. じん肺および室内・大気環境汚染による肺疾患. アルミニウム肺. 別冊日本臨床 新領域別症候群シリーズ No.8 呼吸器症候群 (第2版) I その他の呼吸器疾患を含めて : pp530-532, 2008.
 
5) 清家正博, 他 : アルミニウム肺に顕微鏡的多発血管炎による間質性肺炎の合併が疑われた1例. 日呼吸会誌 38 : 408-412, 2000.
 
6) 犬塚賀奈子, 他 : 両側気胸を繰り返す上葉優位の肺線維化病変を呈したアルミニウム加工業者の1例 日呼吸会誌 48 : 492-496, 2010.
Medical*Online
7) Hull MJ, Abraham JL : Aluminum welding fume-induced pneumoconiosis. Hum Pathol 33 : 819-825, 2002.
PubMed
8) Chen WJ, Monnat RJ Jr, Chen M, et al : Aluminum induced pulmonary granulomatosis. Hum Pathol 9 : 705-711, 1978.
PubMed
9) 梅村朋弘, 日下幸則, 飴嶋慎吾 : II. びまん性肺疾患 D. じん肺および室内・大気環境汚染による肺疾患. インジウム肺. 別冊日本臨床 新領域別症候群シリーズ No.8 呼吸器症候群 (第2版) I その他の呼吸器疾患を含めて : 541-545, 2008.
 
10) 田口治 : インジウム肺の3例 日呼吸会誌 44 (7) : 532-536, 2006.
Medical*Online
11) Chonan T, Taguchi O, Omae K : Interstitial pulmonary disorders in indium-processing workers. Eur Respir J 29 : 317-324, 2007.
PubMed
12) 長南達也, 田口治 : インジウム錫酸化物加工労働者に発生した間質性肺炎について. 日呼吸会誌 42 Suppl : 185, 2004.
 
13) Homma S, Miyamoto A, Sakamoto S, et al : Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide. Eur Respir J 25 : 200-204, 2005.
 
14) 森山寛史, 寺田正樹, 高田俊範, 杉本栄一 : II. びまん性肺疾患 D. じん肺および室内・大気環境汚染による肺疾患. 超硬合金肺. 別冊日本臨床 新領域別症候群シリーズ No.8 呼吸器症候群 (第2版) I その他の呼吸器疾患を含めて : 569-571, 2008.
 
15) 酒井真紀, 他 : 鉄の研磨作業者に発症した超硬合金肺の1例. 日呼吸会誌 48 : 282-286, 2010.
Medical*Online
P.253 掲載の参考文献
1) 日本呼吸器学会薬剤性肺障害ガイドライン作成委員会編 : 薬剤性肺障害の評価, 治療についてのガイドライン メディカルレビュー社 東京 2006.
 
2) 金澤實 : 薬剤性肺障害の新知見 日内会誌 97 : 2250-2255, 2008.
 
3) 吾妻安良太, 工藤翔二 : 薬剤性肺炎と日本人 日内会誌 96 : 1077-1082, 2007.
 
4) Ohnishi H, et al : Circulating KL-6 levels in patients with drug-induced pneumonitis. Thorax 58 : 872-875, 2003.
PubMed
5) Tomioka H, et al : Gold-induced pulmonary disease : clinical features, outcome, and differentiation from rheumatoid lung disease. Am J Respir Crit Care Med 155 : 1011-1020, 1997.
 
6) Alarcon GS, et al : Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group.Ann Intern Med 127 : 356-364, 1997.
 
7) Jarand J, et al : Amiodaronoma : an unusual form of amiodarone-induced pulmonary toxicity. CMAJ 10 : 1411-1413, 2007.
PubMed
8) Kudoh S, et al : Interstitial lung disease in Japanese patients with lung cancer. A cohort and nested case-control study. Am J Respir Crit Care Med 177 : 1348-1357, 2008.
PubMed
9) Niho S, et al : Interstitial shadow on chest CT is associated with the onset of interstitial lung disease caused by chemotherapeutic drugs. Jpn J Clin Oncol 36 : 269-273, 2006.
PubMed
P.259 掲載の参考文献
1) Cordier JF, Cottin V : Eosinophilic pneumonias. In : Interstitial Lung Disease. Ed. by Schwarz MI, King TEJr. 5th Ed. Shelton : People'sMedical Publishing House - USA : p833, 2010.
 
2) Allen JN, Davis WB.Eosinophilic lung diseases. Am J Respir Crit Care Med 150 : 1423-1438, 1994.
 
3) Hayakawa H, Sato A, Toyoshima M, et al : A clinical study of idiopathic eosinophilic pneumonia. Chest 105 : 1462, 1994.
PubMed
4) Christoforidis AJ, William Molnor, et al : Eosinophilic pneumonia : Report of two cases with pulmonary biopsy. JAMA 173 : 157-161, 1960.
 
5) Carrington CB, Addington WW, GoffAM, et al : Chronic eosinophilic pneumonia.New Engl J Med 280 : 787-798, 1969.
PubMed
6) Kita H, Sur S, Hunt LW, et al. Cytokine production at the site of disease in chronic eosinophilic pneumonia. Am J Respir Crit Care Med. 153 : 1437-1441, 1996.
PubMed
7) Saita N., Yamanaka T., Kohrogi H, et al : Apoptotic response of eosinophils in chronic eosinophilic pneumonia.Eur Respir J 17 : 190-194, 2001.
PubMed
8) 望月吉郎, 小橋陽一郎, 中原保治, 他 : 慢性好酸球性肺炎の予後の検討. 日呼吸会誌 40 : 851-855, 2002.
Medical*Online
9) Kitaichi M : Eosinophilic lung disease-pathologic view. Korean J Allergy 17 : 449-463, 1997.
 
10) 佐々木由美子, 井上義一 : 慢性好酸球性肺炎, 間質性肺疾患診療マニュアル. 久保惠嗣, 藤田次郎編集, 初版. 東京. 南江堂. p302, 2010.
 
11) Naughton M, Fahy J, FitzGerald MX : Chronic eosnophilic pneumonia. A long-term follow-up of 12 patients. Chest 103 : 162-165, 1993.
 
12) Allen JN, Pacht ER, Gadek JE, et al : Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 321 : 569-574, 1989.
PubMed
13) William N. Rom, Michael Weiden, Roberto Gracia, et al : Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust : Am J Respir Crit Care Med 166 : 797-800, 2002.
 
14) Nakahara Y, Hayashi S, Kawashima M, et al : Increased Interleukin-5 Levels in bronchoalveolar lavage fluid is a major factor for eoshinophil accumulation in acute eosinophilic pneumonia. Respiration 68 : 389-395, 2001.
 
15) Yamaguchi S, Okubo Y, Hossain M,et al : IL-5 predominant in bronchoalveolar lavage fluid and peripheral blood in a patient with acute eosinophilic pneumonia. Inter Med 34 : 65-68, 1995.
 
16) 中島正光 : 急性好酸球性肺炎, 間質性肺疾患診療マニュアル. 久保惠嗣, 藤田次郎編集, 初版. 東京. 南江堂. p299, 2010.
 
17) Tazelaar HD, Linz LJ, Colby TV, et al : Acute eosinophilic pneumonia : Histopathologic findings in nine patients. Am J Respir Crit Care Med 155 : 296-302, 1997.
PubMed
18) Philit F, B Etienne-Mastoianni : A Parrot, Idiopathic acute eosinophic pneumonia A study of 22 patients, Am J Respir Crit Care Med 166 : 1235-1239, 2002.
 
P.271 掲載の参考文献
1) Jennette CJ, Falk RJ, Andrassi K, et al : Nomencalture of systemic vasculitides. Proposal of an International Consensus Conference. Arthritis Rheum 37 : 187-192, 1994.
 
2) 中林公正 : ANCA 関連疾患の臨床. 日内科学会誌 89 : 520-523, 2000.
 
3) Liebow AA : Pulmonary angiitis and granulomatosis. Am Rev Respir Dis 108 : 1-18, 1973.
PubMed
4) DeRemee RA, Weiland LH, McDonald TJ : Respiratory vasculitis. Mayo Clin Proc 55 : 492-498, 1980.
PubMed
5) Fulmer JD, Kaltrider HB : The pulmonary vasculitides. Chest 82 : 615-624, 1982.
 
6) Dreisin RB : Pulmonary vasculitis. Clin Chest Med 3 : 607-618, 1982.
PubMed
7) Cotch MF, Hoffman GS, Yerg DE, et al : The epidemiology of Wegener's granulomatosis. Arthritis Rheum 39 : 87-92, 1996.
PubMed
8) Hoffman GS, Kerr GS, Leavitt RY, et al : Wegener granulomatosis : an analysis of 158 patients. Ann Intern Med 116 : 488-494, 1992.
PubMed
9) Daum TE, Specks U, Colby TV, et al : Tracheobronchial involvement in Wegener's granulomatosis. Am J Respir Crit Care Med 151 : 522-526, 1995.
PubMed
10) Nishino H, Rubino FA, DeRemee RA, et al : Neurological involvement in Wegener's granulomatosis. Ann Neurol 33 : 4-9, 1993.
PubMed
11) Carrington CB, Liebow A : Limited forms of angiitis and granulomatosis of Wegener's type. Am J Med. 41 : 497-527, 1966.
 
12) DeRemee RA, McDonald TJ, Harrison EG, et al : Wegener's granulomatosis. Anatomic correlates, a proposed classification. Mayo Clin Proc 51 : 777-781, 1976.
PubMed
13) Jayne D, for the European Vasculitis Study Group (EUVAS). Update on the European Vasculitis Study Group trials. Curr Opin Rheumatol 13 : 48-55, 2001.
 
14) Nolle B, Specks U, Ludemann J, et al : Anticytoplasmic autoantibodies : Their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 111 : 28-40, 1989.
PubMed
15) Kerr GS, Fleisher TA, Hallahan CW, et al : Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 36 : 365-371, 1993.
PubMed
16) Bax J, Gooszen HC, Hoortje SJ : Acute fluminating alveolar hemorrhage as presenting symptom in Wegener's granulomatosis : anticytoplasmic antibodies as a diagnostic tool. Eur J Respir Dis 71 : 202-205, 1987.
 
17) Reuter M, Schnabel A, Wesner F, et al : Pulmonary Wegener's granulomatosis : correlation between high-resolution CT findings and clinical scoring of disease activity. Chest 114 : 500-506, 1998.
PubMed
18) Blingny D, Mahara A, Letoumelin P, et al : Predicting mortality in systemic Wegener's granulomatosis : a survival analysis based on 93 patients. Arthritis Rheum 51 : 83-91, 2004.
 
19) Lane SE, Watts RA, Shepstone L, et al : Primary systemic vasculitis : clinical features and mortality. Q J Med 98 : 97-111, 2005.
 
20) Krafcik SS, Covin RB, Lynch JP, Sitrin RG : Wegener's granulomatosis in the elderly. Chest 109 : 430-437, 1996.
PubMed
21) Churg J, Strauss L : Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol 27 : 277-301, 1951.
PubMed
22) Wechsler ME, Finn D, Gunawardena D, et al : Churg-Strauss syndrome in patients receiving Montelukast as treatment for asthma. Chest 117 : 708-713, 2000.
PubMed
23) Keogh KA, Specks U : Churg-Strauss Syndrome : clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med 115 : 284-290, 2003.
PubMed
24) Gross WL, Schnabel A, Trabandt A : New perspectives In pulmonary angiitis : From pulmonary angiitis and granulomatosis to ANCA associated vasculitis. Sarcoidosis Vasc Diffuse Lung Dis 17 : 33-52, 2000.
PubMed
25) Chumbley LC, Harrison EG, DeRemee RA : Allergic granulomatos : New perspectives In pulmonary angiitis : From pulmonary angiitis and granulomatosis to ANCA associated vasculitis. Mayo Clin Proc 52 : 477-484, 1977.
 
26) 野間恵之, 種田和清, 小橋陽一郎 : アレルギー性肉芽腫性血管炎と気管支中心性肉芽腫症. 臨床画像 18 : 825-829, 1998.
 
27) Katzenstein AA : Diagnostic features and differential diagnosis of Churg-Strauss syndrome In the lung. Am J Clin Pathol 114 : 767-772, 2000.
 
28) Masi AT, Hunder GG, Lie JT, et al : The American College of Rheumatology 1990 criteria for the classification of Churg-Staruss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 33 : 1094-1100, 1990.
PubMed
29) Tzelepis GE, Kokosi M, Tzioufas A, et al : Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J 36 : 116-121, 2010.
PubMed
30) Corral-Gudino L, Borao-Cengotita-Bengoa M, del Pino-Montes J, et al : Overall survival, renal survival and relapse in patients with microscopic polyangiitis : a systemic review of current evidence. Rheumatolgy 50 : 1414-1423, 2011.
 
P.275 掲載の参考文献
1) Schwarz MI : The diffuse alveolar hemorrhage syndromes. Up To Date 19. 3, 2011.
 
2) Lara AR, et al : Diffuse alveolar hemorrhage. Chest 137 : 1164-1171, 2010.
PubMed
3) Lassence AD, et al : Alveolar hemorrhage. Diagnostic criteria and results in 194 immunocompromised hosts. Am J Respir Crit Care Med 151 : 157-163, 1995.
 
4) 村瀬公彦, 他 : びまん性肺胞出血症例の臨床的検討. 気管支学 32 : 14-21, 2010.
Medical*Online
5) Szczepiorkowski ZM, et al : Guidelines on the use of therapeutic apheresis in clinical practiceevidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apheresis 22 : 106-175, 2007.
 
6) de Prost N, et al : Diffuse alveolar haemorrhage : factors associated with in-hospital and long-term mortality. Eur Resp J 35 : 1303-1311, 2010.
PubMed
P.278 掲載の参考文献
1) Williamson WA, Tronic BS, Levitan N, et al : Pulmonary venous infarction. Chest 102 : 937-940, 1992.
PubMed
2) 河端美則, 叶内哲, 星俊子, 他 : 肺腫瘍に伴う肺梗塞の病理発生-静脈性梗塞の存在について- 肺癌 41 : 755-762, 2001.
 
3) Freiman DG, Suyemoto J, Wessler S : Frequency of pulmonary thromboembolism in man. N Engl J Med 272 : 1278-1280, 1965.
 
4) White RH : The Epidemiology of Venous Thromboembolism, Circulation 107 : 14-18, 2003.
 
5) Nakamura M, Okada O, Sakuma M, et al : Incidence and clinical characteristics of chronic pulmonary thromboembolism in Japan compared with acute pulmonary thromboembolism : results of a multicenter registry of the Japanese Society of Pulmonary Embolism Research. Circulation Journal 66 : 257-260, 2002.
PubMed
6) 中野赳, 伊藤早苗, 竹沢英郎 : 肺塞栓症の疫学. 日本医事新報 2949 : 43-47, 1980.
 
7) Torbicki A, Perrier A, Konstantinides S, et al : Guidelines on the diagnosis and management of acute pulmonary embolism : the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 29 : 2276-2315, 2008.
 
8) 河端美則, 星永進, 高柳昇, 他 : 主に肺腫瘍にみられる肺梗塞の自然史に関する病理学的研究-肺梗塞は肺胞壁出血を初発とする-. 日呼吸会誌 47 : 851-857, 2009.
Medical*Online
9) Ruiz-Gimenez N, Friera A, Artieda P, et al : Rapid D-dimer test combined a clinical model for deep vein thrombosis. Validation with ultrasonography and clinical follow-up in 383 patients. Thromb Haemost 91 : 1237-1246, 2004.
PubMed
10) 大坪まゆみ, 荻野歩, 福島藤平, 他 : 肺梗塞のCT. 臨床放射線 40 : 101-108, 1995.
 
11) Fraser RS, Muller NL, Colman N, et al : Fraser and Pare's diagnosis of diseases of the chest ; 4th ed, Philadelphia, Saunders, 1999.
 
12) Tapson VF : Acute pulmonary embolism. N Engl J Med 358 : 1037-1052, 2008.
PubMed
13) Ota M, Nakamura M, Yamada N, et al : Prognostic significance of early diagnosis in acute pulmonary thromboembolism with circulatory failure. Heart Vessels 17 : 7-11, 2002.
PubMed
14) Ribeiro A, Lindmarker P, Johnsson H, et al : Pulmonary embolism : one-year follow-up with echocardiography doppler and five-year survival analysis. Circulation 99 : 1325-1330, 1999.
PubMed
P.284 掲載の参考文献
1) Ashbaugh DG, Bigelow DB, Petty TL, et al : Acute respiratory distress in adults. Lancet 2 : 319-323, 1967.
PubMed
2) Petty TL, Ashbaugh DG : The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management. Chest 60 : 233-239, 1971.
PubMed
3) Bernard GR, Artigas A, Brigham KL, et al : The American-European Consensus Conference on ARDS : Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149 : 818-824, 1994.
PubMed
4) 社団法人日本呼吸器学会ARDSガイドライン作成委員会 : ALI/ARDS診療のためのガイドライン第2版, 秀潤社, 2010.
 
5) Luhr OR, Antonsen K, Karisson M, et al : Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome. Am J Respir Crit Care Med 159 : 1849-1861, 1999.
 
6) Arroliga AC, Ghamra ZW, Perez Trepichio A, et al : Incidence of ARDS in an adult population of northeast Ohio. Chest 121 : 1972-1976, 2002.
 
7) Bersten AD, Edibam C, Hunt T, et al : Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian States. Am j Respire Crit Care Med 165 : 443-448, 2002.
 
8) Goss CH, Brower RG, Hudson LD, et al : Incidence of acute lung injury in the United States. Crit Care Med 31 : 1607-1611, 2003.
PubMed
9) Rubenfeld GD, Caldwell E, Peabody E, et al : Incidence and outcome of acute lung injury. N Engl J Med 353 : 1685-1693.
PubMed
10) Wind J, Versteegt J, Twisk J, et al : Epidemiology of acute lung injury and acute respiratory distress syndrome in the Netherlands : a survey. Respir Med 101 : 2091-2098, 2007.
PubMed
11) 織田成人, 平澤博之, 北村信哉, 他 : 千葉県における急性肺障害 (ALI) /急性呼吸窮迫症候群 (ARDS) に関する疫学調査-人口当たりの罹患率および転帰に関する多施設前向き共同研究結果-. 日救急医会誌 18 : 219-228, 2007.
 
12) Li G, Malinchoc M, Cartin-Ceba R, et al : Eight-year trend of acute respiratory distress syndrome : a population-based study in Olmsted County, Minnesota. Am J respire Crit Care Med 183 : 59-66, 2011.
 
13) Piantadosi CA, Schwartz DA : The acute respiratory distress syndrome. Ann Intern Med 141 : 460-470, 2004.
PubMed
14) Katzenstein AA, Askin FB : Surgical pathology of non-neoplastic lung disease. Major problems in pathology. Forth edition. Saunders, Philadelphia, 2006.
 
15) Esteban A, Fernandez-Segoviano P, Frutos-Vivar F, et al : Comparison of clinical criteria for acute respiratory distress syndrome with autopsy findings. Ann Inter Med 141 : 440-445, 2004.
 
16) Papazian L, Doddoli C, Chetaille B, et al : A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med 35 : 755-762, 2007.
PubMed
17) Donati SY, Papazian L : Role of open-lung biopsy in acute respiratory distress syndrome. Curr Opin Crit Care 14 : 75-79, 2008.
PubMed
18) Webb WR, Muller NL, Naidich DP : High-resolution CT of the lung. Forth Edition. Lippincott Williams & Wilkins, Philadelphia, 2009.
 
19) Desai SR, Wells AU, Rubens MB, et al : Acute respiratory distress syndrome : CT abnormalities at long-term follow-up. Radiology 210 : 29-35, 1999.
PubMed
20) Ichikado K, Suga M, Muranaka H, et al : Prediction of prognosis for acute respiratory distress syndrome with thin-section CT : validation in 44 cases. Radiology 238 : 321-329, 2006.
PubMed
21) Ventilation with low tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 342 : 1301-1308, 2000.
 
22) Petrucci N, Iacoveli W : Ventilation with lower tidal volumes versus traditional tidal volumes in adults for acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev ; CD003844, 2004.
 
23) Putensen C, Theuerkauf N, Zinserling J, et al : Meta-analysis : ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury. Ann Inter Med 151 : 566-576, 2009.
 
24) Brower RG, Lanken PN, MacIntyre N, et al : Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 251 : 327-336, 2004.
 
25) Mercat A, Richard JC, Vielle B, et al : Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome : a randomized controlled trial. JAMA 299 : 646-655, 2008.
PubMed
26) Meade MO, Cook DJ, Guyatt GH, et al : Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome : a randomized controlled trial. JAMA 299 : 637-645, 2008.
PubMed
27) Briel M, Meada M, Mercat A, et al : Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome : systematic review and metaanalysis. JAMA 303 : 865-873, 2010.
 
28) Amato MB, Barbas CS, Medeiros DM, et al : Effect of a protective ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338 : 347-354, 1998.
PubMed
29) Villar J, Kacmarrek RM, Peres-Mendez L, et al : A high positive end-expiratory pressure, low tidal volume ventilation strategy improves outcome in persistent acute respiratory distress syndrome : a randomized controlled trial. Crit Care Med 34 : 1311-1318, 2006.
 
30) Fan E, Wilcox ME, Brower RG, et al : Recruitment maneuvers for acute lung injury : a systematic review. Am J Respir Crit Care Med 278 ; 1156-1163, 2008.
 
31) Hilbert G, Gruson D, Vargas F, et al : Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344 : 481-487, 2001.
PubMed
32) Abrouq F, Ouanes-Besbes L, Dachraoui F, et al : An updated study-level meta-analysis of randomized controlled trials on proning in ARDS and acute lung injury. Crit Care 15 ; R6, 2011.
 
33) Papazian L, Forel JM, Gacouin A, et al : Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 363 : 1107-1116, 2010.
PubMed
34) Tang BM, Craig JC, Eslick GD, et al : Use of corticosteroids in acute lung injury and acute respiratory distress syndrome : a systematic review and meta-analysis. Crit Care Med 37 : 1594-1603, 2009.
PubMed
35) National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trial Network. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluidmanagement strategies in acute lung injury. N Engl J Med 354 : 2564-2575, 2006.
PubMed
36) Pontes-Arruda A, Demichele S, Seth A, et al : The use of inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome : a meta-analysis of outcome data. JPEN J Parenter Enteral Nutr 32 : 596-605, 2008.
PubMed
37) Zambon M, Vincent JL : Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest 133 : 1120-1127, 2008.
PubMed
38) Herridge MS, Tansey CM, Matte A, et al : Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 364 : 1293-1304, 2011.
PubMed
P.294 掲載の参考文献
1) Noguchi M, Morikawa A, Kawasaki M, et al : Small adenocarcinoma of the Lung. Histologic Characteristics and Prognosis. Cancer 75 : 2844-2852, 1995.
PubMed
2) Travis WD, Brambilla E, Noguchi M, et al : International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thoracic Oncol 6 : 244-285, 2011.
 
3) Akira M. Atagi S, Kawahara M, et al : High-Resolution CT Findings of Diffuse Bronchioloalveolar Carcinoma in 38 Patients. AJR 173 : 1623-1629, 1999.
PubMed
4) Webb WR, Muller NL, Naidich DP. : High-Resolution CT of the Lung. 4th. edition., Lippincott Williams & Wilkins. Philadelphia : 241-272, 2008.
 
5) Cadranel J, Quoix E, Baudrin L, et al : IFCT-0401 trial : A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma with Bronchioloalveolar Carcinoma Subtype. J Thorac Oncol 4 : 1126-1135, 2009.
 
6) Fraser RS, Muller NL, Colman N, et al : Diagnosis of Disease of the Chest. 4th. edition, WB Saunders. Philadelphia : 1381-1417, 1999.
 
7) Stein MG, Mayo J, Muller N, et al. Pulmonary Lymphangitic Spread of Carcinoma : Appearance on CT scans. Radiology 162 : 371-375, 1987.
 
8) Travis WD, Colby TV, Corrin B, et al : Histological Typing of Lung and Pleural Tumours. 3rd. edition, Springer. Berlin ; 1999.
 
9) 岡輝明 : BALTとその疾患 (肺のリンパ球性病変あるいはリンパ増殖性疾患) の病理. 呼吸 22 : 841-849, 2003.
Medical*Online
10) Katzenstein AA : Katzenstein and Askin's surgical pathology of non-neoplastic lung disease, 4th. Edition, WB Saunders, Philadelphia : 237-259, 2006.
 
11) Travis WD, Galvin JR : Non-neoplastic pulmonary lymphoid lesions. Thorax 56 : 964-971, 2001.
PubMed
12) Swigris JJ, Berry GJ, Raffin TA, et al : Lymphoid Interstitial pneumonia, A Narrative Review. Chest 122 : 2150-2164, 2002.
PubMed
13) 岡輝明 : 肺のリンパ増殖性疾患の病理診断. 病理と臨床 26 : 510-511, 2008.
Medical*Online
14) Yousem SA, Colby TV, Carrington CB : Follicular bronchitis/bronchiolitis. Hum Pathol 16 : 700-706, 1985.
PubMed
15) Abbodanzo SL, Rush W, Bijwaard KE, et al : Nodular lymphoid hyperplasia of the Lung : A Clinicopathologic Study of 14 Cases. Am J Surg Pathol 24 : 587-597, 2000.
 
16) Filly R, Blank N, Castellino RA : Radiographic Distribution of Intrathoracic Disease in Previously Untreated Patients with Hodgin's Disease and Non-Hodgkin's Lymphoma. Radiology 120 : 277-281, 1976.
 
17) Cordier JF, Chailleux E, Lauque D, et al : Primary Pulmonary Lymphomas : A Clinical Study of 70 Cases in Nonimmunocompromised Patients. Chest 103 : 201-208, 1993.
PubMed
18) Kobayashi Y, Maekawa M, Natsuno Y, et al : Detection of t (11 ; 18) in MALT-Type Lymphoma With Dual-Color Fluorescence In Situ Hybridization and Reverse Transcriptase-Polymerase Chain Reaction Analysis. Diagn Mol Pathol 10 : 207-213, 2001.
 
19) Guinee DG, Jaffe E, Kingma D, et al : Pulmonary Lymphomatoid Granulomatosis : Evidence for a Proliferation of Epstein-Barr Virus Infected B-lymphocytes with a Prominent T-cell Component and Vasculitis. Am J Surg Pathol 18 : 753-764, 1994.
 
20) Rezk SA, Weiss LM : Epstein-Barr virus-associated lymphoprpliferative disorders. Human Patol 38 : 1293-1304, 2007.
 
21) Katzenstein AA, Doxtader E, Narendra S : Lymphomatoid Grnulomatosis, Insights Gained Over 4 Decades. Am J Surg Pathol 34 : e35-48, 2010.
 
22) King TE Jr : Interstitial Lung Disease, fifth-edition. Peaple's Medical Publishing House. Shelton : 1053-1055, 2011.
 
23) Matsue K, Asada N, Takeuchi M, et al : A clinicopathological study of 13 cases of intravascular lymphoma : experience in a single institution over a 9-yr period. Eur J Haematol 80 : 236-244, 2007.
 
24) Murase T, Nakamura S, Kawauchi K, et al : An Asian variant of intravascular large B-cell lymphoma : clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 111 : 826-834, 2000.
 
25) Ponzoni M, Ferreri AJ, Campo E, et al : Definition, Diagnosis, and Management of Intravascular Large B-cell Lymphoma : Proposals and Perspectives From an International Consensus Meeting. J Clin Oncol 25 : 3168-3173, 2007.
 
26) Asada N, Odawara J, Kimura S, et al : Use of Random Skin Biopsy for Diagnosis of Intravascular Large B-cell Lymphoma. Mayo Clin Proc 82 : 1525-1527, 2007.
 
27) Chen KTK : Multicentric Castleman's disease and Kaposi's sarcoma. Am J Surg Pathol 8 : 287-293, 1984.
 
28) Bragg DG, Chor PJ, Murray KA, et al : Lymphoproliferative Disorders of the Lung : Histopathology, Clinical Manifestations, and Imaging Features. AJR 163 : 273-281, 1994.
PubMed
29) 岡輝明 : IPL/MCDの肺病変の病理像. 日胸 66 : 229-235, 2007.
Medical*Online
30) Dispenzieri A : Castlemann Disease. Cancer treat res 142 : 293-330, 2008.
 
31) Kamel OW, Van de Rijn M, Weiss LM, et al : Reversible Lymphomas Associated with Epstein-Barr Virus Occurring during Methotrexate Therapy for Rheumatoid Arthritis and Dermatomyositis. N Engl J Med 328 : 1317-1321, 1993.
PubMed
32) 塚崎邦弘 : ATL. 臨床血液 51 : 1595-1606, 2010.
 
33) 木村郁朗 : HTLV-1 associated bronchiole-alveolar disoeder (HABA). 日本臨床 47 : 283-293, 1988.
 
34) 北市正則, 西村浩一, 泉孝英, 他 : HTLV-1 関連気道病変. 病理と臨床 20 : 944-949, 2002.
 
35) Okada F, Ando Y, Kondo Y, et al : Thoracic Ct findings of adult T-cell leukemia or lymphoma. AJR Am J Roentgenol 182 : 761-767, 2004.
PubMed
36) Okada F, Ando Y, Yoshitake S, et al : Pulmonary CT Findings in 320 Carriers of Human T-Lymphotropic Virus Type 1. Radiology 240 : 559-564, 2006.
PubMed
P.304 掲載の参考文献
1) Bruce DM, et al : Lymphangitis carcinomatosa : a literature review. J R Coll Surg Edinb 41 : 7-13, 1996.
PubMed
2) 河端美則, 片桐史郎 : 続 肺癌の遠隔転移 4. 癌性リンパ管症 病理と臨床. 肺癌の臨床 4 : 353-359, 2001.
 
3) 深山正久, 島田素子, 比島恒和, 他 : 肺リンパ球増殖性疾患病理と臨床, 14 : 195-204, 1996.
 
4) 小橋陽一郎 : リンパ球性間質性肺炎 (LIP) /偽リンパ腫pseudolymphomaの病理. 病理と臨床 17 : 135-140, 1999.
 
5) 岡輝明 : 6. IPL/MCD の肺病変. Annual Review 呼吸器 : 122-130, 2000.
 
6) 松井祥子 : IgG4関連肺疾患の肺病変. 日胸 67 : 378-386, 2008.
 
P.311 掲載の参考文献
1) Rosen SH, Castleman B, Liebow AA : Pulmonary alveolar proteinosis. N Eng J Med 258 : 1123, 1958
 
2) 岡捨己, 金上晴夫, 那須省三郎, 他 : 肺胞蛋白症 (pulmonary alveolar proteinosis) の症例と考察. 日本臨床 19 : 391, 1960.
 
3) 平成22年度厚生労働科学研究費補助金難治性疾患克服研究事業肺胞蛋白症の難治化要因の解明, 診断, 治療, 管理の標準化と指針の確立研究班. 井上義一, 中田光, 監修. 平成22年度研究報告書. 肺胞蛋白症の診断, 治療, 管理の指針 (案). 2011.
 
4) Stanley E, Lieschke GJ, Grail D, et al : Granulocyte/macrophage colony-stimulating factordeficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci 91 : 5592, 1994.
PubMed
5) Reed JA, Ikegami M, Cianciolo ER, et al : Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient. mice. Am J Physiol 276 : L556-563, 1999.
PubMed
6) Kitamura T, Tanaka N, Watanabe J, et al : Idiopathic pulmonary alveolar proteinosis as an autoimmune diseases with neutralizing antibody against granulocyte-macrophage colony stimulating factor. J Exp Med 190 : 875, 1999.
PubMed
7) Trapnell BC, Whitsett JA, Nakata K : Pulmonary alveolar proteinosis. N Engl J Med 349 : 2527, 2003.
PubMed
8) Sakagami T, Uchida K, Suzuki T, et al : Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis. N Engl J Med 361 (27) : 2679-2681, 2009.
PubMed
9) Uchida K, Nakata K, Suzuki T, et al : Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood 113 (11) : 2547-2556, 2009.
PubMed
10) Seymour JF, Presneill JJ : Pulmonary alveolar proteinosis : progress in the first 44 years. Am J Respir Crit Care Med 166 : 215, 2002.
PubMed
11) Presneill JJ, Nakata K, Inoue Y, et al : Pulmonary alveolar proteinosis. Clin Chest Med 25 : 593, 2004.
PubMed
12) Ishii H, Tazawa R, Kaneko C, et al : Clinical features of secondary pulmonary alveolar proteinosis : pre-mortem cases in Japan. Eur Respir J 37 (2) : 465-468, 2011.
PubMed
13) Inoue Y, Trapnell BC, Tazawa R, et al : Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 177 (7) : 752-762, 2008.
PubMed
14) Ishii H, Trapnell BC, Tazawa R, et al : Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis. Chest 136 (5) : 1348-1355, 2009.
PubMed
15) Webb WR, Muller NL, Naidich DP : Alveolar proteinosis. in high resolution CT of the lung, 3rd eds. Lippincott Williams & Wilkins, PA, p390-393, 2001.
 
16) 井上義一 : 肺胞蛋白症の診断, 管理と血清マーカー. 細胞 34 : 8, 2002.
 
17) Chou CW, Lin FC, Tung SM, et al : Diagnosis of pulmonary alveolar proteinosis : usefulness of papanicolaou-stained smears of bronchoalveolar lavage fluid. Arch Intern Med 161 : 562, 2001.
PubMed
18) Arai T, Hamano E, Inoue Y, et al : Ryushi T, Nukiwa T, Sakatani M, Nakata K. Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF. Respir Med 98 : 1227, 2004.
 
19) Tazawa R, Trapnell BC, Inoue Y, et al : Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 181 (12) : 1345-1354, 2010.
PubMed
P.316 掲載の参考文献
1) Vassallo R, Ryu JH, Colby TV, et al : Pulmonary Langerhans'-cell histiocytosis. N Engl J Med 342 : 1969-1978, 2000.
PubMed
2) Tazi A : Adult pulmonary Langerhans' cell histiocytosis. Eur Respir J 27 : 1272-1285, 2006.
PubMed
3) Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet 1 : 208-209, 1987.
PubMed
4) Lichtenstein L : Histiocytosis X : integration of eosinophilic granuloma of bone, Lettere-Siwe disease, and Schuller-Christian disease as related manifestation of a single nosologic entity. AMA Arch Pathol 56 : 84-102, 1953.
 
5) 井上義一 : ランゲルハンス細胞組織球症の病態と臨床 : 総括. 日サ会誌 29 (1) : 95-97, 2009.
 
6) Gaensler EA, Carrington CB : Open biopsy for chronic diffuse infiltrative lung disease : clinical, roentgenographic, and physiological correlation in 502 patients. Ann Thorac Surg 30 (5) : 411-426, 1980.
PubMed
7) Watanabe T, Tatsumi K, Hashimoto S, et al : Clinico-epidemiological features of pulmonary histiocytosis X. Intern Med 40 (10) : 998-1003, 2001.
 
8) Alston RD, Tatevossian RG, McNally RJ, et al : Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998. Pediatric blood & cancer 48 (5) : 555-560, 2007.
PubMed
9) Vassallo R, Ryu JH, Schroeder DR, et al : Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med 346 (7) : 484-490, 2002.
PubMed
10) 杉本親寿, 井上義一 : 肺ランゲルハンス細胞組織球症. 呼吸 30巻1号 : 57-62, 2011.
 
11) 藤本圭作, 久保恵嗣 : 若年発症COPD (若年性肺気腫), 肺ランゲルハンス細胞ヒスチオサイトーシス (ヒスチオサイトーシス X), 肺胞低換気症候群に関する全国疫学調査. 平成18年度厚生労働省科学研究費.
 
12) Konno S, Hizawa N, Betsuyama T, et al : Adult langerhans cell histiocytosis with independently relapsing lung and liver lesions that was successfully treated with etoposide. Internal Medicine 46 (15) : 1231-1235, 2007.
 
13) Bernstrand C, Cederlund K, Ashtrom L, et al : Smoking preceded pulmonary involvement in adults with Langerhans cell histiocytosis diagnosed in childhood. Acta Paediatr 89 (11) : 1389-1392, 2000.
PubMed
14) Vermaelen K, Pauwels R : Pulmonary dendritic cells. Am J Rrespir Crit Care Med 172 (5) : 530-551, 2005.
 
15) Coury F, Annels N, Rivollier A, et al : Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nature medicine 14 (1) : 81-87, 2008.
PubMed
16) Fleming MD, Pinkus JL, Alexander SW, et al : Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis. Blood 101 : 2473-2475, 2003.
PubMed
17) 浅本仁, 北市正則, 長井苑子, 他 : 我が国における肺好酸球性肉芽腫症-17症例についての臨床的分析-. 日胸疾会誌 33 (12) : 1372-1381, 1955.
 
18) Delobbe A, Durieu J, Duhamel A, et al : Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Groupe d'Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du Nord. Eur Respir J 9 : 2002-2006, 1996.
 
19) Fartoukh M, Humbert M, Capron F, et al : Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 161 : 216-223, 2000.
PubMed
20) Howarth DM, Gilchrist GS, Mullan BP, et al : Langerhans cell histiosytosis : diagnosis, natural history, management and outcome. Cancer 85 (10) : 2278-2290, 1999.
PubMed
21) Kambouchner M, Basset F, Marchal J. et al : Tree-dimensional characterization of pathologic lesions in pulmonary langerhans cell histiocytosis. Am J Respir Crit Care Med 166 : 1483-1490, 2002.
 
22) Krajicek BJ, Ryu JH, Hartman TE, et al : Abnormal fluorodeoxyglucose PET in pulmonary langerhans cell histiocytosis. Chest 135 : 1542-1549, 2009.
PubMed
P.324 掲載の参考文献
1) Lautenbacher R : Dysembriomes metoti@iques des reins, carcinose submiliere aigue puomon avec amphyseme generalize et double pneumothorax. AnnMed Interne (Paris) 5 : 435-450, 1918.
 
2) 山中晃, 斎木茂樹 : びまん性過誤腫性肺脈管筋腫症 : 慢性閉塞性肺疾患鑑別のために. 肺と心 17 : 171-181, 1970.
 
3) Kitaichi M, Nishimura K, Itoh H, et al : Pulmonary lymphangioleiomyomatosis : a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med 151 : 527-533, 1995.
PubMed
4) McCormack FX, Sullivan EJ, Inoue Y : Lymphangioleio-myomatosis. Murray & Nadel's textbookof respiratory medicine. Ed. Mason RJ, Broaddus VC, MartinTR, et al. Saunders Elsevier : 1496-1515, 2010.
 
5) Kumasaka T, Seyama K, Mitani K, et al : Lymphangiogenesis-mediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis. Am J Surg Pathol x29 (10) : 1356-1366, 2005.
 
6) Inoue Y, King TE Jr, Barker E, et al : Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis. Am J Respir Crit Care Med 166 (5) : 765-773, 2002.
PubMed
7) 広瀬雅樹, 井上義一 : リンパ脈管筋腫症に関する分子生物学的解析. 最新医学 65 (9) : 146-154, 2010.
 
8) Hayashida M, Seyama K, Inoue Y, et al : The epidemiology of lymphangioleiomyomatosis in Japan : A nationwide cross-sectional study of presenting features and prognostic factors. Respirology 12 : 523-530, 2007.
PubMed
9) 林田美江, 久保惠嗣, 瀬山邦明, 他 : リンパ脈管筋腫 lymphangioleiomyomatosis (LAM) 診断基準. 日呼吸会誌 46 : 425-427, 2008.
Medical*Online
10) Silverstein EF, Ellis KWolffM, et al : Pulmonary lymphangiomyomatosis. AJR Am J Roentrogenol 120 : 832-850, 1974.
 
11) Young L, Inoue Y, McCormack FX : Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis. N Engl J Med 358 (2) : 199-200, 2008.
PubMed
12) Johnson SR, Cordier JF, Lazor R, et al (ERS task force) : European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J 35 : 14-26, 2010.
PubMed
13) 結節性硬化症の診断基準・治療ガイドライン作成委員会 : 結節性硬化症の診断基準および治療ガイドライン日皮会誌 : 118, 1667-1676, 2008.
 
14) 林田美江, 藤本圭作, 久保惠嗣, 他 : リンパ脈管筋腫lymphangioleiomyomatosis (LAM) の治療と管理の手引き. 日呼吸会誌 46 (6) : 428-431, 2008.
 
15) 大家晃子, 井上義一 : リンパ脈管筋腫症. In 工藤翔二, 中田紘一郎, 貫和敏博編. 呼吸器疾患の最新の治療 2007-2009. 南江堂, 318-320, 2007.
 
16) 井上義一 : リンパ脈管筋腫症とその周辺に対する新規分子標的治療薬の展望. 日本胸部臨床, 日本胸部臨床 70 : 1031-1039, 2011.
 
17) Bissler JJ, McCormack FX, Young LR, et al : Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 358 : 140-151, 2008.
PubMed
18) McCormack FX, Inoue Y, Moss J, et al : Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 364 (17) : 1595-606, 2011.
PubMed
P.328 掲載の参考文献
1) Spencer H : Pathology of the lung. 5th ed. Oxford : Pergamon Press : 733-739, 1995.
 
2) Schwarz MI : Respiratory tract amyloidosis. In interstitial lung disease, BC Dechker Inc, New York : 877-908, 2003.
 
3) Rahman NA, Fruchter O, Shitrit D, et al : Flexible bronchoscopic management of benign tracheal stenosis : long term follow-up of 115 patients. J Cardiothorac Surg 5 : 2, 2010.
PubMed
4) Rajagopala S, Singh N, Gupta K, et al : Pulmonary amyloidosis in Sjogren's syndrome : a case report and systematic review of the literature. Respirology 15 (5) : 860-866, 2010.
PubMed
5) Jeong YJ, Lee KS, Chung MP, et al : Amyloidosis and lymphoproliferative disease in Sjogren syndrome : thin-section computed tomography findings and histopathologic comparisons. J Comput Assist Tomogr 28 (6) : 776-771, 2004.
PubMed
6) Seo JH, Lee SW, Ahn BC, et al : Pulmonary amyloidosis mimicking multiple metastatic lesions on F-18 FDG PET/CT. Lung Cancer Mar 67 (3) : 376-379, 2010.
 
7) Berk JL, Keane J, Seldin DC, et al : Persistent pleural effusions in primary systemic amyloidosis : etiology and prognosis. Chest 124 (3) : 969-977, 2003.
PubMed
8) Lachmann HJ, Gallimore R, Gillmore J, et al : Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. Br J Haematol 122 (1) : 78-84, 2003.
PubMed
9) Kalra S, Utz JP, Edell ES, et al : External-beam radiation therapy in the treatment of diffuse tracheobronchial amyloidosis. Mayo Clin Proc 76 (8) : 853-856, 2001.
PubMed
10) Livneh A, Zemer D, Langevitz P, et al. Colchicine in the treatment of AA and AL amyloidosis. Semin Arthritis Rheum 23 (3) : 206-214, 1993.
PubMed
11) 須谷顕尚, 田部一秋, 永田真, 他 : Dimethyl sulfoxide が有効であった原発性肺アミロイドーシスの1例. 日呼吸会誌 42 ; 835-830, 2004.
 
P.332 掲載の参考文献
1) 立花暉夫 : 肺胞微石症, 稀少肺疾患をめぐる最近の話題. 呼吸器科 5 : 99-105, 2004.
 
2) Takahashi H,Chiba H,Shiratori M, et al : Elevated serum surfactant protein A and D in pulmonary alveolar microlithiasis. Respirology 11 : 330-333, 2006.
 
3) 萩原弘一 : 肺胞微石症疾患遺伝子の同定. 日内会誌 95 : 1036-1041, 2006.
 
4) Huqun, Izumi S, Miyazawa H, et al : Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Amer J Respir Crit Care Med 175 : 263-268, 2007.
 
5) 萩原弘一, 立花暉夫, 上甲剛 : 肺胞微石症. 日本臨牀 新領域別症候群シリーズ No8 呼吸器症候群 (第2版) I-その他の呼吸器疾患を含めて-II びまん性肺疾患 C. まれなびまん性肺疾患 : 492-501, 2008.
 
6) 萩原弘一 : 遺伝性呼吸器疾患の遺伝子診断. 日胸 67 : 11 増刊号 : S273-274, 2008.
 
7) Tachibana T, Hagiwara K, Johkoh T : Pulmonary alveolar microlithiasis : review and management. Current Opinion in Pulmonary Medicine 15 : 486-490, 2009.
PubMed
8) Hagiwara K, Johkoh T, Tachibana T. : Pulmonary alveolar microlithiasis. McCormack FX, Panos RJ, Trapnell BC, eds. Molecular Basis of Pulmonary Disease : Insights from Rare Lung Disorders. In Respiratory Medicine, Rounds S, series editor. Humana Press ; Springer Science and Business Media, LLC. New York : 325-328, 2010.
 
9) 立花暉夫, 上甲剛, 萩原弘一, 他 : 日本の肺胞微石症, 剖検例の臨床的検討. 日呼吸誌 162 : 2 増刊号, 2013.
 
P.338 掲載の参考文献
1) 嚥下性肺疾患研究会編 : 嚥下性肺疾患の診断と治療. ファイザー. 2003.
 
2) 板橋繁, 佐々木英忠 : 高齢者肺炎. 呼吸 19 : 363-373, 2000.
 
3) 新井正, 藤原久義 : 不顕性誤嚥 Geriatric Medicine 39 : 231-237, 2001.
Medical*Online
4) Kikuchi R, Watanabe N, Konno T, et al : High incidence of silent aspiration in elderly patients with community-acquired pneumonia. Am J Res Crit Care Med 150 : 251-253, 1994.
 
5) Mark PE, Kaplan D : Aspiration pneumonia and dysphagia in the elderly. Chest 124 : 328-336, 2003.
 
6) 窪田俊夫, 三島博信, 花田実 : 脳血管障害による麻酔性嚥下障害 : スクリーニングテストとその臨床応用. 総合リハ 10 : 271-276, 1982.
 
7) Baba Y, Teramoto S, Hasegawa H, et al : Characteristics and limitation of portable bedside swallowing test in elderly with dementia : comparison between the repetitive saliva swallowing test and the simple swallowing provocation test. Nihon Ronen Igakkai Zasshi 42 : 323-327, 2005.
PubMed
8) Teramoto S, Matsuse T, Fukuchi Y, et al : Simple two-step swallowing provocation test for elderly patients with aspiration pneumonia. Lancet 353 : 1243, 1999.
PubMed
9) Ott DJ, Pikna LA : Clinical and videofluoroscopic evaluation of swallowing disorders. Am J Roentgenol. 161 : 507-513, 1993.
 
10) Teramoto S, Matsuse T, Ouchi Y : Clinical significance of cough as a defense mechanism or a symptom in elderly patients with aspiration and diffuse aspiration bronchiolitis. Chest 115 : 602-603, 1999.
PubMed
11) Yoneyama T, Yoshida M, Matsui T, et al : Oral care and pneumonia. Lancet 354 : 515, 1999.
PubMed
12) Teramoto S, Ouchi T : ACE inhibitorsand prevention of aspiration pneumoniain elderly hypertensives. Lancet 353 : 843, 1999.
 
13) Teramoto S, Matsuse T, Ouchi T : Amantadine and pneumonia in elderly stroke patients. Lancet 353 : 2156, 1999.
PubMed
P.345 掲載の参考文献
1) Wheeler JH, Fishman EK : Computed tomography in the management of chest infections : current status. Clin Infect Dis 23 : 232-240, 1996.
PubMed
2) 日本呼吸器学会呼吸器感染症に関するガイドライン作成委員会. 成人市中肺炎診療ガイドライン. 東京 : 日本呼吸器学会 ; 2007.
 
3) Miyashita N, Sugiu T, Kawai Y, et al : Radiographic features of Mycoplasma pneumoniae pneumonia : differential diagnosis and performance timing. BMC Med Imaging 9 : 7, 2009.
PubMed
4) Webb WR, Muller NL, Naidich DP : Infections. In High-resolution CT of the lung. 4th ed. Philadellphia : Lippincott Williams & Wilkins : 415-461, 2009.
 
5) Nambu A, Saito A, Araki T, et al : Chlamydia pneumoniae : comparison with findings of Mycoplasma pneumoniae and Streptococcus pneumoniae at thin-section CT. Radiology 238 : 330-338, 2006.
PubMed
6) Tan MJ, Tan JS, Hamor RH, File TM, Jr, Breiman RF : The radiologic manifestations of Legionnaire's disease. The Ohio Community-Based Pneumonia Incidence Study Group. Chest 117 : 398-403, 2000.
PubMed
7) Cook RJ, Ashton RW, Aughenbaugh GL, Ryu JH : Septic pulmonary embolism : presenting features and clinical course of 14 patients. Chest 128 : 162-166, 2005.
PubMed
8) Keane J, Gershon S, Wise RP, et al : Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345 : 1098-1104, 2001.
PubMed
9) Im JG, Itoh H, Shim YS, et al : Pulmonary tuberculosis : CT findings-early active disease and sequential change with antituberculous therapy. Radiology 186 : 653-660, 1993.
PubMed
10) Griffith DE, Aksamit T, Brown-Elliott BA, et al : An official ATS/IDSA statement : diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175 : 367-416, 2007.
PubMed
11) Kousha M, Tadi R, Soubani AO : Pulmonary aspergillosis : a clinical review. Eur Respir Rev 20 : 156-174, 2011.
PubMed
12) Chang WC, Tzao C, Hsu HH, et al : Pulmonary cryptococcosis : comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients. Chest 129 : 333-340, 2006.
PubMed
13) Thomas CF, Jr., Limper AH : Pneumocystis pneumonia. N Engl J Med 350 : 2487-2498, 2004.
PubMed
14) Tasaka S, Hasegawa N, Kobayashi S, et al : Serum indicators for the diagnosis of pneumocystis pneumonia. Chest 131 : 1173-1180, 2007.
PubMed
15) 新井徹, 井上義一, 田村太朗, 他 : 特発性間質性肺炎および膠原病肺の免疫抑制療法中に発生したサイトメガロウイルス抗原血症の検討. びまん性肺疾患に関する調査研究班 (貫和班) 平成19年度研究報告書 : 108-112.
 
16) Oikonomou A, Muller NL, Nantel S : Radiographic and high-resolution CT findings of influenza virus pneumonia in patients with hematologic malignancies. AJR Am J Roentgenol 181 : 507-511, 2003.
PubMed
P.351 掲載の参考文献
1) Rees D, Murray J. Silica : silicosis and tuberculosis. Int J Tuberc Lung Dis 11 : 356-369, 2007.
 
2) 深在性真菌症のガイドライン作成委員会編 : 深在性真菌症の診断・治療ガイドライン 2007.
 
3) Walsh TJ, Anaissie EJ, Denning DW, et al : Treatment of aspergillosis : clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46 : 327-360, 2008.
 
4) Pena TA, Soubani AO, Samavati L. : Aspergillus lung disease in patients with sarcoidosis : a case series and review of the literature. Lung 189 : 167-172, 2011.
PubMed
5) Baughman RP, Lower EE: Fungal infections as a complication of therapy for sarcoidosis. QJM 98 : 451-456, 2005.
PubMed
6) Corbett EL, Churchyard GJ, Clayton T, et al : Risk factors for pulmonary mycobacterial disease in South African gold miners. A case-control study. Am J Respir Crit Care Med 159 : 94-99, 1999.
 
7) Ito Y, Hirai T, Maekawa K, et al : Predictors of fi ve-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease. Int J Tuberc Lung Dis. 2011 [Epub ahead of print].
 
8) Devouassoux G, Cottin V, Liote H, et al : Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis. Eur Respir J 33 : 1053-1061, 2009.
PubMed
9) Geri G, Dadoun S, Bui T, et al: Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases. BMC Infect Dis 11 : 304, 2011.
PubMed
10) Borie R, Schneider S, Debray MP, et al : Severe chronic bronchiolitis as the presenting feature of primary Sjogren's syndrome. Respir Med 105 : 130-136, 2011.
PubMed
11) Wootton SC, Kim DS, Kondoh Y, et al: Viral infection in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183 : 1698-1702, 2011.
PubMed
12) De Pauw B, Walsh TJ, Donnelly JP, et al : Revised defi nitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46 : 1813-1821, 2008.
 
13) Harigai M, Koike R, Miyasaka N, et al : Pneumocystis pneumonia associated with infliximab in Japan. Engl J Med 357 : 1874-1876, 2007.
 
14) Matsumura Y, Ito Y, Iinuma Y, et al : Quantitative real-time PCR and the (1→3)-β-d-glucan assay for differentiation between Pneumocystis jiroveci pneumonia and colonization. Clin Microbiol Infect. 2011. [Epub ahead of print]
 
15) Maskell NA, Waine DJ, Lindley A, et al : Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy : a prospective study. Thorax 58: 594-597, 2003.
PubMed
16） Morris A, Wei K, Afshar K, et al : Epidemiology and clinical significance of Pneumocystis colonization. J Infect Dis 197 : 10-17, 2008.
PubMed
P.358 掲載の参考文献
1) Murray-Nadel Textbook of Respiratory Medicine Fourth edition Saunders, 2010.
 
2) Wormser GP, et al eds : AIDS and Other Manifestations of HIV Infection. Noyes Publications, Park Ridge : 408-444, 1987.
 
3) SPACH & HOOTON HIVマニュアル 日本医学館, 1996.
 
4) 抗HIV治療ガイドライン 平成22年度厚生労働省科学研修費補助金エイズ対策研究事業 HIV感染症及びその合併症の課題を克服する研究班. 2011年3月.
 
5) HIN感染症治療研究会HIV感染症「治療の手引き」第15版2011年12月発行.
 
6) Zolopa A, Andersen J, Powderly W, et al : Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections : a multicenter randomized strategy trial. PLoS ONE 4 : e5575, 2009.
PubMed
7) Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents (米国DHHS, January 11, 2011版)
 
8) Frederick Southwick編集 : 感染症診療スタンダードマニュアル第2版 (日本語版) 501, 羊土社, 2011.
 
9) Stansell JD, Osmond DH, Charlebois E, et al : Predictors of pneumocystis carinii pneumonia in HIVinfected persons. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med 155 : 60-66, 1997.
 
10) 2010年エイズ発生動向年報 表11 AIDS 報告症例における指標疾患の分布 厚生労働省エイズ動向委員会. 平成23年5月23日.
 
11) Kovacs JA, Hiemenz JW, Macher AM, et al : pneumocystis carinii pneumonia : A comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 100 : 663-671, 1984.
PubMed
12) Chow C,Templeton PA, White CS : Lung cysts associated with pneumocystis carinii pneumonia : Radiographic characteristics, natural history, and complications. Am J Roentgenol 161 : 527, 1993.
 
13) Gruden JF, Huang L, Turner J, et al : High-resolution CT in the evaluation of clinically suspected Pneumocystis carinii pneumonia in AIDS patients with normal equivocal or nonspecific radiographic findings. Am J Roentgenol 169 : 967, 1997.
PubMed
14) Fraser and Pare's Diagnosis of Diseases of the CHEST Fourth Edition Saunders,1999.
 
15) Thomas CF, Limper AH : Pneumocystis Pneumonia. N Engl J Med ; 350 : 2487-2498, 2004.
PubMed
16) Flori P, Bellete B, Durand F, et al : Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens. Journal of Medical Microbiology 53 : 603-607, 2004.
PubMed
17) Huang L, Morris A, Limper AH, et al : An Official ATS workshop summary : Recent advances and future directions in Pneumocystis Pneumonia (PCP). Proc Am Thorac Soc 3 : 655-664, 2006.
PubMed
18) CDC : Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents : Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 58 : 1-198, 2009.
 
19) 永井英明, 川辺芳子, 有賀晴之, 他 : HIV感染症における結核感染診断に対してのQuantiFERONR-TB 第2世代の有用性についての検討. 結核 82 : 635-640, 2007.
 
P.365 掲載の参考文献
1) Medlar EM : The behavior of pulmonary tuberculous lesions. A pathological study. Am Rev Tuberculosis and Pulmonary Diseases, 71 : 1-244, 1995.
 
2) 岩崎龍郎 : 結核の病理, 財団法人結核予防会, p.220, 1951 (復刻版1976).
 
3) Flint A, Colby TV : Chapter Two. Infectious disorders presenting as diffuse lung disease. In : Surgical Pathology of Diffuse Infiltrative Lung Disease, Grune & Stratton Inc, Orlando : 13-62, 1987. (泉孝英, 北市正則監訳 : びまん性肺疾患の生検診断, 金芳堂, 1989, p.172.).
 
4) Colby TV, Lombard C, Yousem SA, Kitaichi M : Chapter 5, Infections. In : Atlas of Pulmonary Surgical Pathology, W.B. Souders Co., Philadelphia : 155-204, 1991.
 
5) Thurlbeck WM, Miller RR, Mueller NL Rosenow ECIII : Diffuse Diseases of the Lung. A Team Approach. Chapter 4. : Acute infiltrative lung disease in the nonimmunocompromised host, Chapter 5 : . Acute infiltrative lung disease in the immunocompromised host. B.C. Decker, Philadelphia : 43-63, 65-91, 1991.
 
6) Kradin RL, Mark EJ : Pulmonary infections. In : Kradin RL (ed) : Diagnostic Pathology of Infectious Disease. Sunders Elsevier, Philadelphia : 125-188, 2010.
 
7) Corrin B, Nicholson A : Infectiopus diseases. In : Pathology of the Lungs, Churchill Livingstone Elsevier, Edinburgh, Third Ed : 155-262, 2011.
 
8) 北市正則 : 肺感染症の病理. 松本慶蔵, 安藤正幸, 佐々木英忠, 福地義之助編集 : 肺炎, 医薬ジャーナル社, 大阪 : 60-71, 2003.
 
9) 北市正則 : 肺感染症の病理所見. 斉藤厚編集 : 新しい診断と治療のABC17/呼吸器 4. 肺炎. 最新医学社, 大阪 : 23-41, 2003.
 
10) Longcope WT, Freiman DG : A study of sarcoidosis. Based on a combined investigation of 160 cases including 30 autopsies from the Johns Hopkins Hospital and Massachusetts General Hospital. Medicine 31 : 1-132, 152.
 
11) Liebow AA. The J : Burs Amberson Lecture. Pulmonary angiitis and granulomatosis. Am Rev Respir Dis 108 : 1-18, 1973.
 
12) American Thoracic Society : Statement on sarcoidosis. Am J Respir Crit Care Med 160 : 736-755, 1999.
PubMed
13) Myers JL, El-Zammar O : Pathology of drug-induced lung disease. In : Katzenstein ALA. Surgical Pathology of Non-Neoplastic Lung Disease, 4th Ed, Sunders Elsevier, Philadelphia : 85-125, 2006.
 
14) 北市正則 : サルコイドーシス, 過敏性肺臓炎, 慢性ベリリウム肺の肺病変の病理組織学的比較検討. 日胸疾会誌 22 : 769-782, 1984.
 
15) Kitaichi M : Pathology of pulmonary sarcoidosis. Clinics in Dermatology 4 : 108-116, 1986.
PubMed
16) 北市正則 : 特集サルコイドーシス 1988. サルコイドーシスの病理組織像. サルコイドーシスの病理像. 最新医学 43 : 1383-1386, 1446-1453, 1988.
 
17) Kitaichi M. Prevalence of sarcoidosis around the world. Sarcoidosis Vasculitis and Diffuse Lung Diseases 15 : 16-18, 1998.
 
18) 北市正則 : 第2章 肺結核の診断・治療. B. 肺結核と鑑別すべき疾患. 3. 病理所見からの鑑別. 泉孝英監修, 冨岡洋海編集, 結核 第4版, 医学書院, 東京 : 161-165, 2006.
 
19) 北市正則 : 第8章サルコイドーシス以外の肉芽腫性疾患. 1. 病理. 安藤正幸, 四元秀毅監修, 日本サルコイドーシス/ 肉芽腫性疾患学会編集, サルコイドーシスとその他の肉芽腫性疾患. 克誠堂, 東京 : 250-256, 2006.
 
P.372 掲載の参考文献
1) Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y, Kira S, Izumi T : Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest. Jan ; 83 (1) : 636-639, 1983.
 
2) Kitaichi M, Nishimura K, Izumi T : Diffuse panbronchiolitis, In : Sharma OP, ed. Lung Diseases in the Tropics : Mercel Dekker, New York : 479-509, 1991.
 
3) 中田紘一郎 : びまん性汎細気管支炎の診断指針及び治療指針の日本呼吸器学会と合同による普及について. 厚生科学研究びまん性肺疾患研究班平成13年度研究報告書. 31-37, 2002.
 
4) Nishimura K, Kitaichi M, Izumi T, Itoh H : Diffuse panbronchiolitis : correlation of high-resolution CT and pathologic findings. Radiology Sep 184 (3) : 779-785, 1992.
PubMed
5) Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M : Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med. Jun ; 157 (6 Pt 1) : 1829-1832, 1998.
 
6) Friedlander AL, Albert RK : Chronic macrolide therapy in inflammatory airways diseases. Chest 138 : 1202-1212, 2010.
PubMed
7) Nicod LP : Mechanisms of airway obliteration after lung transplantation. Proc Am Thorac Soc. Jul 3 (5) : 444-449, 2006.
PubMed
8) Estenne M, Maurer JR, Boehler A, et al : Bronchiolitis obliterans syndrome 2001 : an update of the diagnostic criteria. J Heart Lung Transplant. Mar 21 (3) : 297-310, 2002.
PubMed
9) Filipovich AH, Weisdorf D, Pavletic S, et al : National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease : I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. Dec 11 (12) : 945-956, 2005.
 
10) Soubani AO, Uberti JP : Bronchiolitis obliterans following haematopoietic stem cell transplantation. Eur Respir J. May 29 (5) : 1007-1019, 2007.
PubMed
11) Lai RS, Chiang AA, Wu MT, et al : Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan. Lancet 348 : 83-85, 1996.
PubMed
12) Kreiss K, Gomaa A, Kullman G, Fedan K, Simoes EJ, Enright PL : Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med. Aug 1 ; 347 (5) : 330-338, 2002.
 
13) Differentiation of bacterial and non-bacterial community-acquired pneumonia by thin-section computed tomography. Eur J Radiol. Dec 72 (3) : 388-395, 2009.
PubMed
14) O'Donnell AE : Bronchiestasis. Chest 134 : 815-823, 2008.
 
15) Takayanagi N, Nakazawa M, Kawabata Y, et al : Chronic bronchiolitis with associated eosinophilic lung disease (eosinophilic bronchiolitis). Respiration 68 : 319-322, 2001.
 
P.378 掲載の参考文献
1) Hiwatari N, Shimura S, Takishima T : Pulmonary emphysema followed by pulmonary fibrosis of undetermined cause. Respiration 60 : 354-358, 1993.
PubMed
2) Nishimura K, Kitaichi M, Izumi T, Nagai S, Kanaoka M, Itoh H : Usual interstitial pneumonia : histologic correlation with high-resolution CT. Radiology 182 : 337-342, 1992.
PubMed
3) Wiggins J, Strickland B, Turner-Warwick M : Combined cryptogenic fibrosing alveolitis and emphysema : the value of high resolution computed tomography in assessment. Respir Med 84 : 365-369, 1990.
PubMed
4) Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, Israel-Biet D, Court-Fortune I, Valeyre D, Cordier JF : Combined pulmonary fibrosis and emphysema : a distinct underrecognised entity. Eur Respir J 26 : 586-593, 2005.
PubMed
5) Cottin V, Cordier JF : The syndrome of combined pulmonary fibrosis and emphysema. Chest 136 : 1-2, 2009.
PubMed
6) Jankowich MD, Polsky M, Klein M, Rounds S : Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration 75 : 411-417, 2008.
PubMed
7) Grubstein A, Bendayan D, Schactman I, Cohen M, Shitrit D, Kramer MR : Concomitant upperlobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers : report of eight cases and review of the literature. Respir Med 99 : 948-954, 2005.
PubMed
8) Rogliani P, Mura M, Mattia P, Ferlosio A, Farinelli G, Mariotta S, Graziano P, Pezzuto G, Ricci A, Saltini C, Orlandi A : HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema. Respir Med 102 : 1753-1761, 2008.
PubMed
9) Mura M, Zompatori M, Pacilli AM, Fasano L, Schiavina M, Fabbri M : The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis. Respir Care 51 : 257-265, 2006.
PubMed
10) Cottin V, Le Pavec J, Prevot G, Mal H, Humbert M, Simonneau G, Cordier JF : Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 35 : 105-111, 2010.
PubMed
11) Mejia M, Carrillo G, Rojas-Serrano J, Estrada A, Suarez T, Alonso D, Barrientos E, Gaxiola M, Navarro C, Selman M : Idiopathic pulmonary fibrosis and emphysema : decreased survival associated with severe pulmonary arterial hypertension. Chest 136 : 10-15, 2009.
PubMed
12) Akagi T, Matsumoto T, Harada T, Tanaka M, Kuraki T, Fujita M, Watanabe K : Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respir Med 103 : 1209-1215, 2009.
PubMed
13) Jankowich MD, Rounds S : Combined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysema. Lung 188 : 365-373, 2010.
PubMed
14) Kurashima K, Takayanagi N, Tsuchiya N, Kanauchi T, Ueda M, Hoshi T, Miyahara Y, Sugita Y : The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis. Respirology 15 : 843-848, 2010.
PubMed
15) Kitaguchi Y, Fujimoto K, Hanaoka M, Kawakami S, Honda T, Kubo K : Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 15 : 265-271, 2010.
PubMed
16) Washko GR, Hunninghake GM, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, Ross JC, Estepar RS, Lynch DA, Brehm JM, Andriole KP, Diaz AA, Khorasani R, D'Aco K, Sciurba FC, Silverman EK, Hatabu H, Rosas IO : Lung volumes and emphysema in smokers with interstitial lung abnormalities. The New England journal of medicine 364 : 897-906, 2011.
PubMed
17) Usui K, Tanai C, Tanaka Y, Noda H, Ishihara T : The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer. Respirology 16 : 326-331, 2011.
PubMed
P.386 掲載の参考文献
1) Heard BE : Pathology of Chronic Bronchitis and Emphysema, J.&A. Churchill, LTD, London : 136, 1969.
 
2) 高久文麿編集 : Stedman's English-Japanese Medical Dictionary, 3rd Ed, Medical View, 東京 : 477-478, 1990.
 
3) Talamo RC, Blennerhasset JB, Austen KF : Familial emphysema and alpha1-antitrypsin deficiency. New Engl J Med 275 : 1301-1304, 1966.
 
4) Taraseviciene-Stewert L, Volekel NF : Molecular pathogenesis of emphysema. J Clin Invest 118 : 394-402, (Ref 3 is Laennec (1819)), 2008.
 
5) Laennec RTH : De l'auscultation mediate, Traite du diagnostic des poumons et du Coeur, Brosson et Chande, Paris, France, Vol 1, 210, 1819.
 
6) Fletcher CM, Gilson JG, Hugh-Jones P, Scadding JG : Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions. A report of the conclusions of a CIBA Guest Symposium. Thorax 14 : 286-299, 1959.
 
7) Thurlbeck WM : Chapter One : Historical, Chapter Four : Morphology of emphysema and emphysema-like conditions. In : Chronic Airflow Obstruction in Lung Disease, W.B. Saunders Company, Philadelphia : 456 (1-11, 96-234), 1976.
 
8) Gough J : Discussion on the diagnosis of pulmonary emphysema. The pathological diagnosis of emphysema. Pro Roy Soc Med 45 : 570-577, 1952.
 
9) Denolin H, Fletcher CM, et al : World Health Organization. Chronic cor pulmonare : report of an expert committee. World Health Organization Technical Report Series, No. 213 : 15 (Circulation 1963 ; 27 : 594-615), 1961.
 
10) Harris HW, Menfely GR, Renzetti AD Jr, Steele JD, Wyatt JP : American Thoracic Society. Chronic bronchitis, asthma, and pulmonary emphysema. A statement by the committee on diagnostic standards for nontuberculous respiratory diseases. Am Rev Respir Dis 85 : 762-768, 1962.
 
11) Snider GJ, Kleinerman J, Thurlbeck WM, Bengali ZH : Report of a National Heart, Lung, and Blood Institute, Division of Lung Disease Workshop, The definition of emphysema. Am Rev Respr Dis 132 : 182-185, 1985.
 
12) Tuder RM, Voelkel NF : Chapter 6. Pathobiology of emphysema. In : Voelkel NF and McNee W (eds), Chronic Obstructive Lung Diseases, BC Decker Inc, Hamilton : 63-75, 2008.
 
13) Yoshida T, Tuder RM : Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiology Review 87 : 1047-1082, 2007.
 
14) Austin JHM, Mueller NL, Friedman PJ, Hansell DM, Naidich DP, et al : Glossary of terms for CT of the lungs : recommendations of the Nomenclature Committee of the Fleischner Society. Radiology 200 : 327-331, 1996.
 
15) Takabe K, Seyama K, Shinada H, Noguchi T, Miyahara Y, et al : A new variant of alpha-1-antitrysin deficiency (Siiyama) associated with pulmonary emphysema. Intern Med 31 : 702-707, 1992.
 
16) Wood AM, Stockley RA : Alpha one antitrypsin deficiency : from gene to treatment. Respiration 74 : 481-492, 2007.
PubMed
17) Seyama K, Nukiwa T, Souma S, Shimizu K, Kira S : α1-antitrypsi-deficinet variant Siiyama (Ser53【TCC】to Phe53【TTC】is prevalent in Japan. Status of α1-antitrypsin deficiency in Japan. Am J Respir Crit Care Med 152 : 2119-2126, 1995.
 
18) Needham M, Stockley RA : α1-Antitrypsin deficiency・3 : Clinical manifestations and natural history. Thorax 59 : 441-445, 2004.
 
19) Heppleston AG : The pathology of honeycomb lung. Thorax 11 : 77-93. 1956.
PubMed
20) Sobonya RE. Emphysema. In : Saldana MJ (ed). Pathology of Pulmonary Disease, J.B. Lippincott Co, Philadelphia : 275-294, 1994.
 
21) Lamb D : Chapter 19. Chronic bronchitis, emphysema, and the pathological basis of chronic obstructive pulmonary disease. In : Hasleton PS (ed), Spencer's Pathology of the Lung, Fifth Ed, McGraw-Hill, New York : 597-629, 1996.
 
22) Fukuchi Y, et al : Guidelines for the Diagnosis and Treatment of COPD (Chronic Obstructive Pulmonary Disease), 2nd Edition, Pocket Guide, Committee for the Second Edition of the COPD Guidelines of the Japanese Respiratory Society, The Japanese Respiratory Society : 2-3, 2004.
 
23) Nagai A, et al : Guidelines for the Diagnosis and Treatment of COPD (Chronic Obstructive Pulmonary Disease), 3rd Edition, Pocket Guide, Committee for the Third Edition of the COPD Guidelines of the Japanese Respiratory Society, The Japanese Respiratory Society, p.5. 2010.
 
24) American Thoracic Society. Cigarette smoking and health. Am J Respir Crit Care Med 153 : 861-865, 1996.
PubMed
25) Celli BR, MacNee W : ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD : a summary of the ATS/ERS position paper. Eur Resp J 23 : 932-946, 2004.
 
26) Pauwels MSA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS : NHLBI/WHO Workshop Summary. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163 : 1256-1276, 2001.
 
27) Barnes PJ : Review article. Medical Progress. Chronic obstructive pulmonary disease. New Engl J Med 343 : 269-280, 2000.
 
28) Rodoriguez-Roisin R (ed) : Chapter 4. Pathology, Pathogenesis, and Pathophysiology. In : Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2010 Global Initiative for Chronic Obstructive Lung Disease, Inc : 23-30, (Available from : http://www.goldcopd.org/), Updated 2010.
 
29) Hogg JC, Chu F, Utokaparch S, Woods R, Eliott WM, et al : The nature of small-airway obstruction in chronic obstructive pulmonary disease. New Engl J Med 350 : 2645-2653, 2004.
 
30) Miller WS : A study of the human pleura pulmonalis : Its relation to the blebs and bullae of emphysema. Am J Roent and Radium Therapy 15 : 399-497, 1926.
 
31) Miller MS : A further study of emphysematous blebs. Am J Roent and Radium Therapy 18 : 42-47, 1927.
 
32) Reid L : Chapter XIV, Bullae.p.211-240. In : The Pathology of Emphysema, Year Book Medical Publishers, Inc, Chicago : 372, 1967.
 
33) Thurlbeck WM, Miller RR, Mueller NL Rosenow ECIII : Diffuse Diseases of the Lung. A Team Approach. Chapter 12. Chronic airflow obstruction. B.C.Decker, Philadelphia : 204-225, 1991.
 
34) 北市正則, 高木理博, 玉舎学 : のう胞性 (気腔開大性) 肺疾患の病理 : 研究の歴史と疾患の成り立ち. 呼吸器科 15 : 269-277, 2009.
 
35) Kitaichi M, Nishimura K, Itoh H, Izumi T : Pulmonary lymphangioleiomyomatosis : a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med 151 : 527-533, 1995.
PubMed
36) 林田美江, 久保惠嗣, 瀬山邦明, 熊坂利夫, 井上義一, 他 : 厚生労働省難治性疾患克服研究事業呼吸不全に関する調査研究班. 特別報告. リンパ脈管筋腫症lymphangioleiomyomatosis (LAM) 診断基準. 日呼吸会誌 46 : 425-427, 2008.
 
37) Birt AR, Hogg GR, Dube WJ : Hereditary multiple fiobrofolliculomas with trichodiscomas and acrochondrons. Arch Dermatol 113 : 1674-1677, 1977.
PubMed
38) Menko F, von Steensel MAM, Giraud S, Friis-Hansen L, Richard S, et al : diagnosis and management. Lancet Oncol 10 : 1199-1206, 2009.
 
39) Adrey BP, Smith ND, Navar R, Yang XJ : Birt-Hogg-Dube syndrome. Clinicopathologic findings and genetic alterations. Arch Path Lab Med 130 : 1865-1870, 2006.
 
40) Cottin V, Nunes H, Brillet P-Y, Delavai P, Devouassoux G, et al : Combined pulmonary fibrosis and emphysema : a distinct underrecognized entity. Eur Resp J 26 : 586-593, 2005.
 
41) Cottin V, Cordier J-F : The syndrome of combined pulmonary fibrosis and emphysema. Chest 136 : 1-2, 2009.
PubMed
42) Cottin V, Le Pavec J, Prevot G, Mal H, Hambert M, et al : Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 35 : 105-111, 2010.
 
43) Kawabata Y, Hoshi E, Mura K, Ikeya T, Takahashi N, et al : Smoking-related changes in the background lung of specimens resected for lung cancer : a semiquantitative study with correlation to postoperative course. Histopathology 53 : 707-714, 2008.
 
44) Corrin B, Nicholson AG : Interstitial lung disease. In : Pathology of the Lungs, Third Ed., Churchill Livingstone Elsevier, Edinburgh : 266-305, 2011.
 
45) Leopold JG, Gough J : The centrilobular form of hypertrophic emphysema and its relation to chronic bronchitis. Thorax 12 : 219-235, 1957.
PubMed
46) Heard BE : A pathological study of emphysema of the lungs with chronic bronchitis. Thorax 13 : 136-149, 1958.
PubMed
47) Voelkel NE, Petty TL : Chapter 1. History of chronic obstructive pulmonary disease. In : Voelkel NF, McNee W (eds), Chronic Obstructive Lung Disease, 2nd Ed., BC Decker, Inc., Hamilton : 1-8, 2008.
 
48) Symposium on Emphysema and "Chronic Bronchitis" Syndrome, Aspen, Colorado, June 13-15, 1958. Am Rev Resp Dis 80 : 1-213, 1959.
 
P.396 掲載の参考文献
1) Galie N, Hoeper MM, et al : Guidelines for the diagnosis and treatment of pulmonary hypertension : the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 30 : 2493-2537, 2009.
 
2) Barst RJ, Gibbs JS, et al : Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 54 (1 Suppl) : S78-84, 2009.
 
3) International PPH Consortium. Heterozygous germline mutations in BMPR2, encoding a TGFbeta receptor, cause familial primary pulmonary hypertension. Nat Genet 26 : 81-84, 2000.
PubMed
4) Lee SD, Shroyer KR, et al : Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 101 : 927-934, 1998.
 
5) 吉田俊治, 深谷修作 : 膠原病性肺高血圧症の頻度と病態の解析. 全身性自己免疫疾患における難治性自己免疫疾患の診断と治療法に関する研究班. 平成15年度総括・分担研究報告書 : 40-43, 2004.
 
6) Simonneau G, Robbins IM, et al : Updated clinical classification of pulmonary hypertension. Am J Coll Cardiol 54 : S43-54, 2009.
 
7) Chung L, Liu J, et al : Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL : identifying systemic sclerosis as a unique phenotype. Chest 138 : 1383-1394, 2010.
PubMed
8) Sanchez O, Sitbon O, et al : Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest 130 : 182-189, 2006.
PubMed
9) Humbert M, Sitbon O, et al : Treatment of pulmonary arterial hypertension. N Engl J Med 351 : 1425-1436, 2004.
PubMed

症例

P.405 掲載の参考文献
1) Rollins S, Colby T, Clayton F. Open lung biopsy in Mycoplasma pneumoniae pneumonia. Arch Pathol Lab Med 110 : 34-41, 1986.
PubMed
2) Haier J, Nasralla M, Franco AR,et al. Detection of mycoplasmal infections in blood of patients with rheumatoid arthritis. Rheumatology (Oxford). 38 (6) : 504-509, 1999 Jun.
PubMed
3) Horowitz S, Evinson B, Borer A, et al. Mycoplasma fermentans in rheumatoid arthritis and other inflammatory arthritides. J Rheumatol 27 (12) : 2747-2753, 2000 Dec.
PubMed
4) Ramirez AS, Rosas A, Hernandez-Beriain JA. Relationship between rheumatoid arthritis and Mycoplasma pneumoniae : a case-control study. Rheumatology (Oxford). 2005 Jul ; 44 (7) : 912-914, Epub 2005 Apr 6.
 
P.408 掲載の参考文献
1) Engleman P, Liebow AA, Gmelich J, et al : Pulmonary hyalinizing granuloma. Am Rev Respir Dis 115 : 997-1008, 1977.
PubMed
2) Yousem SA, Hochholzer L : Pulmonary hyalinizing granuloma. Am J Clin Pathol 87 : 1-6, 1987.
PubMed
3) Pinckard JK, Rosenbluth DB, Patel K, et al : Pulmonary hyalinizing granuloma associated with Aspergillus infection. Int J Surg Pathol 11 : 39-42, 2003.
PubMed
4) Winger DI, Spiegler P, Trow TK, et al : Radiology-Pathology Conference : pulmonary hyalinizing granuloma associated with lupus-like anticoagulant and Morvan's Syndrome," Clinical Imaging 31 : 264-268, 2007.
 
5) Chalaoui J, Gregoire P, Sylvestre J, et al : Pulmonary hyalinizing granuloma : a cause of pulmonary nodules. Radiology 152 : 23-26, 1984.
PubMed
6) Drasin H, Blume MR, Rosenbaum EH, et al : Pulmonary hyalinizing granulomas in a patient with malignant lymphoma, with development nine years later of multiple myeloma and systemic amyloidosis. Cancer 44 : 215-220, 1979.
 
7) Ren Y, Raitz EN, Lee KR, et al : Pulmonary small lymphocytic lymphoma (mucosa-associated lymphoid tissue type) associated with pulmonary hyalinizing granuloma. Chest 120 : 1027-1030, 2001.
PubMed
8) Anazawa Y, Nagai H, Motomiya M, et al : A case of pulmonary hyalinizing granuloma. Tohoku J Exp Med 167 : 39-45, 1992.
PubMed
9) Castleman B, Iverson L, Menendez VP : Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 9 : 822-830, 1956.
 
10) Keller AR, Hochholzer L, Castleman B : Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29 : 670-683, 1972.
PubMed
11) Gaba AR, Stein RS, Sweet DL, et al. Multicentric giant lymphnode hyperplasia. Am J Clin Pathol 69 : 86-90, 1978.
 
12) Chen KT : Multicentric Castleman's disease and Kaposi's sarcoma. Am J Surg Pathol 8 : 287-293, 1984.
PubMed
13) Atagi S, Sakatani M, Akira M, et al : Pulmonary hyalinizing granuloma with Castleman's disease. Internal Medicine 33 : 689-691, 1994.
PubMed
P.414 掲載の参考文献
1) Battesti JP, Georges R, Basset F, et al : Chronic cor pulmonale in pulmonary sarcoidosis. Thorax 33 : 76-84, 1978.
PubMed
2) Martin J, Dowling G : Sudden death associated with compression of pulmonary arteries in sarcoidosis. Can Med Assoc J 133 : 423-424, 1985.
 
3) Turiaf J, Battesti JP, Marland P, et al : Sarcoidosis involving large pulmonary arteries, in Johns Williams W, Davies BH (eds). Eighth International Conference on Sarcoidosis and Other Granulomatous Diseases. Cardiff, Wales, Alpha Omega : 3-8, 1980.
 
4) Hietala SO, Stinnett RG, Faunce HF, et al : Pulmonary artery narrowing in sarcoidosis. JAMA 237 : 572-573, 1977.
PubMed
5) Honda T, Hayasaka M, Hachiya T, et al : Unilateral hilar lymphadenopathy of sarcoidosis or sarcoid reaction compressing the trunk of the right pulmonary artery. Respiration 67 : 330-332, 2000.
PubMed
6) Dumas de la Roque A, Maitre S, Resten A, et al : Hilar adenopathy compressing the pulmonary arteries in the course of sarcoidosis. Rev Mal Respir 24 : 1151-1154, 2007.
PubMed
P.420 掲載の参考文献
1) Damuth TE, Bower JS, Cho K, et al : Major pulmonary artery stenosis causing pulmonary hypertension in sarcoidosis. Chest 781 : 888-891, 1980.
 
2) Takemura T, Matsui Y, Saiki S, et al : Pulmonary vascular involvement in sarcoidosis. Human pathology 23 : 1216-1223, 1992.
PubMed
3) Mangla A, Fisher J, Libby DM, et al : Sarcoidosis, pulmonary hypertension, and acquired peripheral pulmonary artery stenosis. Catheterization and Cardiovascular Diagnosis 11 ; 69-74, 1985.
PubMed
4) 安東優, 宮崎英二, 松本哲郎, 他 : 多発性に区域, 亜区域枝領域肺動脈の血流障害を認めたサルコイドーシスの1例. 日本胸部疾患学会誌 32 ; 328-333, 1994.
 
5) Murray-Nadel Textbook of Respiratory Medicine Fourth edition Saunders, 1850-1858, 2010.
 
6) Schomengerdt C, Suyemoto R, Main Fl : Granulomatous and fibrous mediastinitis. Journal of Thoracic and Cardiovascular Surgery 3 : 365-379, 1969.
 
7) Devaraj A, Griffin N, Nicholson AG, et al : Computed tomography findings in fibrosing mediastinitis. Clinical Radiology 621 : 781-786, 2007.
 
8) Toonkel R, Borczuk A, Pearson G, et al : Sarcoidosis-associated fibrosing mediastinitis with resultant pulmonary hypertension : A case report and review of the literature. Respiration 79 : 341-345, 2010.
PubMed
P.424 掲載の参考文献
1) Liebow AA : The J. Burns Amberson lecture : pulmonary angitis and granulomatosis. Am Rev Respir Dis 108 : 1-18, 1973.
 
2) Travis WD, Colby TV, Koss MN : Non-neoplastic Disorders of the Lower Respiratory Tract. American Registry of Pathology, Washington 251-254, 2002.
 
3) Ishige I, Usui Y, Takemura T, et al : Quantitative PCR of mycobacterial and propionibacterial DNA in lymphnodes of Japanese patients with sarcoidosis. Lancet 354 : 120-123, 1999.
 
4) Yamada T, Eishi Y, Ikeda S, et al : In situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition. J Pathol 198 : 541-547, 2002.
PubMed
5) Arai T, Inoue Y, Eishi Y, et al : Propionibacterium acnes in granulomas of a patient with necrotizing sarcoid granulomatosis. Thorax 63 : 90-91, 2008.
PubMed
6) Saldana MJ : Necrotizing sarcoid granulomatosis : clinicopathologic observation in 24 patients [Abstract]. Lab Invest 38 : 364, 1978.
 
7) Chrug A, Carrington CB, Gupta R : Necrotizing sarcoid granulomatosis. Chest 76 : 406-413, 1979.
 
8) Koss MN, Hochholzer I, Feigin DS, et al : Necrotizing sarcoid-like granulomatosis : clinical pathologic, and immunopathologic findings. Hum pathol 11S : 510-519, 1980.
 
P.427 掲載の参考文献
1) Travis WD, King Jr TE : American Thoracic Society/ European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002.
 
2) Akira M, et al : Serial computed tomographic evaluation in desquamative interstitial pneumonia. Thorax 52 : 333-337, 1997.
PubMed
P.435 掲載の参考文献
1) Ando S, Arai T, Inoue Y, et al : NSIP in a curry sauce factory worker. Thorax 61 : 1012-1013, 2006.
 
2) Travis WD, Colby TV, Koss MN : Non-neoplastic Disorders of the Lower Respiratory Tract. American Registry of Pathology, Washington : 115-123, 2002.
 
3) Arakawa H, Honma K, Saito Y, et al : Pleural disease in silicosis : pleural thickening, effusion and invagination. Radiology 236 : 685-693, 2005.
PubMed
4) Buechner HA. Bagassosis : a true pneumoconiosis. Ind Med Surg 31 : 311-314, 1962.
PubMed
5) Fraser RS, Colman N, Muller NL, et al : Immunologic lung disease. In Synopsis of diseases of the chest, 3rd ed. Philadelphia : Elsevier Saunders 505-511, 2005.
 
6) Cooper JAD, Jr. Occupational asthma, byssinosis, and industrial bronchitis. In : Fishman AP, Elias JA, Fishman JA, et al : ed. Fishman's pulmonary diseases and disorders. 4th ed. New York. Mc Grow Hill : 981-991, 2007.
 
7) 倉島一喜, 高柳昇, 前野有理, 他 : 進行性の気腫性嚢胞を合併し, 気胸を繰り返した慢性鳩飼病の1 例. 日呼吸会誌 41 : 416-420, 2003.
 
8) 山口修二, 藤内智, 秋葉裕二, 他 : 両側気胸と縦隔気腫を合併した農夫肺の1例. 日胸疾会誌 35 : 650-655, 1997.
 
9) Alleman T, Darcey DJ. Case report : Bronchiolitis obleterans organizing pneumonia in a spice process technician. J Occup Envirin Med 44 : 215-216, 2002.
 
P.440 掲載の参考文献
1) Rom WN, Weiden M, Garcia R, et al : Acute Eosinophilic Pneumonia in a New York City Firefighter Exposed to World Trade Center Dust. Am J Respir Crit Care Med 166 : 797-800, 2002.
 
2) 産業医学総合研究所 有害性評価研究部 京野洋子 : 繊維状鉱物による肺の障害 http://www.jniosh.go.jp/old/niih/jp/current/topics/senijyou_hai.html
 
3) 産業医学総合研究所 実験動物管理室 戸谷忠雄 : 繊維長が異なるクリソタイル繊維の急性肺障害 http://www.jniosh.go.jp/old/niih/jp/current/topics/senichou.html
 
4) Baan RA, Gross Y : Man-made mineral (vitreous) fibres : evaluations of cancer hazards by the IARC Monographs Programme. Mutation Research 553 : 43-58, 2004.
 
P.446 掲載の参考文献
1) Mietinnen M : Vacular tumors. In : Diagnostic Soft Tissue Pathology, Churchill Livingstone, New York : 311-342, 2003.
 
2) Fletcher CD, Beham A, Bekir S, Clarke AM, Marley NJ : Epithelioid angiosarcoma of deep soft tissue. A distinctive tumor readily mistaken for an epithelial neoplasm. Am J Surg Pathol 15 : 915-924, 1991.
 
3) Weis SW, Goldbrum JR : Malignant vascular tumors. In : Enzinger band Weiss's Soft Tissue Tumors. Fifth Ed, Mosby Elsevier, Philadelphia : 703-732, 2008.
 
4) Falk H, Herbert J, Crowley S, Ishak KG, Thomas LB, Popper H, Caldwell GG : Epidemiology of hepatic angiosarcoma in the United States : 1964-1974. Environme Healt Perspectives 41 : 197-113, 1981.
 
5) Cordier J-F : Eosinophilic pneumonias. In : Schwarz MI, King, TEJr (eds). Interstitial Lung Disease, Fourth edition, BC Decker Inc, Hamilton : 657-700, 2003.
 
6) Gotlib J, Cools J, Malone JM, Schriener SL, Gilland G, Coutre SE : The FIPL-ODGFR α fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinopphilic leukemia : implication for diagnosis, classification, and managenemnt. Blood 103 : 2879-2891, 2004.
 
7) Lo Re V, 3rd, Fox KR, Ferrari VA, et al : Hypereosinophilia associated with cardiac rhabdomyosarcoma. Am J Hematol 74 : 64-67, 2003.
PubMed
8) Onishi S, Hojo N, Sakai I, et al : Secondary amyloidosis and eosinophilia in a patient with uterine leiomyosarcoma. Jpn J Clin Oncol 35 : 617-621, 2005.
 
9) Wasserman SI, Goetzl EJ, Ellman L, et al : Tumor-associated eosinophilotactic factor. N Engl J Med. 290 : 420-424, 1974.
PubMed
P.449 掲載の参考文献
1) Schonlein H : Allgemeine und Specielle Pathologie und Therapie.Vol.2. Third edition.Wurzburg, Herisau, 1837.
 
2) Henoch EH : Uber ein eigenthumliche Form von Purpura.Berl Klin Wochenschr 11 : 641-643, 1874.
 
3) Hassan F, et al : Pulmonary Lnvolvement in Henoch-Schonlein purpura.Mayo Clin Proc 79 : 1151-1157, 2004.
 
P.452 掲載の参考文献
1) Cordier JF : Cryptogenic organising pneumonia. Eur Respir J 28 : 422, 2006.
PubMed
2) Muller NL, Staples CA, Miller RR : Bronchiolitis obliterans organizing pneumonia : CT features in 14 patients. AJR Am J Roentgenol 154 : 983, 1990.
PubMed
P.456 掲載の参考文献
1) 金兼弘和, 他 : モダンメディア 56 (5) : 93-99, 2010.
 
2) Kimura : Rev Med Virol 16 (4) : 251-261, 2006.
PubMed
3) Straus : J Infect Dis 157 (3) : 405-412, 1988.
 
P.460 掲載の参考文献
1) Ando M, Arima K, Yoneda R, et al : Japanese summer-type hypersensitivity pneumonitis : geographic distribution, home environment, and clinical characteristics of 621 cases. Am Rev Respir Dis 144 : 765-769, 1991.
PubMed
2) Hendrick DJ, Faux JA, Marshall, R : Budgerigar-fancier's lung : the commonest variety of allergic alveolitis in Britain. British Medical Journal, 2 : 81-84, 1978.
PubMed
3) Fan LL : Hypersensitivity pneumonitis in children. Current Opinion in Pediatrics 14 : 323-326, 2002.
PubMed
4) Pepys J : Hypersensitivity Diseases of the Lungs due to Fungi and Organic Dusts. pp.1-147, S. Karger AG. Basel, 1969.
 
5) McSharry C, Anderson K, Boyd G : A review of antigen diversity causing lung disease among pigeon breeders. Clinical and experimental allergy 30 : 1221-1229, 2000.
 
6) 宮治誠, 西村和子 : 住まいとカビと病原性. pp 5-207, 八坂書房, 東京, 2009.
 
7) Heyder J, Gebhart J, Rudolf G, et al : Deposition of particles in the human respiratory tract in the size range 0.005-15μm. J Aerosol Sci 17 (5) : 811-825, 1986.
 
P.463 掲載の参考文献
1) Castellino RA, Blank N, Cassady JR, et al : Roentgenologic aspects of Hodgkin's disease. Cancer 31 : 316-323, 1973.
PubMed
2) Filly R, Blank N, Castellino RA : Radiographic distribution of intrathoracic disease in previously untreated patients with Hodgkin's disease and non-Hodgkin's lymphoma. Radiology 120 : 277-281, 1976.
 
3) Rosenberg SA, Diamond HD, Jaslowitz B, et al : Lymphosarcoma : a review of 1269 cases. Medicine 40 : 31-84, 1961.
PubMed
4) 中村尚生, 栗原泰之, 中島康雄, 他 : 肺のリンパ増殖性疾患. 臨床画像 16 : 798-804, 2000.
 
5) Bieliauskas S, Reyes-Trocchia A, Krasan GP, et al : Lymphoma Presenting as Multiple Cavitary Pulmonary Nodules With Associated Mediastinal Adenopathy and Neck Mass. J Pediatr Hematol Oncol 31 : 730-733, 2009.
 
P.467 掲載の参考文献
1) 新井徹 : 特発性肺血鉄症. 北村諭, 工藤翔二, 石井芳樹編. 別冊・医学のあゆみ. 呼吸器疾患 ver. 5-state of arts. 医歯薬出版, 東京 : 334-336, 2008.
 
2) Fontenot AP, Schwarz MI : Diffuse alveolar hemorrhage. In : Schwarz MI, King TE Jr. ed. Interstitial Lung Disease. 4th ed. Hamilton, Ontario : BC Decker : 634-644, 2003.
 
3) Ohga S, Takahashi K, Miyazaki S, Kato H, Ueda K : Idiopathic pulmonary haemosiderosis in Japan : 39 possible case from a survey questionnaire. Eur J Pediatr 154 : 994-995, 1995.
 
4) Ioachimescu OC, Sieber S, Kotch A : Idiopathic pulmonary haemosiderosis revisited. Eur Respir J 24 : 162-167, 2004.
PubMed
5) Saeed MM, Woo MS, Maclaughlin EF, Margetis MF, Keens TG : Prognosis in Pediatric idiopathic haemosiderosis. Chest 116 : 721-725, 1999.
PubMed
6) 村瀬公彦, 櫻井綾子, 立川良, 竹島好, 富井啓介 : びまん性肺胞出血症例の臨床的検討. 気管支学 32 : 14-21, 2010.
 
7) 新実彰男, 網谷良一, 倉澤卓也, 橋本尚子, 加藤元一, 板東憲司, 伊藤春海, 久世文幸 : 特発性肺ヘモジデローシスの2症例-CT所見を中心に-日本胸部疾患学会誌 30 : 1749-1755, 1992.
 
8) Roggli VL, Butnor KJ : Pneumoconioses. In Leslie KO, Wick MR ed. Practical Pulmonary Pathology. A Diagnostic Approach. Churchill Livingstone ; 322-324, 2005.
 
9) Akira M : Uncommon pneumoconiosis. CT and pathologic findings. Radiology 197 : 403-409, 1995.
PubMed
10) Ioachimescu OC, Stoller JK : Diffuse alveolar hemorrhage. Diagnosing it and finding the cause. Cleve Clin J Med 75 : 258-280, 2008.
PubMed
P.470 掲載の参考文献
1) Sutinen S, Reijula K, Huhti E, et al : Extrinsic allergic bronchiolo-alveolitis : serology and biopsy findings. Eur J Respir Dis 64 : 271-282, 1983.
PubMed
2) Warren CP, Tse KS : Cherniack. Mechanical properties of the lung in extrinsic allergic alveolitis. Thorax 33 : 315-321, 1978.
PubMed
3) 岩神真一郎, 椎名健二, 大和田明彦, 他 : 著明な閉塞性換気障害を示した夏型過敏性肺像炎の1例. 日呼吸会誌 36 : 1048-1052, 1998.
 
P.473 掲載の参考文献
1) Fienberg R : The protracted superficial phenomenon in pathergic (Wegener's) granulomatosis. Hum Pathol 12 (5) : 458-467, 1981.
PubMed
2) Prevalence and spectrum of rheumatic diseases associated with proteinase3 - antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase - ANCA. Rheumatology 40 (2) : 178-184, 2001.
 
3) Chen M, et al : Renal histology in Chinese patients with anti-myeloperoxidase autoantibodypositive Wegener's granulomatosis. Nephrol Dial Transplant 22 : 139-145, 2007.
PubMed
P.477 掲載の参考文献
1) Jeong YJ, Lee KS, Chung MP,et al : Amyloidosis and lymphoproliferative disease in Sjogren syndrome : thin-section computed tomography findings and histopathologic comparisons. J Comput Assist Tomogr 28 : 776-781, 2004.
PubMed
2) Kobayashi H, Matsuoka R, Kitamura S, et al : Sjogren's syndrome with multiple bullae and pulmonary nodular amyloidosis.Chest 94 : 438-440, 1988.
PubMed
3) 細野達也, 坂東政司, 鈴木恵理, 他 : 結節性肺アミロイドーシスを伴う多発性肺嚢胞を呈したシェーグレン症候群の1例. 日呼吸会誌 45 : 869-873, 2007.
Medical*Online
4) 照内聡美, 坂東政司, 弘中貢, 他 : 多発性肺嚢胞と結節性肺アミロイドーシスを伴ったSjoegren症候群の1例. 日呼吸会誌 38 : 918-922, 2000.
 
5) Bonner H Jr, Ennis RS, Geelhoed GW, et al : Lymphoid infiltration and amyloidosis of lung in Sjogren's syndrome. Arch Pathol. 95 : 42-44, 1973.
PubMed
6) Schlegel J, Kienast K, Storkel S, et al : Primary pulmonary nodular amyloidosis and multiple emphysematous bullae in Sjogren syndrome. Pneumologie 46 : 634-637, 1992.
PubMed
7) Franquet T, Diaz C, Domingo P, et al : Air trapping in primary Sjogren syndrome : correlation of expiratory CT with pulmonary function tests. J Comput Assist Tomogr 23 : 169-173, 1999.
PubMed
P.481 掲載の参考文献
1) Kradin RL, Mark EJ : Benign lymphoid disorders of the lung, with a theory regarding their development. Hum Pathol. 14 : 857-867, 1983.
PubMed
2) Susan L. Walter A, Karen R, Bijwaard E, et al : Nodular Lymphoid Hyperplasia of the Lung A Clinicopathologic Study of 14 Cases. Am J Surg Patho 24 : 587-597, 2000.
 
3) Miyoshi S, Hamada H, Katayama H, Higaki J, et al : A case of pulmonary nodular lymphoid hyperplasia with a resected cavity followed by spontaneous regression of the remaining lesions. Intern Med 49 : 1617-1621, 2010.
PubMed
P.485 掲載の参考文献
1) 竹崎彰夫, 新井徹, 西山明秀, 他 : 日呼吸会誌 49 : 890-896, 2011.
Medical*Online
2) Kane RD, Hawkins HK, Miller JA, et al : Microscopic pulmonary tumor emboli associated with dyspnea. Cancer 36 : 1473-1482, 1975.
PubMed
3) Winterbauer RH, Elfenbein IB, Ball WC Jr : Incidence and clinical significance of tumor embolization to the lung. Am J Med 45 : 271-290, 1968.
 
4) von Herbay A, Illes A, Waldherr R, et al : Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer 66 : 587-592, 1990.
PubMed
5) 石黒卓, 高柳昇, 安藤正志, 他 : 化学療法が有効であったPulmonary tumor thrombotic microangiopathyの1例. 日呼吸会誌 49 : 681-687, 2011.
Medical*Online
6) Kinuya K, Yamanouchi K, Terahata S : Diagnosis : pulmonary tumor thrombotic microangiopathy developing cor pulmonale. Ann Nucl Med 16 : 220, 2002.
PubMed
7) 宇留賀公紀, 黒崎敦子, 藤井丈士, 他 : Pulomnary tumor thrombotic microangiopathy (PTTM) の臨床像, 画像よび病理学的特徴. 臨床放射線 54 : 27-32, 2009.
 
8) 加賀田豊, 中西邦昭, 尾関雄一, 他 : Pulmonary Tumor Thrombotic Microangiopathyの免疫組織学的検討 TF, FGFとVEGFの役割. 脈管学 43 : 679-684, 2003.
 
9) 鈴木学, 木田恵子, 伊藤永喜, 他 : 急速な経過をたどったpulmonary tumor thrombotic microangiopathyの1剖検例. 日呼吸会誌 45 : 560-565, 2007.
 
10) 野口真吾, 今永知俊, 清水真喜子, 他 : 経気管支肺生検にて診断しえたpulmonary tumor thrombotic microangiopathyの1例. 日呼吸会誌 46 : 493-496, 2008.
Medical*Online
11) 宇留賀公紀, 諸川納早, 榎本崇宏, 他 : CTガイド下肺生検にて診断しえたpulmonary tumor thrombotic microangiopathy を伴った原発性肺腺癌の1例. 日呼吸会誌 46 : 928-933, 2008.
Medical*Online
12) Masson RG, Ruggieri J : Pulmonary microvascular cytology. Chest 88 : 908-914, 1985.
PubMed
P.489 掲載の参考文献
1) Filly R, Blank N, Castellino RA : Radiographic distribution of intrathoracic disease in previously untreated patients with Hodgkin's disease and non-Hodgkin's lymphoma. Radiology 120 : 277-281, 1976.
 
2) Tredaniel J, Peillon I, Ferme C, et al : Endobronchial presentation of Hodgkin's disease : a report of nine cases and review of the literature. Eur Respir J 7 : 1852-1855, 1994.
PubMed
3) Kiani B, Magro CM, Ross P : Endobronchial presentation of Hodgkin lymphoma : a review of the literature. Ann Thorac Surg 76 : 967-972, 2003.
PubMed
4) Yousem SA, Weiss LM, Colby TV : Primary pulmonary Hodgkin's disease. A clinicopathologic study of 15 cases. Cancer 57 : 1217-1224, 1986.
PubMed
5) 安東優, 伊東猛雄, 横山敦, 他 : 非乾酪性類上皮肉芽腫を伴ったホジキンリンパ腫の1例. 日サ会誌 27 : 75-79, 2007.
 
6) Brincker H : Sarcoid reactions in malignant tumours. Cancer Treat Rev 13 : 147-156, 1986.
PubMed
P.493 掲載の参考文献
1) Castleman B, Towne VW : Case records of the Massachusetts General Hospital ; weekly clinicopathological exercises ; founded by Richard C. Cabot. N Engl J Med 251 : 396-400, 1954.
 
2) Sato Y, Kojima M, Takata K, Morito T, Mizobuchi K, Tanaka T, Inoue D, Shiomi H, Iwao H, Yoshino T : Multicentric Castleman's disease with abundant IgG4-positive cells : a clinical and pathological analysis of six cases. J Clin Pathol 63 : 1084-1089, 2010.
 
P.496 掲載の参考文献
1) Spencer H, Hasleton PS : Spencer's Pathology of the Lung. 5th ed, McGraw-Hill 776-783, 1996.
 
2) Crosvie WA, et al : Pulmonary amyloidosis with impaired gas transfer. Thorax 27 : 625, 1972.
 
P.500 掲載の参考文献
1) Hamano H, Kawa S, Horiuchi A, et al : High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344 : 732-738, 2001.
PubMed
2) Zen Y, Kitagawa S, Minato H, et al : IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol 36 : 710-717, 2005.
PubMed
3) ZenY, Fujii T, Harada K, et al : Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 45 : 1538-1546, 2007.
 
4) Shrestha B, Sekiguchi H, Colby TV, et al : Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis : report of 6 and 12 cases with similar histopathology. Am J Surg Pathol 33 : 1450-1462, 2009.
PubMed
P.503 掲載の参考文献
1) Hamano H, Kawa S, Horiuchi A, et al : High serum IgG4 concentration in patients with sclerosing pancreatitis. N Engl J Med 344 : 732-738, 2001.
PubMed
2) Kamisawa T, Funata N, Hayashi Y et al : A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 38 : 982-984, 2003.
PubMed
3) Taniguchi T, et al : Interstitial pneumonia associated with autoimmune pancreatitis. Gut 53 : 770-771, 2004.
PubMed
4) Duvic C, et al : Retroperitoneal fibrosis, sclerosing pancreatitis and bronchiolitis obliterans with organizing pneumonia. Nephrol Dial. Transplant 19 : 2397-2399, 2004.
 
5) Kamisawa T and Okamoto A : Autoimmunepancreatitis : proposal of IgG4-related sclerosing disease. J Gastroenterol 41 : 613-625, 2006.
 
6) Hilar lymphadenopathy associated with autoimmune pancreatitis. Pancreas 33 : 101-102, 2006.
PubMed
7) Zen Y, et al : IgG4-related Lung and Pleural Disease : A Clinicopathologic Study of 21 Cases. Am J Surg Pathol 33 : 1886-1893, 2009.
PubMed
P.509 掲載の参考文献
1) Williams KM, Chien JW, Gladwin MT, et al : Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation. JAMA, July 15 Vol 302 (3) : 306-314, 2009.
 
2) Ueda K, Watadani T, Maeda E, et al : Outcome and treatment of late-onset noninfectious pulmonary complications after allogeneic haematopoietic SCT. Bone Marrow Transplantation 45 : 1719-1727, 2010.
PubMed
3) Filipovich AH, Weisdorf D, Pavletic S, et al : National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease, I : diagnosis and staging working group report. Biol Blood Marrow Transplant. 11 (12) : 945-956, 2005.
 
4) Chien JW, Martin PJ, Gooley TA, et al : Airflow Obstruction after Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation. Am J Respir Crit Care Med ; 168 (2) : 208-214, 2003.
PubMed
5) 伊達洋至 : 肺移植と閉塞性細気管支炎. 医学のあゆみ. 232 (4) : 253-256, 2010.
Medical*Online
P.512 掲載の参考文献
1) Troyanov Y, TargoffIN, Tremblay JL, et al : Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies : analysis of 100 French Canadian patients. Medicine (Baltimore) 84 : 231-249, 2005.
PubMed
2) TargoffIN, Mamyrova G, Trieu EP, et al : A novel autoantibody to a 155-kD protein is associated with dermatomyositis. Arthritis Rheum 54 : 3682-3689, 2006.
PubMed
3) Kaji K, Fujimoto M, Hasegawa M, et al : Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis : an association with malignancy. Rheumatology (Oxford) 46 : 25-28, 2007.
PubMed
P.515 掲載の参考文献
1) Nappee J,Bobrie, Lambard D : Pneumoconiose au cerium. Arch Mal. Prof 33 : 13-18, 1972.
PubMed
2) Husain MH, Dick JA, Kaplan YS : Rare earth pneumoconiosis. J. Soc. Occup. Med 30 : 15-19, 1980.
PubMed
3) Heuck F, Hoschek R : Cer pneumoconiosis. AJR 104 : 777-783, 1968.
 
4) Vacaturo G,Colombo F, Zanoni M, et al : Human Exposure to Heavy Metals. Rare Earth Pneuhmoconiosis in Occupational Workers. Chest 83 : 780-783, 1983.
 
5) Sulotto F, Romano C, Berra A, et al : Rare earth pneumoconiosis : A new case. Am J Industr Med 9 : 567-575, 1986.
 
6) 村田嘉彦, 佐藤信英, 倉島篤行, 他 : アーク灯を使用した印刷工にみられた希土類による塵肺症の2例. 日胸疾会誌 23 (6) : 699-698, 1985.
 
7) 玉虫文一, 他編 : 希土類元素. 生化学辞典, 第3版, 岩波書店 : p.300, 1981.
 
8) Parkes WR : The Rare Earth metase or Lantanides.in : Occupational Lung Disorders 2nd edition. Bufferworths 125, 1982.
 
P.520 掲載の参考文献
1) Katzenstein LA, Mukhopadhyay S, Zanardi C, et al : Clinically occult interstitial fibrosis in smokers : classification and significance of a surprisingly common finding in lobectomy specimens. Human Pathology 41 : 316-325, 2010.
 
2) Snider GL, Kleinerman J, Thurlbeck WM, Bengali ZH : The definition of emphysema. Am Rev Respir Dos 132 : 182-185, 1985.
 
3) Thurlbeck WM, Mueller NL : Emphysema : Definition, imaging, and quantification. AJR 163 : 1017-1025, 1994.
 
4) American Thoracic Society. Cigaretts smoking and health. Am J Respirat Crit Care Med 153 : 861-865, 1996.
 
5) Ryu JH, Colby TV, Hartman TE, Vassallo RV : Smoking-related interstitial lung disease : a concise review. Eur Respir J 17 : 122-132, 2001.
 
6) Auerbach O, Garfinkel L, Hammond EC : Relation of smoking and age to findings in lung parenchyma : a microscopic study. Chest 64 : 29-35, 1974.
 
7) Fraig M, Sheesha U, Savici D, et al : Respiratory bronchiolitis : a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Sur Pathol 26 : 647-653, 2002.
 
8) Yousem SA : Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia : a proposal. Mod Pathol 19 : 1474-1479, 2006.
 
9) Kawabata Y, Hoshi E, Murai K, et al : Smoking-related changes in the background lung of specimens respected for lung cancer : a semiquantitative study with correlation to postoperative course. Histopathology 53 : 707-714, 2008.
 
P.525 掲載の参考文献
1) Farver CF, Dail DH : Endogenous Mineralization, Inclusions, and Deposition Disorders. In : Tomashefski, JR. JF, Cagle PT, Farver CF et al. Dail and Hammar's Pulmonary Pathology Volume I Nonneoplastic Lung Disease Third ed. New York Springer : 781-783, 2008.
 
2) Katzenstein AA : Miscellaneous Nonspecific Inflammatory and Destructive Diseases. In : Katzenstein AA. Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease 4th ed. Philadelphia SAUNDERS ELSEVIER : 466-467, 2006.
 
3) Travis WD, Colby TV, Koss MN, et al : Miscellaneous Diseases of Uncertain Etiology. In : Travis WD, Colby TV, Koss MN, et al. Non-Neoplastic Disorders of the Lower Respiratory Tract. Washington, DC American Registry of Pthology : 885-887, 2002.
 
4) Popelka CG, Kleinerman J : Diffuse Pulmonary Ossification. Arch Intern Med 137 : 523-525, 1977.
PubMed
5) Kanne JP, Godwin JD, Takasugi JE, et al : Diffuse pulmonary ossification. J Thorac Imaging 19 : 98-102, 2004.
 
6) Fraser RS, Muller NL, Neil Colman, et al : Metabolic Pulmonary Disease. In : Fraser RS, Muller NL, Neil Colman et al. Fraser and Pare's Diagnosis of Disease of the CHEST Fourth Edition. Philadelphia : W.B. SAUNDERS COMPANY : 2700, 1999.
 
7) Joines RW, Roggli VL : Dendriform Pulmonary Ossification. Am J Clin Pathol 91 : 398-402, 1989.
PubMed
8) Kawakami Y, Abe S, Nishimura M, et al : Diffuse Pulmonary Ossification Associated with Chronic Bronchitis. Jpn J Med 26 : 409-412, 1987.
PubMed
9) Chan ED, Morales DV, Welsh CH, et al : Calcium Deposition with or without Bone Formation in the Lung. Am J Respir Crit Care Med 165 : 1654-1669, 2002.
PubMed
10) 河端美則, 渡辺哲 : 血管型Ehlers-Danlos症候群に見られる胸膜肺病変の病理. 日胸 70 : 345-356, 2011.
Medical*Online
P.529 掲載の参考文献
1) Homma T, Ueno T, Sekizawa K, et al : Interstitial pneumonia developed in a worker dealing with particles containing indium-tin oxide. J Occup Health 45 : 137-139, 2003.
 
2) Chonan T, Taguchi O, Omae K : Interstitial pulmonary disorders in indium -processing workers. Eur Respir J 29 : 317-324, 2007.
PubMed
3) Cummings KJ, Donat WE, Ettensohn DB, et al : Pulmonary alveolar proteinosis in workers at an indium processing facility. Am J Respir Crit Care Med 181 : 458-464, 2009.
PubMed
4) Nagano K, Nishizawa T, Eitaki Y, et al : Pulmonary toxicity in mice by 2- and 13-week inhalation exposures to indium-tin oxide and indium oxide aerosols. J Occup Health 53 : 234-239, 2011.
PubMed
P.532 掲載の参考文献
1) Ito I, et al : Pulmonary manifestations of primary Sjogren's syndrome : a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171 : 632-638, 2005.
PubMed
2) Parambil JG, et al : Interstitial lung disease in primary Sjogren's syndrome. Chest 130 : 1489-1495, 2006.
PubMed
3) Hayakawa H, et al : Diffuse panbronchiolitis and rheumatoid arthritis-associated bronchiolar disease : similarities and differences. Intern Med 37 : 504-508, 1998.
PubMed
4) Sugiyama Y, et al : Diffuse panbronchiolitis and rheumatoid arthritis : a possible correlation with HLA-B54. Intern Med 37 : 504-508, 1998.
 
P.535 掲載の参考文献
1) Lofgren S : Primary pulmonary sarcoidosis. I. Early signs and symptoms. Acta Med Scand 145 : 424-431, 1953.
PubMed
2) Sato T, Tsuru T, Hagiwara K, et al. : Sarcoidosis with acute recurrent polyarthritis and hypercalcemia. Intern Med 45 : 363, 2006.
PubMed
3) Ohta H, Tazawa R, Nakamura A, et al : Acute-onset sarcoidosis with erythema nodosum and polyarthralgia (Lofgren's syndrome) in Japan : a case report and a review of the literature. Intern Med 45 : 659-662, 2006.
 
4) Suzuki E, Kanno T, Ohira H : Acute-onset sarcoidosis with polyarthralgia and hilar lymphadenopathy. Mod Rheumatol 20 : 188-192, 2010.
PubMed
5) Caplan HI, Katz WA, Rubenstein M : Periarticular inflammation, bilateral hilar adenopathy and a sarcoid reaction. Arthritis Care Res 13 : 101-111, 1970.
 
6) Grunewald J, Eklund A : Sex-specific manifestations of Lofgren's syndrome. Am J Respir Crit Care Med 175 : 40-44, 2007.
 
7) Hedfors E, Lindstrom F : HLA-B8/DR3 in sarcoidosis. Correlation to acute onset disease with arthritis. Tissue Antigens 22 : 200-203, 1983.
PubMed
P.538 掲載の参考文献
1) Primack SL, et al : CT findings in 61 patients. Radiology 189 : 681-686, 1993.
PubMed
2) Brauner MW, et al : Pulmonary sarcoidosis : evaluation with high-resolution CT. Radiology 172 : 467-471, 1989.
PubMed
3) Nobata K, et al : Pulmonary sarcoidosis with usual interstitial pneumonia distributed predominantly in the lower lung fields. Intern Med 45 : 359-362, 2006.
PubMed
4) Fraser RS, et al : Fraser and Pare's Diagnosis of Diseases of the Chest. 4th ed. W.B. Saunders, Philadelphia : 1533-1583, 1999.
 
5) Padley SP, et al : Pulmonary sarcoidosis mimicking cryptogenic fibrosing alveolitis on CT. Clin Radiol 51 : 807-810, 1996.
 
6) Tachibana K, et al : A case of sarcoidosis and usual interstitial pneumonia. Intem Med, in press.
 
P.542 掲載の参考文献
1) Constantopoulos SH, Papadimitriou CS, Moutsopoulos HM : Respiratory manifestations in primary Sjogren's syndrome. A clinical, functional, and histologic study. Chest 88 : 226e9, 1985.
PubMed
2) Lahdensuo A, Korpela M : Pulmonary findings in patients with primary Sjogren's syndrome. Chest 108 : 316e9, 1995.
PubMed
3) Yousem SA, Colby TV, Carrington CB : Follicular bronchiolitis/-bronchitis. Hum Patho 116 : 700e6, 1985.
 
4) Wells AU, du Bois RM : Bronchiolitis in association with connective tissue disorders. Clin Chest Med 14 : 655e66, 1993.
PubMed
5) Aerni MR, Vassallo R, Myers JL, Lindell RM, Ryu JH : Follicular bronchiolitis in surgical lung biopsies : clinical implications in 12 patients. Respir Med 102 : 307e12, 2008.
PubMed
6) Masanori Nakanishi, Junya Fukuoka, Tomonori Tanaka, Yoshiki DEmura, Yukihiro Umeda, Shingo Ameshima, Satoshi Nishikawa, Masanori Kitaichi, Harumi Itoh, Takeshi Ishizaki. Small airway disease associated with Sjogren's syndrome : Clinico-pathological correlation. Respiratory Medicine 105 : 1931-1938, 2011.
PubMed
7) Papiris SA, Maniati M, Constantopoulos SH, Roussos C, Moutsopoulos HM, Skopouli FN : Lung involvement in primary Sjo gren's syndrome is mainly related to the small airway disease. Ann Rheum Dis 58 : 61e4, 1999.
 
8) Arakawa H, Webb WR : Air trapping on expiratory highresolution CT scans in the absence of inspiratory scan abnormalities : correlation with pulmonary function tests and differential diagnosis. AJR 170 : 1349e53, 1998.
PubMed
9) Potena A, Corte RL, Fabbri LM, Papi A, Trotta F, Ciaccia A : Increased bronchial responsiveness in primary and secondary Sjogren's syndrome. Eur Respir J 3 : 548e53, 1990.
 
10) Borie R, Schneider S, Debray M-P, Adle-Biasssette H, Danel C, Bergeron A, et al : Severe chronic bronchiolitis as the presenting feature of primary Sjogren's syndrome. Respir Med 105 : 130e6, 2011.
 
11) Haris SR, Mark EJ : Case records of the Massachusetts general hospital. Weekly clinicopathological exercises : case 17-2001 : a 42-year-old man with multiple pulmonary cysts and recurrent respiratory infections. N Engl L Med 344 : 1701e8, 2001.
 

書評

最近チェックした商品履歴

Loading...